10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-K

———————

þ  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: June 30, 2014

or

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from: _____________ to _____________

GelTech Solutions, Inc.

(Exact name of registrant as specified in its charter)

Delaware	0-52993	56-2600575
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation or Organization)	File Number)	Identification No.)

Address of Principal Executive Office: 1460 Park Lane South, Suite 1, Jupiter, Florida  33458

Registrant’s telephone number, including area code: (561) 427-6144

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001, par value

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  ¨ Yes   þ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   ¨ Yes   þ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  þ Yes     ¨ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   þ Yes   ¨ No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  þ

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ¨   þ No

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter was approximately $13.7 million based on December 31, 2013 closing price of $0.70 per share.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.  42,264,310 shares outstanding as of September 26, 2014.

INDEX

		PAGE
	PART I
Item 1.	Business.	1
Item 1A.	Risk Factors.	12
Item 1B.	Unresolved Staff Comments.	12
Item 2.	Properties.	12
Item 3.	Legal Proceedings.	13
Item 4.	Mine Safety Disclosures.	13
	PART II
Item 5.	Market for Registrant’s Common Equity and Related Shareholder Matters and Issuer Purchases of Equity Securities.	14
Item 6.	Selected Financial Data.	14
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	15
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk.	27
Item 8.	Financial Statements and Supplementary Data.	27
Item 9.	Changes In and Disagreements With Accountants on Accounting and Financial Disclosure.	27
Item 9A.	Controls and Procedures.	27
Item 9B.	Other Information.	28
	PART III
Item 10.	Directors, Executive Officers and Corporate Governance.	29
Item 11.	Executive Compensation.	32
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.	35
Item 13.	Certain Relationships and Related Transactions, and Director Independence.	36
Item 14.	Principal Accountants Fees and Services.	38
	PART IV
Item 15.	Exhibits, Financial Statement Schedules.	39

SIGNATURES 41

PART I

ITEM 1. BUSINESS

GelTech is a Delaware corporation organized in 2006. Our current business model is focused on the following environmentally friendly products:

●

FireIce® – a fire suppression and fire retardant product,

●

Emergency Manhole FireIce Delivery System, or EMFIDS – a system which immediately delivers a stream of FireIce® on the ladder and on the utility worker when there is a fire or explosion in the manhole,

●

Soil₂O®– “Dust Control” – a dust control product we introduced in fiscal 2011, which is effective at controlling airborne particulate matter while substantially reducing water usage, and

●

Soil₂O® – a line of agricultural moisture retention products.

FireIce®

Industry Overview

The fire suppression market in the United States is currently estimated at about $888 million and is estimated to exceed $1 billion by 2016 according to the most recent IHS, Inc. report released in November 2012.  Until 1989, halon was a popular fire suppressant because it could be used to protect highly valued assets that would be damaged by traditional water sprinkler systems.  However, in 1989 the Montreal Protocol determined that halon depleted the ozone layer, and in 1994, the United States Environmental Protection Agency banned its production.  Since then, the lack of availability of halon fire suppressants has sparked worldwide efforts in developing alternative firefighting agents and delivery systems. In November 2010, the United Nations Environment Programme adopted a resolution urging states to intensify development of acceptable halon alternatives for fire extinguishing systems used in aircraft and hand-held fire extinguishers.  The following year, the International Civil Aviation Organization agreed to phase out the use of halon in hand-held fire extinguishers on aircraft by 2016.

Our fire suppression business has two marketing thrusts:

●

suppression of structural and other fires within cities and towns, including manhole and utility pole fires, and

●

suppression of wildland fires managed by federal and state land stewardship agencies.

According to the National Fire Protection Association, in 2013 there were 1,240,000 fires in the United States that caused approximately $11.5 billion in damage. In 2013, there were 25,097 structural fires in New York where the fire department budget has an operating budget for fiscal year 2014 of $1.7 billion. The United States Forest Service, or the Forest Service, and the Department of the Interior are responsible for protecting most federal lands from wildfires. For fiscal year 2014, approximately $3.4 billion has been appropriated to the Forest Service and the Department of the Interior for the purpose of protecting federal lands from wildfires, which includes approximately $396 million to be used in the suppression of wildfires.  California has experienced over 4,600 fires involving over 85,000 acres thus far in 2014.

Our Fire-Suppression Products

FireIce® is the registered trade name of our fire suppression product. FireIce® is a dry powder that when added to water in very low concentrations (0.07 to 1.2 percent by weight), rapidly absorbs water to produce a gel whose consistency depends on the selected concentration. The dry powder can be easily mixed with water. Within seconds of being mixed with water, FireIce® is ready to use and turns into a fire preventing, heat absorbing and fire suppressing gel. In many applications the gel forms a cohesive layer which acts as a vapor barrier and prolongs the effectiveness of the water. Due to the gel layer created by FireIce® on burning and adjacent objects, FireIce® also has the ability to suffocate a fire.  

1

FireIce® has the following properties. We believe it:

●

is non-toxic,

●

is environmentally safe,

●

is non-corrosive to metals,

●

mixes easily with water,

●

when mixed with water, will not clog or stick in spraying devices,

●

reduces the threat of a fire rekindling,

●       has superior vertical adhesion ability for structure / exposure protection

●

extinguishes fires more rapidly than traditional methods, and

●

is lighter when mixed with water than competing products thus reducing airframe stress in aerial applications

FireIce is also offered in several colored variations, designed for visibility in air tanker applications.  Two of the colorants, a Fugitive Orange (Sunset Orange) and a Fugitive Blue (Cool Blue) were approved by the USFS Qualified Product List in 1Q2014.  The colored products are designed specifically for wildland applications, and compete with existing long term retardant products that are on the market.

In addition to selling FireIce® by itself, we have developed two products which use FireIce®: (i) EMFIDS and (ii) FireIce® Home Defense Unit.  In fiscal 2014, we also began selling a FireIce® Utility Fire Extinguisher to utility companies for use on utility pole fires and other field applications.  We envision these extinguishers will provide utility companies with an introduction to FireIce® which will lead them to incorporate FireIce® into other areas of their operations.

Since January 2009, our senior management has focused on marketing FireIce® to Consolidated Edison, or Con Ed, to develop a preferred solution in combating manhole and utility pole fires.   This led to the recent development of the EMFIDS which is an innovative system designed to deliver a mixture of FireIce® and water into a manhole. This stream of FireIce® and water is intended to coat the ladder and the utility worker in the event of an incident involving an explosion or fire in the manhole while utility workers are performing routine repairs or maintenance.  The unit has been designed by GelTech to be quickly set up and disassembled by utility crews. EMFIDS delivers FireIce® from 12 custom designed strategically located spray nozzles, six on the ladder itself and six on a halo that fits into the opening of the manhole.  The FireIce® and water mixture is contained in a pressurized tank which is mounted to the utility company’s vehicle and is connected to the unit by one hose; that connects to both the ladder and the halo.  EMFIDS can be activated three ways (1) manually by pressing an activation button on the control panel located in the maintenance vehicle, (2) automatically by a heat sensor located on the halo and (3) manually by pressing an activation button located on the ladder.  Once activated, the system is designed to deliver FireIce® continuously for at least one minute.  The main purpose of EMFIDS is to maintain the integrity of the ladder in the manhole and to coat the utility worker with FireIce®, providing the worker the opportunity to escape the manhole thereby improving the worker’s chance for survival.  Each time a unit is activated, GelTech will require that the unit be returned to a nearby GelTech facility to be cleaned, inspected, recharged and refilled with FireIce® prior to being redeployed in the field.

The Home Defense Unit previously sold in three versions (i) an industrial version which includes a pressure cleaner, a patented wand assembly and FireIce® powder; (ii) a smaller version for homeowners which consists of a smaller pressure cleaner, a patented wand assembly and FireIce® powder; and (iii) the patented wand assembly and FireIce® powder for those homeowners who have pressure cleaners.  Beginning in fiscal 2014, we discontinued sales of pressure cleaners and have limited sales to our patented wand assembly and FireIce® powder which we refer to as the “HDU Wand Kit”.

2

Uses

There are many existing and potential uses for FireIce®. Because it is both a fire suppressant and a medium term fire retardant, FireIce® allows greater flexibility in attacking fires as follows:

●

FireIce® can be sprayed directly on manhole and utility pole fires with our innovative eductor nozzle gun.

●

FireIce® can be dispensed via EMFIDS on the ladder and utility worker during an emergency that occurs while workers are performing repairs or routine maintenance.

●

FireIce® can be applied directly to buildings and other structures as a retardant to protect them from advancing fires.

●

FireIce® can be used in most common wildland and urban firefighting equipment with little or no modification and can be used in direct fire suppression and in structure protection. This includes pressurized water extinguishers, pumper and brush trucks, roll-on or skid units, fixed tanker aircraft and helicopters, backpack extinguishers, or even hand held spray bottles.

●

FireIce® can also be rapidly sprayed on foliage to create a firebreak and prevent the spread of fires.

●

The advantage of using FireIce® in airtankers include a consistent drop pattern, controlled drift, excellent adhesion to canopy and penetration, superior visibility and improved performance as a fire line and direct attack suppressant.

The National Interagency Fire Center reported that in 2014, $1.7 billion was spent by federal agencies to suppress 47,579 wildfires involving 4.3 million acres in the U.S.

Fires are not only a major problem in the United States. In August 2010, Russia suffered immense forest fires causing more than 60 casualties, destroying one third of all crops, and resulting in a nationwide ban on grain exports by the world’s third largest wheat producer. The total damages were estimated to be up to $15 billion to the Russian economy (or one percent of Russia’s Gross Domestic Product).  By July 2012, more than 30 wildfires were blazing in eastern Russia, causing damage to more land than all of the wildfires of 2010.  Due to extreme heat, Australia also faced widespread wildfires in 2012 and 2013.  From September 2012 through January 2013, Australia was battling over 141 wildfires burning through more than 324,000 acres of forest and farmland.  FireIce® can play a major role in extinguishing and containing wildland fires, including forest fires, by being sprayed from airplanes directly over such fires, including in areas too dangerous for ground-based firefighters to enter. FireIce® can also be sprayed from tanker trucks on the edges of these fires.

FireIce® also has a number of potential retail and consumer uses:

●

It can be sprayed out of fire extinguishers.

●

It can be used in a spray bottle by professionals, such as welders, who work with blowtorches.

Sales and Marketing

We market and sell FireIce® through fire equipment distributors, online and direct marketing, attendance at fire industry national trade shows and through our sales staff members who call on potential customers and respond to inquiries.

3

Because of the wildfires which threaten the United States each year, we recognized the potential for FireIce® and the tremendous marketplace for aerial firefighting in conjunction with the Forest Service. GelTech was notified by the Forest Service in March 2011 that FireIce® would be listed on the Forest Service’s Qualified Products List, or the QPL List. Inclusion on the QPL List qualifies our product for use to fight brush and wildfires on State and Federal lands. In May 2012, we were one of two companies awarded blanket purchase agreements by the Forest Service to provide FireIce® product and services in support of single engine air tankers (SEATS), helicopters and very large air tankers (VLATS) in aerial wildland firefighting operations and also for wildland firefighting ground operations. While these agreements do not require the Forest Service or other governmental agencies to use our product or services, the agreements establish the pricing and terms in the event any of these agencies deploy our equipment and product to fight wildfires. This blanket purchase agreement was renewed in May 2014.

Since we received these agreements, we have been deployed by the Bureau of Indian Affairs on wildfires in New Mexico and have been used on a limited basis by the Forest Service to fight fires in Washington. Under the terms of our approval by the Forest Service, FireIce® may be deployed for use on wildfires except in fixed-tank helicopters and multi-engine planes.

In addition, during fiscal 2014 FireIce® was used by state agencies to suppress wildfires in five states in the United States and was used by provincial agencies in two provinces in Canada. Product demonstrations, evaluations and pilot programs are scheduled with state agencies in three additional states and with a federal agency in the fall of 2014.  Despite this progress to date, the Company has not generated material revenue from the application of FireIce® for wildland firefighting.

To date, the sales of the Home Defense Unit have not been material. We expect to support the Home Defense Unit by continuing to market it in California and in other western states where homes are threatened by wildfires. These efforts will be limited to the marketing of our patented HDU Wand Unit and may include local advertising where appropriate and recruiting local distributors. We currently have one distributor in each of Colorado, Montana, Nevada and Southern California.

In July 2013, we received a substantial purchase order from Con Ed for the EMFIDS.  Earlier in 2013, we opened a facility in Brooklyn, New York to support the initial training of fire department and Con Ed personnel in the proper use of FireIce® to combat manhole fires.  Our lease for this facility expired in August 2014 and was not renewed.

We are currently marketing the use of the EMFIDS to other utility companies throughout the United States.

In addition to domestic sales, we have also devoted efforts to sell FireIce® internationally. We believe the international market may provide us an important opportunity.

In November 2011, we entered into an exclusive distribution agreement for Australia. Our distributor, which has operations in 38 countries and generates annual revenues of €2 billion, is required to make minimum annual purchases in order to retain its exclusive status. To date, our Australian distributor has not met their minimum purchase commitments. In March 2012, GelTech entered into a five year exclusive distribution agreement for Turkey. In order to maintain exclusivity, the distributor has agreed to minimum annual purchases totaling $925,000 over the next five years. Initially, our Turkish distributor is required to make minimum purchases of $175,000 through 2013. To date, the Turkish distributor has made product purchases totaling $88,000.

In addition to the distributor agreements in the countries noted above, we have demonstrated our product in Russia and Brazil. These countries are covered by an exclusive agreement with a company in which one owner is a former officer and director of GelTech.  In March 2013, we notified the company that we were terminating the agreement, however we received notification from an attorney representing the distributor that they do not believe our termination was in accordance with the terms of the agreement, although no suit has been filed by the distributor to date. Our relationship with the former officer and director is not good.  See the lawsuit we filed against him in “Item 3 – Legal Proceedings.”  We are currently in dialogue with this former officer to determine if we can reach a settlement.

In our international sales program, we require payment in advance of shipment through irrevocable letters of credit. We also require payment in United States dollars to eliminate the risk of currency fluctuation.

4

During the year ended June 30, 2014, sales of FireIce® and its related products accounted for 80.8% of our revenues.

Raw Materials and Suppliers

The raw materials for FireIce® are in abundant supply. The base ingredients of FireIce® are manufactured by a third party and packaging is performed for us by two other third parties. However, there are also several other companies that are able to manufacture the base ingredients. In addition, there are numerous sources for the parts needed to manufacture the EMFIDS.

Competition

The fire suppression market is highly competitive. However, we believe we will be able to compete effectively because:

●

FireIce® is more effective than other fire suppressants.

●

The price per gallon of FireIce® is significantly less than our competitors’ products.

●

The effectiveness of FireIce® to rapidly extinguish and deter rekindling, allows fire departments to put out fires faster which save manpower and overtime costs associated with spending extra time on a fire scene.

●

Once a fire has been extinguished, any dispensing system used to apply FireIce® can be easily cleaned with water from a garden hose.

●

Currently, FireIce® is the only water enhancing gel that can be easily mixed and applied to fires as a suppressant.

●

When mixed with water, FireIce® weighs less than other fire retardants/suppressants currently being used thus reducing stress on aircraft airframes and improving pilot safety  

●

FireIce® is different from foam. Foam consists of air bubbles in water and a small amount of surfactant. When the bubbles burst, the foam collapses. When mixed with FireIce®, water is held by a three-dimensional network of cross-linked polymers. When FireIce® is applied to the fire, the water evaporates and the liquid collapses, sapping the fire of not only heat but oxygen as well. It takes longer for water to evaporate from our polymer than for air bubbles to burst. We believe this is how FireIce® provides more efficient protection and lasts longer than foam.

In the wildland firefighting industry, the market is made up of the numerous state and federal agencies responsible for protecting state and federal wildlands and parks. The market leader in the wildland chemicals industry is Phoschek. Because of the strong relationships Phoschek has with these agencies, many dating back to the 1960’s, and the natural resistance to change, which can be even greater in the government sector, we have encountered significant resistance as we attempt to gain market share. Nonetheless, we believe that FireIce® has distinct advantages over Phoschek’s products in aerial attack and ground operations. FireIce® is significantly less expensive to purchase and operate, more effective at suppressing fires, is non-corrosive to aircraft parts, is lighter than current Phoschek products thus reducing airframe stress and maximum load issues, is not harmful to plant fish and wildlife and has superior drop characteristics... Phoschek is classified by the US Forest Service as a long-term retardant, but current tactics include using it in direct attack. FireIce® classified by the US Forest Service as water enhancer and has been effectively used by multiple agencies in “direct attack” and as medium-term retardant is used in “indirect attack”.  Direct attack is when the product is dropped directly on the edge of a fire. Indirect attack is when the product is used to create a fire break in front of the fire. Some long-term retardant gels take time to dry and cure in order to create a fire break. FireIce® is ready immediately to be used on fires. Based on these factors and our successes with the state and federal agencies that have used FireIce®, we believe we will eventually overcome the competitive barriers.

5

Another significant competitor is Tyco Fire & Security, a major business segment of publicly-traded Tyco International Ltd. (NYSE: TYC). Tyco Fire & Security produces ANSUL®, a premium brand of special hazard fire protection products including fire extinguishers and hand line units, pre-engineered restaurant, vehicle, and industrial systems; sophisticated fire detection/suppression systems and a complete line of dry chemical, foam, and gaseous extinguishing agents. Tyco Fire & Security is a very well-funded company and has significantly more financial, marketing and sales resources than us. Ansul’s main sales thrust is the installation of “in building” fire suppression systems, but they manufacture a wide variety of products. They also have a very extensive distributor list and have a significant share of the market that we are attempting to enter.

National Foam, part of the Kidde Fire Fighting organization, is a manufacturer of foam concentrate, foam proportioning systems, fixed and portable foam firefighting equipment, monitors, nozzles and specialized big flow pumping solutions. National Foam has historically been at the forefront of foam firefighting and fire control technology and is the acknowledged world leader in providing foam based solutions. Other brands associated with National Foam include: Feecon, offering airport crash rescue and general mobile firefighting equipment and Wirt Knox, offering a range of hose racks, reels, carts and general hose storage accessories. National Foam has significant financial resources and is part of a large firefighting company conglomerate. Thus, it has significantly more financial, marketing and sales resources than we do.

Thermo-Gel® provides the firefighting industry with a product that can be used for structure protection, exposure protection, defensible perimeters and wet lines. This product consists of superabsorbent polymers-polyacrylamide and sodium polyacrylate, mineral oil, and surfactants, and is supplied as a liquid concentrate which is mixed in an eductor. It does require special expensive equipment to use. Thermo-Gel is used in fighting active fires, wildland fires, prescribed burns, aviation applications, and in the protection of all types of structures from homes to commercial and industrial investments. This product has been approved by the Forest Service. In addition to the expense of the equipment needed to use the product, ThermoGel also requires frequent agitation to remain usable, has poor drop characteristics, requires a 30 minute hydration time and is difficult to clean off of aircraft, mixing equipment and airport tarmacs.

There are no systems comparable to EMFIDS that are readily available in the market.  There are other safety products for utility workers, but none are capable of delivering fire suppression and structure protection immediately following an underground event. 

Seasonality

There is no real seasonality to structural fires. These occur throughout the year. In wildland fires, FireIce® use will be more likely during the warmer, drier summer months when forest and other wildland fires are more prevalent. However, in Southern California wildland fires occur year round and are most damaging in September and October. This seasonality may be minimized if we are able to expand our distribution internationally to countries in the Southern hemisphere. The occurrence rate for manhole fires is highest in the summer and winter months.

Utility workers perform maintenance on underground systems year round.  As such, demand for EMFIDS should be year round, however there may be some seasonality based upon utility capital budgeting cycles.

6

Soil₂O “Dust Control”

Industry Overview 

Dust control is vital to several industries including agriculture, construction, mining and transportation. In response to the level of dust emissions from agricultural, mining and other industries, the Environmental Protection Agency, or the EPA, issued proposed rules titled National Ambient Air Quality Standards for Particulate Matter which were published in the Federal Register on June 29, 2012. These proposed rules reduce the amount of allowable dust released in the air by one-half. According to the EPA’s website, dust accounts for over 25% of particle matter smaller than 2.5 micrometers in diameter, which are the major cause of reduced visibility or haze in parts of the U.S., and it accounts for over 78% of particle matter smaller than 10 micrometers in diameter, which causes respiratory related health issues. Dust also causes environmental damage such as acid rain, increased acidity in lakes and streams, depletion of nutrients in the soil and damage to sensitive forests and farm crops. In terms of agriculture, the U.S. Department of Agriculture, or USDA, estimates the total annual cost of soil erosion from agriculture in the U.S. is about $44 billion per year.  According to the Global Education Project, nearly one-third of the world’s cropland has been abandoned because of soil erosion and degradation over the past 40 years.  In terms of mining, according to the U.S. Geological Survey, a bureau of the U.S. Department of the Interior, reported that in 2012, there were about 4,155 stone quarries and 93 stone mines which release large amounts of dust in the atmosphere.

The Product

In May 2011, GelTech launched a new product called Soil₂O® “Dust Control” using its environmentally friendly Soil₂O® product. “Dust Control” is useful in a variety of commercial and industrial markets with dust control and moisture retention problems including road construction sites, rock pits, unpaved roadways, landfills and coal piles. In contrast to the standard product used on gravel roads and rock pits and other dust causing surfaces, Soil₂O® “Dust Control” is environmentally friendly and requires significantly less water. Water is commonly transported to sites in large trucks. Thus, “Dust Control” reduces a company’s carbon footprint by reducing the number of vehicle trips. In addition, fewer trips reduces labor, water and fuel costs and reduces the wear and tear on vehicles and equipment.

Uses

Soil₂O® “Dust Control” may be used in a variety of ways to control dust in multiple industries, including the following:

●

Soil₂O® “Dust Control” may be sprayed on mining, rock quarry or landfill haul roads to eliminate dust from constant traffic,

●

Soil₂O® “Dust Control” can be sprayed on quarry conveyor belts to reduce airborne dust, and

●

Soil₂O® “Dust Control” can be sprayed on coal ash beds to reduce airborne dust at coal fired power plants.

●

Soil₂O® “Dust Control” can be sprayed on horse tracks and corrals to reduce airborne dust.

●

Soil₂O® “Dust Control” can be used to maintain unpaved raceways and parking lots at rural dirt tracks used for auto racing.

Benefits

Soil₂O® “Dust Control” is beneficial because it will reduce the number of times companies will need to spray haul roads, thus reducing water usage, fuel, vehicle maintenance and labor costs. In addition, the product is non-toxic and environmentally friendly and can be integrated into the reclamation process for mining companies.

Sales and Marketing

We began sales of Soil₂O® “Dust Control” in Southern California in December 2010 and have two full-time employees responsible for selling the product, focusing on dust control for the rock quarry, construction, and agricultural industries. For the year ended June 30, 2014, Soil₂O® “Dust Control” accounted for 17.3% of our revenue.

7

In January 2014, the Company entered into a national vendor agreement with White Cap HD Supply, the leading distributor of specialty hardware, tools and materials for large and medium-sized contractors.  Under the agreement, White Cap is currently stocking Soil₂O® “Dust Control”, Soil₂O® Soil Cap and related equipment in the southwestern United States, primarily in the southern California and Arizona market.  It is mutually anticipated that they will expand to additional markets beginning next spring.

In July 2014, the Company introduced a companion product to Soil₂O® “Dust Control”.  The product called Soil₂O® Soil Cap is a highly effective solution to stabilize stockpile dust and limit erosion caused by rain and wind.  Soil₂O® Soil Cap penetrates and bonds with stockpile aggregate creating a durable, waterproof shell.  Soil₂O® Soil Cap is effective for use on any stockpile or low traffic area susceptible to airborne dust or erosion. White Cap HD Supply has been successful in the marketing this product.

Competition

Competition in the dust control industry runs the gamut from regional providers of product, trucks and equipment to multinational chemical companies providing chemical solutions and application equipment on a global basis. Generally speaking, the industry consists of products made up of chemical compounds that are in some form or fashion petroleum based, are much more expensive per application and are not environmentally friendly. A large number of companies have chosen to use water alone to mitigate airborne particulate matter. For these companies, our product can be most helpful by reducing the number of watering trips necessary to control dust thus reducing the overall cost of dust control and reducing the cost of any remediation which may be required by current EPA guidelines.

There are a few niche dust control products in the marketplace. The main and most widely used product is Magnesium Chloride, or MagChloride. MagChloride has a hygroscopic quality which has the ability to absorb moisture from the air, controlling the number of small particles which become airborne. MagChloride still needs many laps with a water truck to keep it hydrated and working. After just a few applications our “Dust Control” product helps to limit the times a water truck is needed, saving fuel, labor costs, and thousands of gallons of water per day.

Soil₂O®- Agricultural Application

Industry Overview

According to the USDA, although less than 15 percent of U.S. cropland is irrigated, agriculture accounts for 80 percent of the nation’s consumptive water use.  According to the World Bank, agricultural water management is a vital practice in ensuring food security, poverty reduction, and environmental protection.  However, irrigation in all forms costs billions of dollars a year.  The total estimated cost for irrigation in 2013 for the Central Valley Project in California alone was $3.6 million.  The total value of all loans currently held by the World Bank for irrigation and drainage is $4.7 billion.  After decades of successfully expanding irrigation and improving productivity, farmers and managers face an emerging crisis in the form of poorly performing irrigation schemes, slow modernization, declining investment, constrained water availability, and environmental degradation. Similarly, irrigation for golf courses can be costly as well.  According to the United States Golf Association, it is not uncommon for irrigation systems to cost more than $1 million per golf course.  Effective irrigation and water management practices can help maintain profitability for farmers and golf course managers in an era of increasingly limited and more costly water supplies.  

Drought conditions also affect the cost of agriculture and water consumption.  In August 2012, drought conditions in the U.S. caused corn yields – which account for nearly 40% of the global harvest – to be 17% lower than expected, contributing to a rise in food prices.  In response, the federal government passed a $383 million emergency drought aid package for farmers, also known as the Agricultural Disaster Assistance Act of 2012.  Furthermore, President Obama announced that farmers would be provided with nearly $80 million in additional funding, and several State legislatures passed emergency drought assistance legislation as well.  

8

The Product

We are marketing two distinct versions of Soil₂O®; a unique, topically applied version (Soil₂O® Topical) and a long term in situ version (Soil₂O® Granular). Soil₂O® Topical is a fine particle blend that is mixed with water and is for use on existing grass and can be applied using any type of spray rig or backpack sprayer. Soil₂O® Granular has been formulated to be tilled into the top four to six inches of the soil to assist in replacing and replanting of grass, including sodding and seeding, and is also recommended to be used during the planting of trees, shrubs, and annuals. Soil₂O® Granular is appropriate for planting situations in which the grass is not already established. We are now selling both versions to our distributors which are marketing the products to the agricultural and other markets.

Soil₂O® Granular’s main ingredient is polyacrilamide cross-linked polymer. Versions of this product have been used in the agricultural industry for many years. Soil₂O® can absorb hundreds of times its weight in water. Water is rapidly drawn into a polymer network where it is stored. As the soil dries out, the polymer releases up to 95% of the water it has absorbed back into the soil. Therefore, the water becomes available when the plants need it most.

Both Soil₂O® Topical and Granular naturally degrade over time in soil. Sunlight and salinity exposure make it break down faster. Soil₂O® Topical is used as a top dressing and sprayed onto already established turf and grasses. Our formulation provides a specifically formulated particle size which, with irrigation, gets down to the roots to supply turf and grasses with water and nutrients. Since the Soil₂O® Topical particle size is very small and not as protected from the ultraviolet light given off by the sun as the granular form, it is broken down much more rapidly than the granular. Soil₂O® Granular is tilled directly into the soil and will last for three to five years without having to be reapplied. The market for the granular product includes newly-designed golf courses, courses doing replanting as part of their continual golf course maintenance or any new landscaping project. Although granular form re-orders for large scale use may be limited due to its long duration in soil, we expect it to be used in both industrial and retail markets for the planting of landscaping which always has constant turnover due to landscaping re-design, re-planting and young tree mortality rates. We are marketing both versions of Soil₂O® to the agricultural market.

Uses

Soil₂O® has multiple potential uses in the agricultural market:

●

Soil₂O® products are specially designed for use as a soil conditioner for water and nutrient retention, interior and exterior farming including growers, turf farms and greenhouses, landscaping, forestry, horticulture and golf course maintenance. Each product’s goal is to increase the water holding capacity of soils and potting mixes, thereby reducing the frequency of irrigation, as well as reducing leaching of valuable nutrients.

●

Soil₂O® can also be beneficial for lawns and sod by improving germination and promoting regular even growth of lawns. This is especially useful for turf farms, golf courses and grass in parks and gardens.

●

Soil₂O® can be effective in agriculture, particularly in commercial farming. By storing water for later release as the soil becomes drier, Soil₂O® delays wilting and makes it possible for certain plants to become better established while waiting for rain or irrigation to begin. In one test, the use of Soil₂O® in rain fed sugar cane increased the yield by approximately 25%.

●

By absorbing fertilizer, Soil₂O® reduces the amount that runs out of the soil and makes it available to the plants for a longer period of time.

●

Soil₂O® can be used in the planting of trees, bushes and saplings by enhancing root development and reducing mortality rates due to transplant shock.

●

Soil₂O® can keep plants, trees and cut flowers hydrated and thereby facilitate their transportation over long distances.

9

We believe that the water scarcity in the U.S. has created an opportunity to demonstrate to governments that Soil₂O® can provide a solution for the agricultural market in areas where farmers use irrigation to water crops. In addition, the agriculture market has a substantial problem in related to fertilizer and nutrient leaching. Soil₂O® has been shown to be successful in retaining fertilizer and nutrients at the root level, thus reducing leaching.

Sales and Marketing

GelTech has limited its marketing efforts for Soil₂O® Topical and Granular to applications for golf courses and commercial landscapers. Golf course superintendents find the product works well on berms and around sand traps where water run-off is an issue. Commercial landscapers use our granular product to improve growth and reduce plant mortality for new plantings.

In the year ended June 30, 2014, Soil₂O® accounted for 2.0% of our revenue.

Raw Materials and Suppliers

Our Soil₂O® base ingredients are manufactured for us by a third party. There are several other companies that are also capable of manufacturing the main ingredients.

Competition

Polymers have been marketed on and off for over 20 years as additions to soil to increase water retention and reduce irrigation. Numerous companies appear to have products that are very similar to Soil₂O®. Some of these companies are:

●

Horticultural Alliance, Inc.

●

Turbo Technologies, Inc.

●

American Soil Technologies, Inc. [OTCBB: SOYL]

The first two are private companies and it is unclear what financial, marketing and sales resources they have compared to us. On the other hand, American Soil Technologies, Inc. files reports with the SEC. However, from American Soil’s filings with the SEC, it is clear that it has experienced significant losses, has nominal revenue and assets, has a large accumulated deficit and has a working capital deficit which may hamper its ability to compete.  It supplies polymer soil additions and other related products. American Soil has an exclusive license to two method patents with cross-linked and linear polymers as their basis. They also have a patent on a slow release liquid fertilizer. American Soil also has two patents on a machine designed to install its liquid products in mature turf as well as some standing crops. Since we do not currently have a patent on Soil₂O® itself or on any of its uses, it is possible that a competitor could reverse engineer Soil₂O® and market it under its own brand name. We have filed a patent application for the Soil₂O® Topical.

Seasonality

We anticipate that sales of Soil₂O® will be higher during the spring and summer quarters. However, we do not expect as much seasonality in the Southeastern areas that generally experience year round growing cycles, with the sale of the agricultural products preceding the growing cycle of various crops. We also believe a demand for Soil₂O® may be higher if the drought conditions affecting the Midwestern and Southwestern U.S. persist.

Intellectual Property  

The following are patents and patents pending for products we currently market or expect to market:

●

U.S. patent application, Serial No. 11/775,512 –Water retention mixture and method for spray application and International Patent application, Serial No. PCT/US2008/069398;

●

U.S. patent application, Serial No. 12/208,832 – Rapid Deployment Fire Retardant Gel Pack and International Patent application, Serial No. PCT/US2009/056532;

10

●

U.S. patent application, Serial No. 12/282,603 – Process and Device for Fire Prevention and Extinguishing;

●

U.S. patent, Patent No. 7,992,647 – Process and Device for Fire Prevention and Extinguishing;

●

U.S. patent application, Serial No. 12/270,485 – Method and Apparatus for Improving Fire Prevention and Extinguishment;

●

U.S. patent, Patent No. D649,294 – Firehose Eductor;

●

U.S. patent application, Serial No. 61/430,601 – Method of Controlling Road Dust in Strip Mines;

●

U.S. patent application, Serial No. 61/430,601 – Strip Mine Conveyor Belt Dust Control;

●

U.S. patent application, Serial No. 12/887,230 – Home Safety Kit;

●

U.S. patent application, Serial No. 61/754,068 – Device for Treating Manhole Electrical Fires;

●

U.S. patent application, Serial No. 61/755,237 – Device for Suppressing Electrical Conduit Fires;

●

U.S. patent application, Serial No. 61/758,594 – Fluid Dispensing ladder;

●

U.S. patent, Patent No. 8,757,280 – Method of Extinguisher Underground Electrical Fires;

●

U.S. patent, Patent No. D637,357 – Fire Extinguisher Dispensing Hose;

●

U.S. patent, Patent No. D684,662 – Firehose Handheld Eductor Nozzle;

●

U.S. patent application, Serial No. 12/870,333 - Water Based Fire Extinguisher.

●

U.S. patent application, Serial No. 14/109,740 – Aerial Bucket Lift Electrical Safety Apparatus;

●

U.S. patent application, Serial No. 62/008,534 – Tanker Truck Eductor System;

●

U.S. patent application, Serial No. 62/016,847 – Utility Pole Protection Device;

●

U.S. patent application, Serial No. 62/018,894 – Method and apparatus for treating underground conduits;

●

U.S. patent application, Serial No. 62/035,226 – Fire Suppression Device for Oil and Gas Containment area;

We also hold patents for our hurricane suppression project. Our Chief Technology Officer continues to develop potential new products. We recently filed new patent applications, some of which are to improve our existing technologies and others are for new products.

We claim trademark rights to the following marks. Federal trademark applications are on file with the United States Trademark Office:

●

GelTech Solutions®

●

FireIce®

●

SkinArmor™

●

Soil₂O®

●

WeatherTech Innovations®

11

Employees

As of September 26, 2014, we had 24 employees of which all are full-time employees. We hire independent contractors on an “as needed” basis only. None of our employees are subject to collective bargaining agreements. We believe that our employee relationships are satisfactory. In addition to our Chief Executive Officer, we employ three other members of the Cordani family. See the section titled “Certain Relationships and Related Transactions, and Director Independence.”

Research and Development

During the last two fiscal years, GelTech spent $274,005 and $179,158 on research and development expenses.

ITEM 1A. RISK FACTORS

Not applicable to smaller reporting companies. However, our principal risk factors are described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our corporate office is located in Jupiter, Florida. We lease our office on a month-to-month basis at a monthly rental fee of $8,417. If we were required to move, we believe that there is a large supply of commercial property available in the general area which we could lease at comparable prices. We also lease space on a month-to-month basis in an industrial yard in California which houses inventory at a monthly cost of $1,750.  In February 2014, the Company signed a 6 month lease for a building in Brooklyn, New York, to support operations in the New York City area, at a monthly rent of $4,000.  GelTech did not renew the lease.

12

ITEM 3. LEGAL PROCEEDINGS

David Hopkins, a former employee, sued GelTech and its Chief Executive Officer, Michael Cordani, in the 15th Judicial Circuit Court in Palm Beach County, on June 23, 2008, alleging breach of a consulting agreement and an employment agreement purportedly entered into in May and June 2007, respectively. In addition, the Complaint sought relief for fraud, civil theft, invasion of privacy and trespass. On July 23, 2012, a jury returned a verdict against GelTech for $1,046,000 ($841,000 for breach of a consulting agreement, $150,000 for fraudulent misrepresentation, $50,000 for invasion of privacy, and $5,000 for trespass) and against only Mr. Cordani for $200,000 (civil theft).  The jury found Mr. Cordani liable on the same claims as GelTech except for the breach of a consulting agreement.

In November 2012, our insurance carrier paid Mr. Hopkins $200,000 related to the invasion of privacy claim and the fraudulent misrepresentation claim.

In January 2013, the Court ruled in favor of GelTech’s post-trial motions dismissing the $200,000 civil theft claim against Mr. Cordani and reducing the verdict against GelTech to $500,000. In February 2013, GelTech was granted a new trial on damages relating to the verdict.  The new trial on damages was held in September 2014.  Post trial briefs and proposed orders are due October 14, 2014, after which the judge will review the briefs and trial testimony and render a final decision.

On June 3, 2013, GelTech filed a lawsuit in the 15th Judicial Circuit Court in Palm Beach County, Florida, against Jerome Eisenberg, a director and former Executive Chairman, for inducing GelTech to enter into an Employment Agreement based on false representations by Mr. Eisenberg that he would facilitate a $25 million financing on behalf of GelTech. GelTech is seeking to have the Court rescind the Employment Agreement and recover the compensation paid to Mr. Eisenberg under the Employment Agreement. Mr. Eisenberg is an officer of a company which had entered into a long-term Distribution Agreement with GelTech in 2009.

In November 2013, Mr. Eisenberg countersued the Company for breach of the Employment Agreement. See “Certain Relationships and Related Transactions, and Director Independence”, under Item 13 Part III of this filing.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable

13

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock is quoted on the Over-the-Counter Bulletin Board, or the Bulletin Board, under the symbol “GLTC”. Our common stock last traded at $0.35 on September 26, 2014. As of that date there were approximately 240 shareholders of record. We believe that additional beneficial owners of our common stock hold shares in street name. The following table provides the high and low bid price information for our common stock for each quarterly period within the two most recent fiscal years as reported by the Bulletin Board. The quotation reflects inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

	High		Low
Fiscal Year
2014
June 30, 2014	$	0.93	$	0.60
March 31, 2014	$	1.00	$	0.64
December 31, 2013	$	1.23	$	0.58
September 30, 2013	$	1.70	$	0.77
2013
June 30, 2013	$	1.20	$	0.855
March 31, 2013	$	1.75	$	0.31
December 31, 2012	$	0.64	$	0.21
September 30, 2012	$	0.99	$	0.55

Dividend Policy

We have not paid cash dividends on our common stock and do not plan to pay such dividends in the foreseeable future. Our Board of Directors, or the Board, will determine our future dividend policy on the basis of many factors, including results of operations, capital requirements, and general business conditions. Dividends, under Delaware General Corporation Law, may only be paid from our net profits or surplus. To date, we have not had a fiscal year with net profits and do not have surplus.

Recent Sales of Unregistered Securities

In addition to those unregistered securities previously disclosed in reports filed with the Securities and Exchange Commission, we have sold securities without registration under the Securities Act of 1933 as described below.

Name or Class of Investor	Date Issued	No. of Securities	Reason for Issuance
Investors (1)	4/4/14 – 5/30/14	152,798 shares of common stock	Investment of approximately $93,000 by four accredited investors

———————

(1) Exempt under Section 4(a)(2) and Rule 506(b) of the Securities Act.

ITEM 6. SELECTED FINANCIAL DATA

Not required for smaller reporting companies.

14

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements.

Overview

GelTech Solutions, Inc., or GelTech, generates revenue primarily from marketing the following three products: (1) FireIce®, a water enhancing powder that can be utilized both as a fire suppressant in urban firefighting, including underground utility fires, and in wildland firefighting and as a medium-term fire retardant to protect wildlands, structures and firefighters; (2) Soil₂O® “Dust Control”, our application which is used for dust mitigation in the aggregate, road construction, mining, as well as, other industries that deal with daily dust control issues and (3) Emergency Manhole FireIce Delivery System, or EMFIDS, an innovative system designed to deliver FireIce® into a manhole in the event of a fire.  Other products currently being marketed include (1) FireIce® Home Defense Unit, a system for applying FireIce® to structures to protect them from wildfires; and (2) Soil₂O®, a product which reduces the use of water and is primarily marketed to golf courses, commercial landscapers and the agriculture market. During the fourth quarter of fiscal 2014, the Company developed and began marketing two new products, (1) GT-W14, an industrial absorbent powder used to contain and clean up industrial liquid spills; and (2) Soil₂O® Soil Cap, a dust suppressant technology designed to stabilize stockpile dust and reduce soil erosion. We have yet to generate significant revenue from these two products and are currently evaluating the potential commercialization of these products.Our financial statements have been prepared on a going concern basis, and we need to generate sufficient material revenues to support the ongoing business of GelTech.

Critical Accounting Estimates

In response to the SEC’s financial reporting release, FR-60, Cautionary Advice Regarding Disclosure About Critical Accounting Policies, the Company has selected its most subjective accounting estimation processes for purposes of explaining the methodology used in calculating the estimate, in addition to the inherent uncertainties pertaining to the estimate and the possible effects on the Company’s financial condition. The accounting estimates discussed below involve certain assumptions that if incorrect could create a material adverse impact on the Company’s results of operations and financial condition.

Revenue Recognition

Under ASC 605-15-25 we recognize sales of our products when each of the following has occurred:

- The price of the product sold is fixed or determinable and evidence of an agreement is present.

- The title and risk of loss of the product has passed to the buyer and the sale is not contingent upon the buyer being able to resell the product.

- We have a reasonable expectation that the buyer has the intent and the ability to pay for the product ordered.

- We have no future obligation to the seller related to the product sold.

Stock-Based Compensation

We have granted stock options to our officers and directors at exercise prices equal to or greater than the fair value of the shares at the date of grant.

Under ASC 718-10 we recognize an expense for the fair value of our outstanding stock options as they vest, whether held by employees or others.

15

We estimate the fair value of each stock option and warrant at the grant date using the Black-Scholes option pricing model based upon certain assumptions which are contained in Note 7 to the Consolidated Financial Statements contained herein. The Black-Scholes model requires the input of highly subjective assumptions including the expected stock price volatility. Because our stock options and warrants have characteristics different from those of traded options, and because changes in the subjective input of assumptions can materially affect the fair value estimate, in our management’s opinion, the existing models may not necessarily provide a reliable single measure of the fair value of such stock options.

We use the trading price of our common stock, or alternatively, the price of recent private placement sales of our common stock in making our estimates.

Results of Operations

The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included elsewhere herein.

For the Fiscal Year Ended June 30, 2014 Compared to the Fiscal Year Ended June 30, 2013.

Revenue

For the fiscal year ended June 30, 2014, which we refer to as “Fiscal 2014”, we had revenue of $814,587 as compared to revenue of $526,010 for the fiscal year ended June 30, 2013, which we refer to as “Fiscal 2013”. Revenue during Fiscal 2014 consisted of sales of EMFIDS, FireIce® and Soil₂O® amounting to $425,000, $222,870 and $156,717, respectively. In addition, the Company recognized revenue of $10,000 from paid for research and development in Fiscal 2014. Revenue in Fiscal 2013 consisted of sales of FireIce® and Soil₂O® amounting to approximately $204,185 and $228,825, respectively. In addition, the Company recognized revenue of $93,000 from paid for research and development in Fiscal 2013.We anticipate that our revenues from both FireIce® and Soil₂O® will increase in fiscal 2015 due to continued sales of FireIce® and the EMFIDS system to the utility industry and due to increased sales of Soil₂O® Dust Control in the southwestern United States.

Cost of Goods Sold

For Fiscal 2014, our costs of goods sold were $393,102 as compared to $180,427 for Fiscal 2013. The change is consistent with the respective revenue from product sales. We expect that our cost of sales will follow the same trend as our revenues in fiscal 2015.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $6,601,353 for Fiscal 2014 as compared to $6,103,435 for Fiscal 2013. This increase is reflective of increases in the following major expense categories:

Salaries and employee benefits – Salaries and employee benefits increased $196,370 as a result of the hiring in July 2013 of a Director of Sales and Operations and in August 2013 of a Director of Utility Markets with combined salaries of $230,000.  This increase was partially offset by a reduction in the use of contract staff in our Brooklyn facility of approximately $40,000.  It is anticipated that these costs will remain constant or slightly decline in fiscal 2015 as we maintain current staffing levels until significant revenues are generated.

Professional fees - Professional fees increased $217,548 related to an increase in legal expenses of $204,000 related to lawsuits by a former employee and a former distributor, and an increase in patent attorney fees of $18,000 related to the new patent filings.

Facilities expense - Facilities expense increased $56,473 related to an increase a full year’s rent and facility related expenses in our Brooklyn facility in Fiscal 2014.  We terminated our lease in Brooklyn in August 2014.

16

Non-cash compensation – Non-cash compensation expense related to director, executive and employee stock options increased $185,299 in Fiscal 2014 primarily related additional option, SARs and RSU grants to employees and directors. We would anticipate that these expenses would be lower in future years as a result of the forfeiture of outstanding options and SARs upon the resignation by the Company’s former President and the clawback of options and RSUs upon the termination of the Company’s former Executive Chairman and a reduction in the number of options granted in Fiscal 2014.

These expense increases were partially offset by a decrease in the following expense category:

Sales and marketing – Sales and Marketing costs decreased $166,932 in Fiscal 2014 resulting from a reduction in advertising expense, and a reduction in search engine optimization costs. It is anticipated that these costs will remain lower in fiscal 2015.

Research and Development Costs

Research and development costs for Fiscal 2014 were $274,005¸ as compared to $179,158 during the Fiscal 2013. The increase in the Fiscal 2014 amount related to continued research and the second generation EMFIDS system, other FireIce® applications in the utility and other industries and other potential products.  The Company received $10,000 for paid for research in Fiscal 2014 to offset these costs.  We expect that these costs will continue at a relatively even level as we continue to explore new products and new applications of our existing products.

Other Income (Expense)

Net other expense for Fiscal 2014 amounted $658,072 as compared to net other income for Fiscal 2013 of $715,263. In Fiscal 2014, net other expense primarily consisted of interest expense of $462,760 and a loss on conversion of interest of $201,175.  In Fiscal 2013, net other income was primarily impacted by a reduction of the accrual for losses from litigation related to a lawsuit by a former employee. The reduction was recorded to reflect insurance payments made to the plaintiff in settlement of the invasion of privacy and fraudulent misrepresentation awards. In February 2013, the Company received a favorable ruling from the trial judge vacating the civil theft award of $600,000 and reducing the breach of consulting agreement award from $841,000 to $500,000. As a result, the Company has recognized other income of $1,141,000 for Fiscal 2013.  This other income was partially offset by interest expense of $473,605, a loss on extinguishment of debt of $21,311, other expense related to losses on sales of two vehicles and a loss on settlement of a lawsuit with a former distributor of $19,114 and the cost of repricing warrants in order to induce their exercise of $70,491.

Net Loss

For Fiscal 2014 our net loss was $7,111,945 as compared to $5,221,747 for Fiscal 2013. The increase in the net loss was the result of the higher total operating expenses and other income as described above which was partially offset by higher gross profit.  Net loss per common share was $0.20 for Fiscal 2014 as compared to a net loss per common share of $0.18 for Fiscal 2013. The weighted average number of shares outstanding was 36,410,142 and 29,479,048 for the fiscal years ended June 30, 2014 and 2013, respectively.

Liquidity and Capital Resources

A summary of our cash flows is as follows:

	Fiscal Year Ended June 30,
	2014			2013
Net cash used in operating activities	$	5,132,019		$	4,195,655
Net cash used in investing activities		72,851			28,496
Net cash provided by financing activities		5,180,861			4,230,232
Net increase (decrease) in cash and cash equivalents	$	(24,009	)	$	6,081

17

Net Cash Used in Operating Activities

For Fiscal 2014, we used net cash of $5,132,019 in operating activities as compared to $4,195,655 for Fiscal 2013. The increase in cash used from operations was primarily the result of the difference between the prior year reversal of the accrual for losses from litigation due to reduction in the amount of the award and a payment by our insurance provider resulting in a decrease in accrued liabilities of $963,325 as compared to Fiscal 2014 which had no such reversal or payment.  Other major factors that impacted the cash used in operations were the amortization of discounts on convertible notes of $223,025, the amortization of the remaining balance of $102,056 of the accrual related to the Termination and Release Agreement with our former President, and the investment in inventory of $266,574.

Cash used from operations in Fiscal 2013 was primarily the result of the difference between the prior year accrual for losses from litigation resulting in an increase in accrued liabilities of $1,625,067 as compared to the current year reversal of those accruals due to a $200,000 payment by the insurance company and the reversal of $941,000 of the accrual as result of rulings by the court.  Other major factors that impacted the cash used in operations were the amortization of discounts on convertible notes of $385,650, and the remaining balance of $102,056 of the accrual related to the Termination and Release Agreement with our former President.  

Net Cash Used in Investing Activities

Cash flows used in investing activities for Fiscal 2014 amounted to $72,851 which consisted of the purchase of a vehicle, mobile mixing equipment and general office equipment.

In Fiscal 2013, cash used in investing activities amounted to $28,496 resulting from the purchase of a new support vehicle for our Brooklyn, New York facility plus minimal purchases of computer equipment, net of the proceeds from the sale of a support vehicle maintained at our California facility.

Net Cash Provided By Financing Activities

Cash flows from financing activities for Fiscal 2014 were $5,180,861 as compared to $4,230,232 for Fiscal 2013. During Fiscal 2014, GelTech received $570,000 from the sale of stock to Lincoln Park Capital Fund, LLC, or Lincoln Park, $2,131,527 from the sale of common stock to accredited investors in private placement transactions, $1,705,000 from the sale of common stock and warrants to accredited investors in private placement transactions, $25,000 from the exercise of warrants for cash and $18,200 from the exercise of options for cash and $1,000,000 from convertible notes with related parties. These receipts were used for working capital, capital expenditures for equipment and vehicles to repay third party convertible notes of $115,822, to repay related party convertible notes of $85,880 and to repay $67,164 of insurance financing.

During Fiscal 2013, GelTech received $810,003 from the sale of stock to Lincoln Park Capital Fund, LLC, or Lincoln Park, $1,658,000 from the sale of common stock to accredited investors in private placement transactions, $300,000 from the sale of common stock and warrants to accredited investors in private placement transactions, $910,000 from the exercise of warrants and $6,534 from the exercise of options, $175,000 from convertible notes issued to third parties and $500,000 from convertible notes issued to related parties. These receipts were used for working capital, capital expenditures for equipment and vehicles, to repay related party advances of $84,380 and to repay $44,925 of insurance financing.   

Historical Financings

As previously disclosed, in January 2012, the Company signed a $5 million Purchase Agreement with Lincoln Park and sold 2,913,997 shares of common stock in exchange for $1,990,003 under the Purchase Agreement. This agreement expired in July 2014.

Since July 1, 2012, GelTech has raised $2,208,000 from the sale of common stock in connection with private placements with 15 accredited investors including Michael Reger, our principal shareholder and Chief Operating Officer, Michael Cordani, our former Chief Executive Officer and Chairman of the Board and Peter Cordani, our Chief Executive Officer.  In consideration for their investments, GelTech issued 4,185,323 shares of common stock at prices ranging from $0.35 to $1.08 per share and 341,912 warrants with exercise prices ranging from $1.25 to $1.30 per share.

18

In September and October 2012, GelTech received $910,000 upon the exercise of 1,820,000 warrants (including 1,200,000 warrants held by Mr. Reger) related to an offer by us to reduce the exercise prices of the warrants to $0.50 per share. Additionally, in September 2012, Mr. Reger converted his $322,996 convertible original issue discount note into 665,992 shares of common stock.

In August 2012, the Company received $175,000 in exchange for six month convertible original issue discount notes in the amount of $179,375 from two accredited investors. The notes are convertible into common stock at $0.50 per share. The notes bear an annual interest rate of 5% and are convertible into GelTech’s common stock at $0.50 per share.  In February 2013, one note holder converted a $102,500 note and was issued 205,000 shares of GelTech’s common stock.

In August 2013 and September 2013, GelTech repaid four convertible original issue discount notes with an aggregate face value of $292,740 in exchange for the payment of $202,923 and the issuance of 243,543 shares of common stock.  These transactions included the payment of $86,049 to our former Executive Chairman in satisfaction of a convertible original issue discount note in the amount of $86,100.

From December 2012 through February 2013, we received $500,000 of loans from Michael Reger.  In connection with these loans and prior loans, all of Mr. Reger’s outstanding loans were consolidated into a $1,997,483 note convertible at $0.35 per share due December 31, 2016, and all of his then outstanding notes were cancelled. Additionally, in July 2013, in consideration for a $1,000,000 loan, GelTech issued Mr. Reger a $1,000,000 five-year note convertible at $1.00 per share and 500,000 five-year warrants exercisable at $1.30.  Each of the notes described in this paragraph bear an annual interest rate of 7.5%.

Since July 1, 2013, GelTech has raised $4,611,527 from the sale of common stock in connection with private placements with twenty one accredited investors including Michael Reger, and Neil Reger, a director.  In consideration for their investments, GelTech issued 7,331,548 shares of common stock at prices ranging from $0.55 to $1.32 per share and 1,938,720 warrants with exercise prices ranging from $1.00 to $2.00 per share.

Liquidity and Capital Resource Considerations

As of September 27, 2014, we had approximately $96,000 in available cash.  Our operations continue to rely on Mr. Reger’s investments.  If Mr. Reger were to cease providing us with working capital or we are unable to generate material revenue, we will have to scale back our operations or cease doing business. See the Risk Factor on page 20. Although we do not anticipate the need to purchase any additional material capital assets in order to carry out our business, it may be necessary for us to purchase additional mobile mixing trucks and support vehicles in the future, depending on demand.  Additionally, we may be required to pay a substantial award to David Hopkins, a former employee and consultant, as a result of the recent trial. See the Risk Factor on page 23 and Legal Proceedings on page 13. If we do not have the money to secure an appeal bond, or if we are unsuccessful, we will be required to pay the amount of the judgment plus statutory interest.

Ultimately, if GelTech is unable to generate substantial cash flows from sales of its products or complete financings, it may not be able to remain operational.

Related Party Transactions

For information on related party transactions and their financial impact, see Note 7 and Note 9 to the consolidated financial statements contained herein.

New Accounting Pronouncements

See Note 1 to our consolidated financial statements included herein for discussion of recent accounting pronouncements contained herein.

Cautionary Note Regarding Forward-Looking Statements

This report includes forward-looking statements including statements regarding expected results from the litigation described herein, our expectations of future revenues and cost of sales, anticipated capital expenditures, expectations regarding our working capital, and our liquidity.

19

All statements other than statements of historical facts contained herein, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements are contained in the Risk Factors that follow. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise. For more information regarding some of the ongoing risks and uncertainties of our business, see the Risk Factors and our other filings with the SEC.

Risk Factors

Investing in our common stock involves a high degree of risk. You should carefully consider the following risk factors before deciding whether to invest in GelTech. If any of the events discussed in the risk factors below occur, our business, consolidated financial condition, results of operations or prospects could be materially and adversely affected. In such case, the value and marketability of the common stock could decline.

Risk Factors Relating to Our Company

Our ability to continue as a going concern is in doubt absent obtaining adequate new debt or equity financing and achieving sufficient sales levels.

We incurred net losses of approximately $7.1 million in fiscal 2014 and $5.2 million in fiscal 2013. We anticipate these losses will continue for the foreseeable future. We have not reached a profitable level of operations, which raises substantial doubt about our ability to continue as a going concern.  Since January 2014, we have received $2,025,000 from our principal shareholder in consideration for common stock and warrants. These funds have enabled us to sustain our operations.  Our continued existence is dependent upon our achieving sufficient sales levels of our products including FireIce®, EMFIDS and Soil₂O® “Dust Control” and obtaining adequate financing.

If we are unable to sell enough of our products, and our principal shareholder discontinues funding our operations, we will need to secure another source of funding in order to satisfy our working capital needs. Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences would require us to scale back our operations which would have an adverse effect on your investment. 

If we do not raise additional debt or equity capital, we may not be able to remain operational.

We owe approximately $3.0 million in long-term convertible debt held by our principal shareholder, which is due in December 2016. Because we are not currently generating positive cash flow, we need to sell debt or equity securities. Because of the lack of available credit for small-cap companies, difficulties for small-cap companies in raising money and our stock price and trading volume, we may be hampered in our ability to raise the necessary working capital. We cannot give you any assurance that any additional financing will be available to us, or if available, will be on terms favorable to us. If we do not raise the necessary working capital and/or increase revenue, we will not be able to remain operational.

Because we have not generated material sales of FireIce® since it was launched over five years ago, there can be no assurances it will be accepted by potential customers.

We launched FireIce® in fiscal 2009 and have not yet achieved a consistent sustainable revenue stream. There are multiple factors, which may prevent us from successfully commercializing FireIce®, our fire suppression gel:

●

We need to convince potential customers, including federal and state governments, that FireIce® is superior to and less costly than competitive products.

●

We may need additional capital in order to demonstrate to governments that we can rapidly fulfill orders.

20

●

In seeking to sell FireIce®, we face substantial competition and must deal with the natural reluctance of people to change.

●

Internationally, we are required to comply with local laws which may require certification of FireIce®, a local partner, local licenses and other matters which are barriers to our selling FireIce®.

Because we have yet to generate material revenue on which to evaluate our potential for future success and to determine if we will be able to execute our business plan, it is difficult to evaluate our future prospects and the risk of success or failure of our business.

While we have conducted development and sales and marketing activities, we have not generated material revenue to date.  In fiscal 2014, we generated revenues of approximately $815,000.  

You must consider our business and prospects in light of the risks and difficulties we will encounter as an early-stage company. These risks include:

●

our ability to effectively and efficiently market and distribute our products,

●

our ability to obtain market acceptance of our current products and future products that may be developed by us, and

●

our ability to sell our products at competitive prices which exceed our per unit costs.

We may not be able to address these risks and difficulties, which could materially and adversely affect our revenue, operating results and our ability to continue to operate our business.

Although we are encouraged by the potential of EMFIDS and its role as a tool for municipal utility companies to provide a safer working environment for their workers, we cannot assure you that we will successfully commercialize it or, if we do, it will generate sufficient revenues and gross profit to support our operations.

Our senior management, including our Chief Executive Officer, has worked over a long period of time with management at Con Ed in New York City.  In Fiscal 2014, we sold $488,758 of EMFIDS and FireIce® to Con Ed.   Since March 2014, these EMFIDS have been used by Con Ed in the field.   However, we have not received any re-orders from Con Ed or any new orders from other utility companies.  We cannot assure you we will generate sufficient revenue and gross profits from the sale of EMFIDS and FireIce® to utility companies.

Because we have not yet generated material revenue to date, it may never result in the generation of material revenue or profitability.

Since our incorporation in 2006, our goal has been to generate revenue from the sale and development of our products including FireIce® and Soil₂O®. Our marketing of these products is subject to a number of risks, including:

●

In seeking to sell FireIce® to government agencies, we will encounter typical risks such as a reluctance to change, the impact of the recession on local government budgets and competition;

●

We have not proven that we have the ability to market and sell our products;

●

Although we have a pending U.S. patent application for Soil₂O® Topical, we have no patent protection for the granular form and there are many products on the market which are advertised as performing similar functions to Soil₂O® Granular; 

●

If the pending patent application is not granted for Soil₂O® Topical , we will face direct competition, which can erode any market share we may achieve and create pricing pressure; and

We cannot assure you that our marketing efforts will result in material sales or that if it does result in material sales, that such sales will necessarily translate into profitability.

21

Our growth strategy reflected in our business plan may not be achievable or may not result in profitability.

We may not be able to implement our growth strategy reflected in our business plan rapidly enough for us to achieve profitability. Our growth strategy is dependent on a number of factors, including market acceptance of our fire suppression gel and our moisture preservation product. We cannot assure you that our potential markets will purchase our products or that those parties will purchase our products at the cost and on the terms assumed in our business plan.

Among other things, implementation of our growth strategy would be adversely affected if:

●

we are not able to attract sufficient customers to the products we offer in light of the price and other terms required in order for us to attain the level of profitability that will enable us to continue to pursue our growth strategy;

●

adequate penetration of new markets at reasonable cost becomes impossible limiting the future demand for our products below the level assumed by our business plan;

●

we were forced to significantly adapt our business plan to meet changes in our markets; and

●

for any reason, we are not able to attract, hire, retain and motivate qualified personnel.

If we cannot manage our growth effectively, we may not become profitable.

Businesses, which grow rapidly often, have difficulty managing their growth. If we grow as rapidly as we anticipate, we will need to expand our management by recruiting and employing experienced executives and key employees capable of providing the necessary support. We cannot assure you that our management will be able to manage our growth effectively or successfully. Our failure to meet these challenges could cause us to lose money, and your investment could be lost.

Among other things, implementation of our growth strategy would be adversely affected if we were not able to attract sufficient customers to the products we offer or plan to offer in light of the price and other terms required in order for us to attain the necessary profitability.

We may not be able to maintain and expand our business if we are not able to retain, hire and integrate key management and operating personnel.

Our success depends in large part on the continued services and efforts of key management personnel. Competition for such employees is intense and the process of locating key personnel with the combination of skills and attributes required to execute our business strategies may be lengthy. The loss of key personnel could have a material adverse impact on our ability to execute our business objectives. We do not have any life insurance on the lives of any of our executive officers.

We could face potential difficulties in locating sufficient manufacturing sources if our products gain widespread commercial acceptance.

We have used third parties to manufacture our products on a limited basis. If we are unable to produce our products in sufficient quantities, on a timely basis and at an acceptable cost, we may lose customers and our business could be harmed. Our ability to expand production could also be hindered by the availability of materials used to manufacture our products or the availability of qualified personnel. These difficulties could result in reduced quality of our products or reduced sales, which could damage our industry reputation and hurt our profitability.

Although we began marketing of Soil₂O® in 2007, we have not achieved material sales.

We launched Soil₂O® in 2007 and have not yet achieved material sales.  In Fiscal 2014, we generated revenue of approximately $156,716 from the sale of Soil₂O®. We have to expand our sales and distribution efforts. Additionally, we must recruit distributors for agricultural usage of Soil₂O®. If we cannot expand our sales and distribution network, our future sales of Soil₂O® will be limited since our sales efforts have been aimed primarily at the agriculture industry in the Southwestern U.S., including California.   

22

If we lose a substantial sum in our pending lawsuit, the judgment creditor will be in a position to seize our assets and cause us to cease operations.

In June 2012, a jury awarded Mr. David Hopkins, a former employee, a total of $1,246,000 for invasion of privacy, trespassing, fraudulent misrepresentation, civil theft and breach of a consulting agreement.  GelTech’s insurance company has paid Mr. Hopkins $200,000 covering the invasion of privacy and fraudulent misrepresentation claims.  GelTech filed post-trial motions and the damages were reduced to $500,000.  Subsequently, a new trial on damages was granted.  See “Item 3. Legal Proceedings.”  In the event that Mr. Hopkins is awarded a substantial award in the new trial, GelTech may not have the money to secure an appeal bond.  In the event that we are unable to post bond, or if an appeal is unsuccessful, we will be required to pay the amount of the judgment plus statutory interest. If we fail to do so, the plaintiff, as a judgment creditor, can take action to seize our assets and we may not be able to remain in business.

Because we do not have a patent on Soil₂O® or its uses, if our competitors are able to reverse engineer our product, our ability to compete effectively may be harmed.

Currently, there are numerous companies that advertise moisture preservation products that appear similar to Soil₂O®. Because we lack any patent protection on Soil₂O® itself and have only a patent pending for the Soil₂O® Topical, there is a substantial risk that one of these competitors could determine how to make the granular form of Soil₂O® and market it under their own brand name; thereby adversely affecting our ability to compete successfully.

A change in environmental regulations may adversely affect the use of FireIce® and Soil₂O® and may hinder our ability to generate revenue from this line of business.

While we believe that FireIce® and Soil₂O® (including Soil₂O® “Dust Control”) are environmentally friendly, we may become subject to changing environmental regulations that could adversely affect the use of it. If we do become subject to environmental regulations, the use of FireIce® and Soil₂O® may be limited as compared to other technologies which may be less expensive or more efficient.

FireIce® and Soil₂O® face substantial competition in the fire suppression and moisture preservation markets, respectively, and there is no guarantee potential customers will select our products over those of our competitors.

We face multiple competitors in the fire suppression, fire retardation and moisture preservation markets. In the fire suppression and retardation fields, we face substantial competition including with one company that is the principal vendor to the Forest Service. In the moisture preservation areas, we face competition from numerous independently owned businesses that have competing and in some case very similar products. In addition, companies may be developing or may, in the future, engage in the development of products and/or technologies competitive with our products. We expect that technological developments will occur and that competition is likely to intensify as new technologies are employed.

Many of our competitors are capable of developing or have developed and are capable of continuing to develop products based on similar or other technology, which are or may be competitive with our products and technologies. We believe several of our competitors in the fire-fighting business have substantially greater financial and other resources, research and development capabilities and more experience in obtaining regulatory approvals, manufacturing and marketing than we do. Because our competitors in the moisture preservation markets are private companies, we are unable to determine the amount of financial and other resources they have available. However, some of these companies appear to have had much greater marketing experience than we have. Potential customers may prefer the pricing terms or service offered by competitors. Furthermore, competitors may have an advantage as a result of having existing business relationships with potential customers.

Because we are seeking to enter into contracts with federal and state governments, we will be subject to a number of risks, which could adversely affect our business.

We are seeking to sell our products, including FireIce®, to federal and state governments. In selling to the government, we will be subject to a number of significant risks including:

●

Increasing state, local and federal budget deficits which can delay and impede our receipt of orders;

23

●

We may not be successful in selling our products to the government, although we will incur material costs as part of our sales efforts;

●

Government contracts often contain unfavorable termination provisions; and

●

We may be subject to audit and modification of agreements by the government in its sole discretion, which subjects us to additional risks.

The government can unilaterally:

●

suspend or prevent us for a set period of time from receiving new contracts or extending existing contracts based on violations or suspected violations of laws or regulations;

●

terminate our existing contracts;

●

reduce the scope and value of our existing contracts;

●

audit and object to our contract-related costs and fees; and

●

change certain terms and conditions in our contracts.

Further, as part of any audit or review, the government may review the adequacy of, and our compliance with, our internal control systems and policies, including those relating to our purchasing, property, compensation and/or management information systems. In addition, if an audit or review uncovers any improper or illegal activity, we may be subject to civil and criminal penalties and administrative sanctions, including termination of our contracts, forfeiture of profits, suspension of payments, fines and suspension or prohibition from doing business with the government or any of its agencies. We could also suffer serious harm to our reputation if allegations of impropriety were made against us.

Even if we are able to successfully enter into contracts to supply federal and state governments with our products, there can be no assurances these contracts will result in substantial revenues or be renewed.

The process of obtaining government contracts is lengthy and uncertain, and we must compete for each contract. Similar to large corporations, government employees resist change and taking risks. This can make it more difficult to obtain government contracts. Moreover, the award of one government contract does not necessarily secure the award of future contracts. Governments are subject to budgetary restrictions, which may limit their ability to buy our products. These budgetary restrictions have been magnified by the current recession, which has resulted in material decreases in tax receipts. Even if we are able to enter into a contract with a government, there is no guarantee it will result in substantial revenues or the contract(s) will be renewed.  

If we face intellectual property litigation filed by third parties, we will be subject to a number of possible adverse consequences including being required to finance very expensive litigation.

Third parties may assert patent and other intellectual property infringement litigation against us claiming our products infringe on its patents or otherwise violates its intellectual property rights. Any lawsuit, whether or not successful, could:

●

divert management’s attention;

●

result in prohibitive costs; or

●

require us to enter into royalty or licensing agreements, which may not be available on acceptable terms, or at all.

24

As a result, any third-party intellectual property claims against us could increase our expenses and adversely affect our business. In addition, agreements with third parties may require us to indemnify them for intellectual property infringement claims, which would increase the cost to us resulting from an adverse ruling on any such claim. Even if we have not infringed any intellectual property rights, we cannot be sure our legal defenses will be successful, and even if we are successful in defending against such claims, our legal defense could require significant financial resources and management time.

If we are unable to protect our intellectual property rights, we may be unable to compete with competitors developing similar technologies.

Our intellectual property including our patents is our key asset. We currently expect to commercialize five U.S. patents and eight patents pending. We regard the protection of our intellectual property as critical to our success. In addition to pursuing patents, we have taken steps to protect our intellectual property by entering into confidentiality agreements with our employees, licensees, independent contractors and other advisors. These agreements may not be enforceable or may not effectively prevent disclosure of confidential information, including trade secrets, and may not provide an adequate remedy in the event of an unauthorized disclosure. Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our intellectual property rights, and failure to obtain or maintain protection of our intellectual property rights could adversely affect our business and financial results.

Risks Related to Our Common Stock

Because the market for our common stock is limited, persons who purchase our common stock may not be able to resell their shares at or above the purchase price paid by them.

Our common stock trades on the OTC Bulletin Board, which we refer to as the “Bulletin Board”, which is not a liquid market. With some limited exceptions, there has not been an active public market for our common stock. We cannot assure you that an active public market for our common stock will develop or be sustained in the future. If an active market for our common stock does not develop or is not sustained, the price may decline.

Because we are subject to the “penny stock” rules, brokers cannot generally solicit the purchase of our common stock which adversely affects its liquidity and market price.

The SEC has adopted regulations which generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share, subject to specific exemptions. The market price of our common stock on the Bulletin Board has been substantially less than $5.00 per share and therefore we are currently considered a “penny stock” according to SEC rules. This designation requires any broker-dealer selling these securities to disclose certain information concerning the transaction, obtain a written agreement from the purchaser and determine that the purchaser is reasonably suitable to purchase the securities. These rules limit the ability of broker-dealers to solicit purchases of our common stock and therefore reduce the liquidity of the public market for our shares.

Moreover, as a result of apparent regulatory pressure from the SEC and the Financial Industry Regulatory Authority, a growing number of broker-dealers decline to permit investors to re-sell shares of penny stocks like GelTech. This may have had and may continue to have a depressive effect upon the common stock price.

Due to factors beyond our control, our stock price may be volatile.

Any of the following factors could affect the market price of our common stock:

●

short selling or manipulative conduct by market makers and others,

●

our failure to generate recurring sustainable revenue,

●

our failure to achieve and maintain profitability,

●

the sale of a large amount of common stock by our shareholders including those who invested prior to commencement of trading,

25

●

actual or anticipated variations in our quarterly results of operations,

●

announcements by us or our competitors of significant contracts, new products, acquisitions, commercial relationships, joint ventures or capital commitments,

●

disclosure of any adverse results in litigation,

●

the loss of major customers or product or component suppliers,

●

the loss of significant business relationships,

●

our failure to meet financial analysts’ performance expectations,

●

changes in earnings estimates and recommendations by financial analysts, or

●

changes in market valuations of similar companies.

In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been instituted. A securities class action suit against us could result in substantial costs and divert our management’s time and attention, which would otherwise be used to benefit our business.

Because the majority of our outstanding shares are freely tradable, sales of these shares could cause the market price of our common stock to drop significantly, even if our business is performing well.

As of the date of this report, we had outstanding approximately 42.3 million shares of common stock, of which our directors and executive officers own approximately 19 million shares, which are subject to the limitations of Rule 144 under the Securities Act of 1933, which we refer to as the “Act”.  Substantially all of the remaining outstanding shares are freely tradable.

In general, Rule 144 provides that any non-affiliate of GelTech, who has held restricted common stock for at least six-months, is entitled to sell their restricted stock freely, provided that GelTech stays current in its SEC filings. After one year, a non-affiliate may sell without any restrictions.

An affiliate of GelTech may sell after six months with the following restrictions: (i) GelTech is current in its filings, (ii) certain manner of sale provisions, (iii) filing of Form 144, and (iv) volume limitations limiting the sale of shares within any three-month period to a number of shares that does not exceed 1% of the total number of outstanding shares. A person who has ceased to be an affiliate at least three months immediately preceding the sale and who has owned such shares of common stock for at least one year is entitled to sell the shares under Rule 144 without regard to any of the limitations described above.

An investment in GelTech may be diluted in the future as a result of the issuance of additional securities or the exercise of options or warrants.

In order to raise additional capital to fund our strategic plan, we may issue additional shares of common stock or securities convertible, exchangeable or exercisable into common stock from time to time, which could result in substantial dilution to any person who purchases our common stock. Because we have a negative net tangible book value, purchasers will suffer substantial dilution. We cannot assure you that we will be successful in raising funds from the sale of common stock or other equity securities.

In the future, we may issue preferred stock without the approval of our shareholders, which could make it more difficult for a third party to acquire us and could depress our stock price.

Our Board may issue, without a vote of our shareholders, one or more series of preferred stock that have more than one vote per share. This could permit our board of directors to issue preferred stock to investors who support us and our management and permit our management to retain control of our business. Additionally, issuance of preferred stock could block an acquisition resulting in both a drop in our stock price and a decline in interest of our common stock.

26

If our common stock becomes subject to a “chill” or a “freeze” imposed by the Depository Trust Company, or DTC, your ability to sell your shares may be limited.

The DTC acts as a depository or nominee for street name shares or stock that investors deposit with their brokers. Although through DTC our common stock is eligible for electronic settlement rather than delivery of paper certificates, DTC in the last several years has imposed a chill or freeze on the deposit, withdrawal and transfer of common stock of issuers whose common stock trades on the Bulletin Board. Depending on the type of restriction, it can prevent shareholders from buying or selling our shares and prevent us from raising money. A chill or freeze may remain imposed on a security for a few days or an extended period of time (in at least one instance a number of years). While we have no reason to believe a chill or freeze will be imposed against our common stock, if it were your ability to sell your shares would be limited.

Since we intend to retain any earnings for development of our business for the foreseeable future, you will likely not receive any dividends for the foreseeable future.

We have not and do not intend to pay any dividends in the foreseeable future, as we intend to retain any earnings for development and expansion of our business operations. As a result, you will not receive any dividends on your investment for an indefinite period of time.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not required for smaller reporting companies.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

See pages F-1 through F-32.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

None.

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures. Our management carried out an evaluation, with the participation of our Principal Executive Officer and Principal Financial Officer, of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act. Based on their evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

Management’s Annual Report on Internal Control over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act). Our management, under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our internal control over financial reporting as of the end of the period covered by this report. In making this assessment, our management used the criteria set forth by the Committee of Sponsor Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (1992 Framework). Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of the end of the period covered by this report based on that criteria.

Our internal control over financial reporting is a process designed under the supervision of our Principal Executive Officer and Principal Financial Officer to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external purposes in accordance with generally accepted accounting principles, or GAAP. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

27

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting. There were no changes in our internal control over financial reporting during the three months ended June 30, 2014 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION.

None.

28

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

The following table represents our Board of Directors as of the filing date of this report:

Name	Age	Position
Peter Cordani	53	Director
Michael Becker	63	Director
Leonard Mass	73	Director
Phil O’Connell, Jr.	74	Director
Neil Reger	76	Director

Peter Cordani has been our Chief Technology Officer since inception, our President since September 2013 and our Chief Executive Officer since January 21, 2014. Mr. Cordani has been a director since July 3, 2007. He is the inventor of all of our intellectual property. Mr. Cordani was selected as a director because of his patent experience and because he is the inventor of our technologies.  

Michael Becker became a director on January 3, 2012. Mr. Becker has been President of the accounting firm Michael C. Becker & Co. since 1979. From 1976 until August 2007, Mr. Becker served on the Miami-Dade Fire Department and retired as the Chief Fire Officer. Mr. Becker is a Certified Public Accountant in Florida. Mr. Becker was selected as a director because of his experience as an accountant, his knowledge of the fire industry and because he is independent.

Leonard Mass became a director on May 11, 2010. Since September 2005, Mr. Mass has been the Vice President of Land Development in the Real Estate Development division of the Drummond Company, Inc. a company which is principally engaged in the business of mining, purchasing, processing and selling of both thermal and metallurgical coal. Mr. Mass was selected as a director for his 40 years of experience in executive management and his background in finance and management and because he is independent.

Phil O’Connell, Jr. became a director in November 2006. Mr. O’Connell is an attorney and has been a partner at the law firm of Ciklin Lubitz Martens & O’Connell and predecessor law firms since 1969. Mr. O’Connell was selected as a director because of his experience as a lawyer and because he is independent.

Neil Reger became a director on October 1, 2013. Since his retirement over five years ago, Mr. Reger has been an active investor. Since his son Michael Reger has been an investor in GelTech, Mr. Reger has consulted with management on GelTech’s operations (without compensation). Mr. Reger was selected as a director because of his 45 years of business and management experience.

Executive Officers

Name	Age	Position
Peter Cordani	53	Chief Executive Officer, President and Chief Technology Officer
Michael Reger	51	Chief Operating Officer
Michael Hull	61	Chief Financial Officer

See above for Mr. Peter Cordani’s biography.

Michael Hull has served as our Chief Financial Officer since March 2008. Until September 1, 2011, Mr. Hull was working for us on a part-time basis. Since then, Mr. Hull has been with us on a full-time basis. From January 2008 until December 2009, Mr. Hull was a Director of CFO Services for WSR Consulting, Inc., which we refer to as WSR, which provides Chief Financial Officer and related services to businesses. Prior to Mr. Hull becoming a full-time employee, WSR provided Chief Financial Officer services to GelTech. Until August 31, 2011, Mr. Hull spent the majority of his time providing accounting services for Ecosphere Technologies, Inc. (OTCBB: ESPH).

29

Michael Reger has been our Chief Operating Officer since March 25, 2013. For over 20 years, Mr. Reger has been a partner at III Associates, a registered investment advisor, and AVM, L.P., an institutional broker dealer.

Mr. Michael Reger, our Chief Operating Officer, is the son of Neil Reger, a director of GelTech. There are no other family relationships between any of the executive officers and directors. Our Bylaws require that each director is elected at our annual meeting of shareholders and holds office until the next annual meeting of shareholders, or until his successor is elected and qualified. See the section titled “Certain Relationships, Related Transactions and Director Independence” below for further information concerning our employment of Cordani family members.

Corporate Governance

Board Responsibilities

The Board oversees, counsels, and directs management in the long-term interest of GelTech and its shareholders. The Board’s responsibilities include establishing broad corporate policies and reviewing the overall performance of GelTech. The Board is not, however, involved in the operating details on a day-to-day basis.

Board Committees and Charters

The Board and its Committees meet throughout the year and act by written consent from time-to-time as appropriate. The Board delegates various responsibilities and authority to different Board Committees. Committees regularly report on their activities and actions to the Board.

The Board currently has and appoints the members of: the Audit Committee, the Compensation Committee, which we refer to as the “Committee,” the Nominating Committee and the Executive Committee. The Audit Committee has a written charter approved by the Board which is attached as Exhibit 99.1 to this report.  

The following table identifies the independent and non-independent current Board and committee members:

Name	Independent	Audit	Compensation	Nominating	Executive
Peter Cordani
Michael Becker	ü	ü	ü		ü
Leonard Mass	ü	ü	ü		ü
Phil O’Connell, Jr.	ü	ü	ü	ü	ü
Neil Reger

Director Independence

Our Board has determined that Messrs. Becker, Mass and O’Connell are independent in accordance with standards under the Nasdaq Listing Rules. Our Board determined that as a result of being (or having a family member who was) employed as an executive officer, Messrs. Peter Cordani and Neil Reger were not independent under the Nasdaq Listing Rules.

Our Board has also determined that Messrs. Becker, Mass and O’Connell are independent under the Nasdaq Listing Rules independence standards for Audit Committee members and Committee members.

Committees of the Board of Directors

Audit Committee

The Audit Committee, which currently consists of Michael Becker, Leonard Mass, and Phil O’Connell, Jr., reviews GelTech’s financial reporting process on behalf of the Board and administers our engagement of the independent registered public accounting firm. The Audit Committee meets with the independent registered public accounting firm, with and without management present, to discuss the results of its examinations, the evaluations of our internal controls, and the overall quality of our financial reporting. Management has the primary responsibility for the financial statements and the reporting process, including the system of internal controls. 

30

Audit Committee Financial Expert

Our Board has determined that Mr. Michael Becker is qualified as an Audit Committee Financial Expert, as that term is defined by the rules of the SEC and in compliance with the Sarbanes-Oxley Act of 2002.

Compensation Committee

The function of the Committee is to determine the compensation of our executive officers. The Committee has the power to set performance targets for determining periodic bonuses payable to executive officers and may review and make recommendations with respect to shareholder proposals related to compensation matters. Additionally, the Committee is responsible for administering the 2007 Equity Incentive Plan, which we refer to as the “Plan.”

Nominating Committee

The responsibilities of the Nominating Committee include the identification of individuals qualified to become Board members, the selection of nominees to stand for election as directors, the oversight of the selection and composition of committees of the Board, establish procedures for the nomination process including procedures and the oversight of the evaluations of the Board and management. The Nominating Committee has not established a policy with regard to the consideration of any candidates recommended by shareholders since no shareholders have made any recommendations. If we receive any shareholder recommended nominations, the Nominating Committee will carefully review the recommendation(s) and consider such recommendation(s) in good faith.

Executive Committee

Our Executive Committee has the authority during intervals between the meetings of the Board to exercise all powers allowed under Delaware law and authority of the Board in the management of our business and affairs.

Code of Ethics

Our Board has adopted a Code of Ethics that applies to all of our employees, including our Chief Executive Officer and Chief Financial Officer. Although not required, the Code of Ethics also applies to our Board. The Code of Ethics provides written standards that we believe are reasonably designed to deter wrongdoing and promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, full, fair, accurate, timely and understandable disclosure and compliance with laws, rules and regulations, including insider trading, corporate opportunities and whistle-blowing or the prompt reporting of illegal or unethical behavior. We will provide a copy of the Code of Ethics to any person without charge, upon request. The request for a copy can be made in writing to GelTech Solutions, Inc., 1460 Park Lane South, Suite 1, Jupiter, Florida 33458, Attention: Mrs. Darlene Cordani.

Communication with our Board of Directors

Although we do not have a formal policy regarding communications with the Board, shareholders may communicate with the Board by writing to us at GelTech Solutions, Inc., 1460 Park Lane South, Suite 1, Jupiter, Florida 33458, Attention: Mrs. Darlene Cordani, or by facsimile (561) 427-6182. Shareholders who would like their submission directed to a member of the Board may so specify, and the communication will be forwarded, as appropriate.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10% of our common stock to file initial reports of ownership and changes in ownership of our common stock and other equity securities with the SEC. These individuals are required by the regulations of the SEC to furnish us with copies of all Section 16(a) forms they file. Based solely on a review of the copies of the forms furnished to us, and written representations from reporting persons that no Forms 5 were required to report delinquent filings, we believe that all filing requirements applicable to our officers, directors and 10% beneficial owners were complied with during fiscal year 2014.

31

ITEM 11. EXECUTIVE COMPENSATION.

The following information is related to the compensation paid, distributed or accrued by us for fiscal 2014 and 2013 to each of our Chief Executive Officers (principal executive officers) serving during fiscal 2014 and the two other most highly compensated executive officers serving at the end of the last fiscal year whose compensation exceeded $100,000, which we refer to as “Named Executive Officers.”

Summary Compensation Table

Name and Principal Position             (a)	Year (b)(1)	Salary ($)(c)(2)	Bonus ($)(d)(2)	Option Awards ($)(f)(3)	All Other Compensation ($)(i)(4)	Total ($)(j)
Peter Cordani	2014	150,000	30,000	252,719	7,200	439,919
Chief Executive Officer, President and Chief Technology Officer	2013	150,000	-0-	377,628	5,400	533,028
Michael Cordani	2014	87,500	65,000	252,719	4,200	409,419
Former Chief Executive Officer	2013	150,000	-0-	377,628	5,400	533,028
Michael Hull	2014	150,000	20,000	252,719	7,200	429,919
Chief Financial Officer	2013	150,000	-0-	377,628	5,400	533,028

———————

(1)

Year:  2014 is comprised of the period from July 1, 2013 until June 30, 2014.

(2)

Salary and Bonus: Represents cash compensation or bonus paid to the Named Executive Officer.  

(3)

Option Awards: The amounts in this column represents the fair value of the award as of the grant date as computed in accordance with FASB Accounting Standards Codification Topic 718. These amounts represent awards that are paid in options to purchase shares of our common stock and stock appreciation rights and do not reflect the actual amounts that may be realized by the Named Executive Officers. Our assumptions with respect to the calculation of their values are set forth in Note 1 in the consolidated financial statements contained herein. See Named Executive Officer Employment Agreements below for further description of the Option Awards.  Awards for 2014 represents a 250,000 option grant which vests based upon certain milestones in GelTech’s stock price.  Option Awards for 2013 represents a 125,000 option grant which vests in three equal annual increments.

(4)

All Other Compensation: Represents car allowance of $600 per month.  

32

Named Executive Officer Employment Agreements

The chart below summarizes the terms and conditions of employment agreements with our Named Executive Officers.

Executive	Term	Base Salary	Equity Grants
Peter Cordani	October 1, 2012 through September 30, 2016	$150,000 per year with increases if performance milestones are met (1)	800,000 stock appreciation rights (2)
Michael Hull	October 1, 2012 through September 30, 2016	$150,000 per year with increases if performance milestones are met (1)	800,000 stock appreciation rights (2)

———————

(1)

Base salary will increase to: (i) $170,000 upon GelTech generating $3,000,000 in revenue in any 12-month period, (ii) $190,000 upon GelTech generating $5,000,000 in any 12-month period and (iii) $200,000 upon GelTech generating $6,000,000 in any 12-month period. The Committee has the discretion to increase each of the Named Executive Officers base salary. Any such discretionary increase must be based on profitability, positive cash flow or such other factors as the Committee deems important.

(2)

Of the securities: (i) 200,000 vested immediately, (ii) 200,000 vest upon GelTech generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 vest upon GelTech generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 vest upon GelTech generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period.

The Committee will have the discretion to award each of the Named Executive Officers a bonus based upon job performance or any other factors determined by the Committee.

Termination Provisions

The table below describes the severance payments that our Named Executive Officers are entitled to in connection with a termination of their employment upon death, disability, dismissal without cause, or for Good Reason. All of the termination provisions are intended to comply with Section 409A of the Internal Revenue Code of 1986 and the Regulations thereunder.

	Peter Cordani	Michael Hull
Death or Total Disability	One year base salary and all equity shall vest	One year base salary and all equity shall vest
Dismissal Without Cause or Termination by Executive for Good Reason (1)	Greater of one year base salary and continuation of base salary through the end of the remaining four year term of the agreement and all equity shall vest	Greater of one year base salary and continuation of base salary through the end of the remaining four year term of the agreement and all equity shall vest

———————

(1)

Good Reason is generally defined as the material diminution of the Named Executive Officers’ duties due to no fault of the executive or any other action or inaction that constitutes a material breach by GelTech under the Employment Agreements.

33

Outstanding Awards at Fiscal Year End

Listed below is information with respect to unexercised options, stock that has not vested, and equity incentive plan awards for each Named Executive Officer outstanding as of June 30, 2014:

Outstanding Equity Awards As of June 30, 2014

Name   (a)	Number of Securities Underlying Unexercised Options (#) Exercisable (b)	Number of Securities Underlying Unexercised Options (#) Unexercisable (c)	Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) (d)	Option Exercise Price ($) (e)	Option Expiration Date (f)
Peter Cordani	185,008	0	0	0.667	March 16, 2018
	750,000	0	0	1.22	December 7, 2020
	175,000	0	0	0.81	September 19, 2021
	100,000	0	50,000 (1)	0.74	June 20, 2022
	200,000	0	600,000 (2)	0.45	October 1, 2022
	41,667	83,333 (3)	0	1.10	June 26, 2023
	0	0	250,000 (4)	1.30	July 28, 2023
Michael Cordani (5)	150,000	0	0	0.667	March 16, 2018
	750,000	0	0	1.22	December 7, 2020
	175,000	0	0	0.81	September 19, 2021
	100,000	0	50,000 (1)	0.74	June 20, 2022
	200,000	0	600,000 (2)	0.45	October 1, 2022
	41,667	83,333 (3)	0	1.10	June 26, 2023
	0	0	250,000 (4)	1.30	July 28,2023
Michael Hull	150,000	0	0	0.60	June 2, 2021
	100,000	0	50,000 (1)	0.74	September 19, 2021
	200,000	0	600,000 (2)	0.45	October 1, 2022
	41,667	83,333 (3)	0	1.10	June 26, 2023
	0	0	250,000 (4)	1.30	July 28, 2023

———————

(1)

Vests based on GelTech meeting certain performance milestones of which two-thirds of the milestones have been met as of the filing date hereof.  

(2)  

Of the securities: (i) 200,000 vested immediately, (ii) 200,000 vest upon GelTech generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 vest upon GelTech generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 vest upon GelTech generating $6,000,000 in revenue in any 12-month period.  

(3)

Vests in two equal increments on June 27, 2015 and 2016.

(4)  

Vests based on GelTech’s stock price meeting certain milestones.  

(5)

All of the options are owned by Mr. Cordani’s surviving wife.  

34

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

The following table sets forth the number of shares of our common stock beneficially owned as of September 26, 2014 by (i) those persons known by us to be owners of more than 5% of our common stock, (ii) each director, (iii) our Named Executive Officers, with the exception of Mr. Michael Cordani who does not need to be included in this table based on SEC regulations and (iv) all of our executive officers and directors of as a group. Unless otherwise specified in the notes to this table, the address for each person is: c/o GelTech Solutions, Inc., 1460 Park Lane South, Suite 1, Jupiter, Florida 33458.

Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Ownership (1)		Percent of Class (1)
Directors and Named Executive Officers:
Common Stock	Peter Cordani (2)		2,134,344		4.9	%
Common Stock	Michael Hull (3)		293,167		*
Common Stock	Michael Becker (4)		121,667		*
Common Stock	Leonard Mass (5)		500,405		*
Common Stock	Phil O’Connell, Jr. (6)		1,802,565		4.2	%
Common Stock	Neil Reger (7)		1,431,772		3.4	%
Common Stock	All directors and executive officers as a group (7 persons) (8)		30,987,623		55.4	%
5% Shareholder:
Common Stock	Michael Reger (9)		24,703,704		47.9	%

———————

* Less than 1%.

(1)

Applicable percentages are based on 42,264,310 shares outstanding as of September 26, 2014, adjusted as required by rules of the SEC. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock underlying options, SARs and warrants and convertible notes currently exercisable or convertible, or exercisable or convertible within 60 days are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any other person. Unless otherwise indicated in the footnotes to this table, GelTech believes that each of the shareholders named in the table has sole voting and investment power with respect to the shares of common stock indicated as beneficially owned by them. The table includes only vested options, SARs and warrants or options and warrants that will vest and become exercisable within 60 days.

(2)

Peter Cordani: Mr. Peter Cordani is a director and executive officer. Includes shares held by North Carolina River Ridge II LLC, a company managed by Mr. Peter Cordani. It owns 652,987 shares of common stock. Thus, under SEC rules, Mr. Peter Cordani is considered the beneficial owner as explained in Note (1). Also includes 1,210,008 shares issuable upon the exercise of vested options. Mr. Cordani is the trustee of three trusts which own 271,349 shares of GelTech.

(3)

Hull: Mr. Hull is an executive officer. Includes 291,667 shares issuable upon the exercise of vested options.

(4)

Becker: Mr. Becker is a director. Includes 90,000 shares issuable upon the exercise of vested options.

(5)

Mass: Mr. Mass is a director. Includes 436,667 shares issuable upon the exercise of vested options.

35

(6)

O’Connell: Mr. O’Connell is a director. Includes 350,000 shares issuable upon the exercise of warrants and 386,667 shares issuable upon the exercise of vested options. Also includes: (i) 95,241 shares jointly held by Mr. O’Connell and his wife, (ii) 915,407 shares held by the Phil D. O’Connell, Jr. Revocable Trust, of which Mr. O’Connell is the trustee, (iii) 23,750 shares held by Mr. O’Connell’s wife and (iv) 40,500 shares held in trusts for Mr. O’Connell’s children, of which Mr. O’Connell is the trustee. Mr. O’Connell disclaims beneficial ownership of the securities held by his wife and this disclosure shall not be deemed an admission that he is the beneficial owner of the securities held by his wife.

(7)

Neil Reger: Mr. Reger is a director.  Includes: (i) 542,307 shares of common stock and 200,000 shares issuable upon the exercise of warrants and 20,000 shares issuable upon the exercise of vested options directly held by Mr. Reger and (ii) 469,465 shares of common stock and 200,000 shares issuable upon exercise of warrants held by Mr. Reger’s wife.

(8)

Total D&O: Includes securities beneficially owned by Michael Reger, our Chief Operating Officer.

(9)

Michael Reger:  Mr. Reger is an executive officer.  These shares all also included in the “All directors and executive officers as a group” beneficial ownership amount. See Note 8 above. Includes 434,681 shares of common stock held in a grantor retained annuity trust of which Mr. Reger is the trustee. Also includes 6,707,094 shares issuable upon the conversion of convertible notes and 2,553,011 shares issuable upon the exercise of warrants. Address is 777 Yamato Road, Suite 300, Boca Raton, Florida 33431.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

The following related parties are employed at GelTech:

●

Darlene Cordani, the wife of Michael Cordani, our former Chief Executive Officer, is our controller and is paid $1,090 per week,

●

Michael and Peter Cordani’s father is employed as a researcher at $2,123 per week, and

●

Michael and Peter Cordani’s mother as a receptionist at $600 per week.

We believe all of these salaries are at or are below the going rate of what such services would cost on the open market.

Mr. Michael Reger, son of Neil Reger, a director, is employed as Chief Operating Officer. Mr. Reger has been paid no compensation for his employment with GelTech.

In September 2012, in connection with GelTech’s offer of a reduced exercise price to all outstanding warrant holders who exercised as of a certain date, Mr. Michael Reger exercised all of his then outstanding warrants at $0.50 per share. In December 2012, Michael Reger lent GelTech $250,000 and was issued a $275,000 one-year 10% original issue discount note convertible at $0.35 per share.

On February 1, 2013, Michael Reger lent GelTech $250,000. In connection with this loan, GelTech consolidated all of the outstanding notes held by Michael Reger and issued him a $1,997,483 note convertible at $0.35 per share due December 31, 2016, which we refer to as the “2013 Note.” The 2013 Note bears an annual interest rate of 7.5% with interest to be paid annually in cash or common stock at $0.35 per share at Michael Reger’s option. Also on February 1, 2013, GelTech issued Michael Reger 210,226 shares of common stock in lieu of a cash payment for $73,579 of interest owed under the notes which were cancelled in connection with the consolidation of his outstanding notes. Since February 1, 2013, Mr. Reger has been issued 428,032 shares of common stock in lieu of cash payments totaling $149,811 for interest under the 2013 Note.

36

Jerome Eisenberg, a former director and Executive Chairman, is an officer of TFISA, LLC, a company that was specifically formed to distribute FireIce® and SkinArmor™. TFISA and GelTech entered into an agreement in July 2009, prior to Mr. Eisenberg becoming a director. For the term of the Agreement, TFISA had exclusive rights to distribute:

●

FireIce® to governmental agencies worldwide including the U.S. excluding (i) any municipal, state owned or volunteer fire-fighting company or any state fire-fighting instrumentality in the U.S. and (ii) sales of FireIce® Products to the Forest Service.

●

SkinArmor™ worldwide; and

●

Eductors to apply FireIce® together with FireIce® Truck to all of Europe and various other countries throughout the world.

As of the filing date hereof, no sales have been made by TFISA. Furthermore, TFISA has not purchased any products from GelTech. In March 2013, GelTech gave TFSIA 180 days’ notice to terminate the Agreement subject to GelTech’s rights under the Agreement. TFSIA's counsel has notified GelTech that it may sue for damages. GelTech's position is that there is no liability and there are no damages since TFISA never generated any sales over four years as an exclusive sales agent.  We are currently in negotiations with our former director and TFISA to resolve this matter.  

On March 9, 2012, Mr. Eisenberg lent GelTech $75,000 and was issued a $76,875 six month original issue discount note with an effective annual interest rate of 5%. The note is convertible into GelTech’s common stock $0.50 per share. In September 2012, Mr. Eisenberg exchanged his note for a one year convertible original issue discount note in the amount of $86,100 convertible at $0.50 per share. In September 2013, GelTech pre-paid Mr. Eisenberg’s note.

In connection with the resignation of our former President, Mr. Joseph Ingarra, GelTech agreed to pay Mr. Ingarra 12 months of severance at the same rate as his current base salary, or $150,000 (plus COBRA reimbursement) payable in accordance with GelTech’s standard payroll practices with the first 10 months paid each month and the last four months paid once a month (in one-half of the monthly rate installments). The severance was in lieu of the approximately 45 months due under his Employment Agreement under certain circumstances. Additionally, GelTech granted Mr. Ingarra 112,500 fully-vested stock options exercisable at $0.39 per share, subject to a lockup agreement for the option shares and the other shares he currently owns. All other stock options and stock appreciation rights, or SARs, previously granted to Mr. Ingarra were cancelled.

In February 2013, GelTech sold 482,758 shares of common stock and received $280,000 from Michael Cordani, and Peter Cordani. In July 2013, Michael Reger lent GelTech $1,000,000. In connection with this loan, GelTech issued Michael Reger a $1,000,000 note convertible at $1.00 per share due July 11, 2018 and 500,000 five-year warrants exercisable at a $1.30 per share. The note bears an annual interest rate of 7.5%.

Since June 2012, Michael Reger has purchased 5,430,079 shares of common stock and been issued 1,710,510 warrants with exercise prices ranging from $1.00 and $2.00 per share for approximately $3,450,000.

See page 30 for disclosure regarding director independence.

37

ITEM 14. PRINCIPAL ACCOUNTANTS FEES AND SERVICES.

All of the services provided and fees charged by Salberg & Company, P.A., or Salberg, were approved by our Audit Committee.  The following table shows the fees paid to Salberg, our principal accountant for the fiscal years ended June 30, 2014 and 2013.

	Fiscal 2014 ($)		Fiscal 2013 ($)
Audit Fees (1)		$69,975		70,400
Audit Related Fees (2)		1,544		7,600
Tax Fees		0		0
All Other Fees		0		0
Total		$71,519		78,000

———————

(1)

Audit fees – these fees relate to the audit of our annual financial statements and the review of our interim quarterly financial statements.

(2)

Audit related fees – these fees relate primarily to the auditors’ review of our registration statements and audit related consulting.

38

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

(1)	Financial Statements. See Index to Consolidated Financial Statements, which appears on page F-1 hereof. The financial statements listed in the accompanying Index to Consolidated Financial Statements are filed herewith in response to this Item.
(2)	Financial Statements Schedules. All schedules are omitted because they are not applicable or because the required information is contained in the Consolidated Financial Statements or notes included herein.
(3)	Exhibits.

EXHIBIT INDEX

Exhibit		Incorporated by Reference			Filed or Furnished
No.	Exhibit Description	Form	Date	Number	Herewith
3.1	Certificate of Incorporation	Sb-2	7/20/07	3.1
3.2	Amended and Restated Bylaws	Sb-2	7/20/07	3.2
3.3	Amendment No. 1 to the Amended and Restated Bylaws	10-K	9/28/10	3.3
3.4	Amendment No. 2 to the Amended and Restated Bylaws	8-K	9/26/11	3.1
10.1	Amended and Restated 2007 Equity Incentive Plan	10-K/A	10/25/13	10.1
10.2	Form of Executive Employment Agreement *	10-Q	2/11/13	10.4
10.3	Jerome Eisenberg Employment Agreement*	10-Q	2/11/13	10.5
10.4	Form of Stock Appreciation Rights Agreement*	10-Q	2/11/13	10.7
10.5	Jerome Eisenberg Restricted Stock Unit Agreement*	10-Q	2/11/13	10.6
10.6	Credit Enhancement and Financing Security Agreement dated May 29, 2009	10-K	9/28/09	10.1
10.7	Revolving Line of Credit Agreement dated May 29, 2009	10-K	9/28/09	10.2
10.8	Renewal of Promissory Note dated May 20, 2010	10-K	9/28/10	10.7
10.9	Credit Enhancement and Financing Security Agreement dated May 20, 2010	10-K	9/28/10	10.8
10.10	Modification of Revolving Line of Credit Agreement dated May 20, 2010	10-K	9/28/10	10.9
10.11	Reger Note dated February 18, 2011	10-Q	5/13/11	10.11
10.12	Reger Stock Purchase Agreement dated February 18, 2011	10-K	9/28/11	10.15
10.13	Reger Note dated March 29, 2012	10-K	9/28/12	10.12
10.14	Reger Note dated December 27, 2012	10-Q	2/11/13	10.2
10.15	Reger Note dated February 1, 2013	10-Q	2/11/13	10.3
10.16	Reger Stock Purchase Agreement dated May 2, 2013	10-K	9/27/13	10.16
10.17	Reger Warrant dated May 2, 2013	10-K	9/27/13	10.17
10.18	Reger Warrant dated May 31, 2013	10-K	9/27/13	10.18
10.19	Reger Convertible Note dated July 11, 2013	S-1A	2/12/14	10.3
10.20	Reger Warrant dated July 11, 2013	10-K	9/24/13	10.20
10.21	Lincoln Park Purchase Agreement dated September 1, 2010	8-K	9/7/10	10.1
10.22	Lincoln Park Registration Rights Agreement dated September 1, 2010	8-K	9/7/10	10.2
10.23	Lincoln Park Warrant dated September 1, 2010	8-K	9/7/10	10.3
10.24	Lincoln Park Purchase Agreement dated January 4, 2012	8-K	1/6/12	10.1

39

10.25	Lincoln Park Registration Rights Agreement dated January 4, 2012	8-K	1/6/12	10.2
10.26	Lincoln Park Termination Agreement dated January 3, 2012	8-K	1/6/12	10.3
10.27	Hull Promissory Note	S-1	1/6/12	10.21
10.28	TFISA Distribution Agreement**	10-Q	2/14/12	10.2
10.29	Amendment No.1 to the TFISA Distribution Agreement**	10-Q	2/14/12	10.3
10.30	Eisenberg Promissory Note	S-1/A	3/13/12	10.24
10.31	Form of Convertible Note – Private Placement	10-Q	5/11/12	10.1
10.32	Ingarra Termination and Release Agreement	10-Q	5/13/13	10.4
10.33	Executive Stock Option Agreement*	10-Q	11/14/13	10.4
10.34	Director Stock Option Agreement				Filed
14.1	Code of Ethics	10-K	9/29/08	14.1
21.1	List of Subsidiaries	10-K	9/28/12	21.1
23.1	Consent of Salberg & Company, P.A.				Filed
31.1	Certification of Principal Executive Officer (Section 302)				Filed
31.2	Certification of Principal Financial Officer (Section 302)				Filed
32.1	Certification of Principal Executive Officer and Principal Financial Officer (Section 906)				Furnished
99.1	Audit Committee Charter				Filed
101 INS	XBRL Instance Document				Furnished***
101 SCH	XBRL Taxonomy Extension Schema				Furnished***
101 CAL	XBRL Taxonomy Extension Calculation Linkbase				Furnished***
101 LAB	XBRL Taxonomy Extension Label Linkbase				Furnished***
101 PRE	XBRL Taxonomy Extension Presentation Linkbase				Furnished***
101 DEF	XBRL Taxonomy Extension Definition Linkbase				Furnished***

———————

*

Management compensatory agreement.

**

Filed pursuant to a confidential treatment request. Portions of the exhibit have been omitted pursuant to the request for confidential treatment.

***

Attached as Exhibit 101 to this report are the Company’s financial statements for the fiscal year ended June 30, 2014 formatted in XBRL (eXtensible Business Reporting Language). The XBRL-related information in Exhibit 101 to this report shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, and is not filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of those sections.

Copies of this filing (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to GelTech Solutions, Inc., 1460 Park Lane South, Suite 1 Jupiter, Florida 33458, Attention: Corporate Secretary.

40

SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: September 29, 2014

GelTech Solutions, Inc.
By:	/s/ PETER CORDANI
	Peter Cordani Chief Executive Officer (Principal Executive Officer)

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signatures	Title	Date
/s/ MICHAEL HULL	Chief Financial Officer (Principal Financial Officer) and Chief Accounting Officer (Principal Accounting Officer)	September 29 2014
Michael Hull
/s/ NEIL REGER	Director	September 29, 2014
Neil Reger
/s/ PETER CORDANI	Director	September 29, 2014
Peter Cordani
/s/ MICHAEL BECKER	Director	September 29, 2014
Michael Becker
/s/ LEONARD MASS	Director	September 29, 2014
Leonard Mass
/s/ PHIL O’CONNELL, JR.	Director	September 29, 2014
Phil O’Connell, Jr.

41

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm	F-2
Consolidated Balance Sheets	F-3
Consolidated Statements of Operations	F-4
Consolidated Statements of Changes in Stockholders’ Equity (Deficit)	F-5
Consolidated Statements of Cash Flows	F-6
Notes to Consolidated Financial Statements	F-8

F - 1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

GelTech Solutions, Inc.

We have audited the accompanying consolidated balance sheets of GelTech Solutions, Inc. and Subsidiaries (the “Company”) as of June 30, 2014 and 2013, and the related consolidated statements of operations, changes in stockholders’ equity (deficit) and cash flows for each of the two years in the period ended June 30, 2014. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of GelTech Solutions, Inc. and Subsidiaries as of June 30, 2014 and 2013, and the consolidated results of its operations and its cash flows for each of the two years in the period ended June 30, 2014, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has a net loss and net cash used in operating activities in 2014 of $7,111,945 and $5,132,019 respectively and has an accumulated deficit and stockholders’ deficit of $35,133,578 and $1,898,315, respectively, at June 30, 2014. These matters raise substantial doubt about the Company's ability to continue as a going concern. Management’s Plan in regards to these matters is also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Salberg & Company, P.A.

Salberg & Company, P.A.

Boca Raton, Florida

September 29, 2014

2295 NW Corporate Blvd., Suite 240 • Boca Raton, FL 33431-7328

Phone: (561) 995-8270 • Toll Free: (866) CPA-8500 • Fax: (561) 995-1920

www.salbergco.com • info@salbergco.com

Member National Association of Certified Valuation Analysts • Registered with the PCAOB

Member CPAConnect with Affiliated Offices Worldwide • Member AICPA Center for Audit Quality

F - 2

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	As of June 30,
	2014			2013
ASSETS
Cash and cash equivalents	$	66,266		$	90,275
Accounts receivable trade, net		35,276			37,277
Inventories		843,864			588,703
Prepaid expenses and other current assets		88,836			66,756
Total current assets		1,034,242			783,011
Furniture, fixtures and equipment, net		175,751			158,184
Deposits		30,086			26,886
Total assets	$	1,240,079		$	968,081
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	$	228,063		$	265,122
Accrued expenses		189,933			176,734
Litigation accrual		505,000			505,000
Accrual for severance agreement		—			102,056
Convertible notes - related parties, net of discount		—			79,261
Convertible notes - third parties, net of discount		—			192,163
Insurance premium finance contract		13,574			11,796
Deferred revenue		—			7,019
Total current liabilities		936,570			1,339,151
Convertible notes - related party, net of discounts		2,201,824			1,899,316
Total liabilities		3,138,394			3,238,467
Commitments and contingencies (Note 10)
Stockholders' deficit
Preferred stock: $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding		—			—
Common stock: $0.001 par value; 50,000,000 shares authorized; 40,301,979 and 33,084,671 shares issued and outstanding as of June 30, 2014 and 2013, respectively.		40,302			33,084
Additional paid in capital		33,194,961			25,718,163
Accumulated deficit		(35,133,578	)		(28,021,633	)
Total stockholders' deficit		(1,898,315	)		(2,270,386	)
Total liabilities and stockholders' deficit	$	1,240,079		$	968,081

The accompanying notes are an integral part of these consolidated financial statements.

F - 3

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Years Ended June 30,
	2014			2013
Sales	$	814,587		$	526,010
Cost of goods sold		393,102			180,427
Gross profit		421,485			345,583
Operating expenses:
Selling, general and administrative expenses		6,601,353			6,103,435
Research and development		274,005			179,158
Total operating expenses		6,875,358			6,282,593
Loss from operations		(6,453,873	)		(5,937,010	)
Other income (expense)
Interest income		276			864
Loss on settlement		—			(5,088	)
Loss on sale of assets		(11,413	)		(9,822	)
Loss on extinguishment of debt		—			(25,515	)
Loss on conversion of interest		(201,175	)		—
Other income (loss)		17,000			1,298,920
Cost of repricing warrants to induce exercise		—			(70,491	)
Interest expense		(462,760	)		(473,605	)
Total other income (expense)		(658,072	)		715,263
Net loss	$	(7,111,945	)	$	(5,221,747	)
Net loss per common share - basic and diluted	$	(0.20	)	$	(0.18	)
Weighted average shares outstanding - basic and diluted		36,410,142			29,479,048

The accompanying notes are an integral part of these consolidated financial statements.

F - 4

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

							Additional
	Common Stock						Paid In			Accumulated
	(Shares)			Par Value			Capital			Deficit			Total
Balance at July 1, 2012		24,914,474		$	24,914		$	19,809,070		$	(22,799,886	)	$	(2,965,902	)
Common stock issued for cash		3,539,321			3,539			1,654,461			—			1,658,000
Common stock issued in connection with stock purchase agreement		1,333,820			1,334			808,669			—			810,003
Common stock and warrants issued for cash		375,000			375			299,625			—			300,000
Common stock issued upon exercise of options		11,667			12			6,522			—			6,534
Common stock issued upon exercise of warrants		1,829,171			1,829			908,171			—			910,000
Common stock issued for interest		210,226			210			77,574						77,784
Grant of restricted stock units		200,000			200			89,800			—			90,000
Convertible note conversions		870,992			871			434,624			—			435,495
Cancellation of restricted stock units grant under clawback provision		(200,000	)		(200	)		(89,800	)		—			(90,000	)
Options and stock appreciation rights vested		—			—			1,407,534			—			1,407,534
Beneficial conversion feature of debt offerings		—			—			309,342			—			309,342
Cost of repricing warrants to induce warrant exercise		—			—			70,491			—			70,491
Cancellation of stock appreciation rights grant under clawback provision		—			—			(67,920	)		—			(67,920	)
Net loss for the fiscal year ended June 30, 2013		—			—			—			(5,221,747	)		(5,221,747	)
Balance at June 30, 2013		33,084,671			33,084			25,718,163			(28,021,633	)		(2,270,386	)
Common stock issued for cash		3,352,726			3,353			2,128,174			—			2,131,527
Common stock issued in connection with stock purchase agreement		577,428			577			569,423			—			570,000
Common stock and warrants issued for cash		2,575,579			2,576			1,702,424			—			1,705,000
Common stock issued upon exercise of options		20,000			20			18,180			—			18,200
Common stock issued upon exercise of warrants		20,000			20			24,980			—			25,000
Common stock issued for interest		436,912			437			354,989			—			355,426
Convertible note conversions		234,663			235			81,897			—			82,132
Options and stock appreciation rights vested		—			—			1,682,833			—			1,682,833
Beneficial conversion feature of debt offerings		—			—			913,898			—			913,898
Net loss for the fiscal year ended June 30, 2014		—			—			—			(7,111,945	)		(7,111,945	)
Balance at June 30, 2014		40,301,979		$	40,302		$	33,194,961		$	(35,133,578	)	$	(1,898,315	)

The accompanying notes are an integral part of these consolidated financial statements.

F - 5

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Year Ended June 30,
	2014			2013
Cash flows from operating activities
Reconciliation of net loss to net cash used in operating activities:
Net loss	$	(7,111,945	)	$	(5,221,747	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		55,284			49,269
Bad debt expense		20,068			—
Amortization of beneficial conversion feature of convertible notes		223,025			—
Amortization of original issue discounts related to convertible notes		5,791			385,650
Equity compensation expense		1,682,833			1,497,534
Cost of repricing warrants to induce exercise		—			70,491
Loss on disposal of assets		11,413			9,822
Loss on stock issued for interest		201,175			4,205
Other income from the clawback of equity compensation		—			(157,920	)
Reversal of litigation accrual		—			(941,000	)
Payment by insurance company of prior period litigation expense		—			(200,000	)
Changes in assets and liabilities:
Accounts receivable		(18,067	)		17,883
Inventories		(266,574	)		(42,585	)
Prepaid expenses and other current assets		46,862			26,500
Other assets		(3,200	)		(11,255	)
Accounts payable		(37,059	)		30,748
Accrual for severance agreement		(102,056	)		102,056
Deferred revenue		(7,019	)		7,019
Accrued expenses		167,450			177,675
Net cash used in operating activities		(5,132,019	)		(4,195,655	)
Cash flows from Investing Activities
Proceeds from sale of asset		—			15,000
Purchases of equipment		(72,851	)		(43,496	)
Net cash used in investing activities		(72,851	)		(28,496	)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements		2,131,527			1,658,000
Proceeds from sale of stock and warrants through private placements		1,705,000			300,000
Proceeds from sale of stock under stock purchase agreement		570,000			810,003
Proceeds from exercise of warrants		25,000			910,000
Proceeds from exercise of stock options		18,200			6,534
Repayments of convertible notes from third parties		(115,822	)		—
Payments on notes with related parties		(85,880	)		(84,380	)
Proceeds from convertible notes with third parties		—			175,000
Proceeds from convertible notes with related parties		1,000,000			500,000
Payments on insurance finance contract		(67,164	)		(44,925	)
Net cash provided by financing activities		5,180,861			4,230,232
Net increase (decrease) in cash and cash equivalents		(24,009	)		6,081
Cash and cash equivalents - beginning		90,275			84,194
Cash and cash equivalents - ending	$	66,266		$	90,275

The accompanying notes are an integral part of these consolidated financial statements.

F - 6

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

	For the Year Ended June 30,
	2014		2013
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	$	2,736	$	2,702
Cash paid for income taxes	$	—	$	—
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	$	68,942	$	47,471
Beneficial conversion feature of convertible notes	$	913,898	$	309,342
Conversion of notes for common stock	$	82,132	$	435,495
Common stock issued for accrued interest	$	154,251	$	77,784

The accompanying notes are an integral part of these consolidated financial statements.

F - 7

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

1.

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

GelTech Solutions, Inc., or GelTech or the Company, generates revenue primarily from marketing the following three products: (1) FireIce®, a water enhancing powder that can be utilized both as a fire suppressant in urban firefighting, including underground utility fires, and in wildland firefighting and as a medium-term fire retardant to protect wildlands, structures and firefighters; (2) Soil₂O® “Dust Control”, our application which is used for dust mitigation in the aggregate, road construction, mining, as well as, other industries that deal with daily dust control issues and (3) Emergency Manhole FireIce Delivery System, or EMFIDS, an innovative system designed to deliver FireIce® into a manhole in the event of a fire. Other products currently being marketed include (1) FireIce® Home Defense Unit, a system for applying FireIce® to structures to protect them from wildfires; and (2) Soil₂O®, a product which reduces the use of water and is primarily marketed to golf courses, commercial landscapers and the agriculture market. During the fourth quarter of fiscal 2014, the Company developed and began marketing two new products, (1) GT-W14, an industrial absorbent powder used to contain and clean up industrial liquid spills; and (2) Soil₂O® Soil Cap, a dust suppressant technology designed to stabilize stockpile dust and reduce soil erosion. Our consolidated financial statements have been prepared on a going concern basis, and we need to generate sufficient material revenues to support the ongoing business of GelTech.

The corporate office is located in Jupiter, Florida.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its three wholly-owned subsidiaries: FireIce Gel, Inc., GelTech International, Inc. and Weather Tech Innovations, Inc. There has been no activity in Weather Tech Innovations, Inc. and GelTech International, Inc. All intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

For the purposes of the statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company’s cash equivalents consist of a brokerage money market account.

Investments in Marketable Securities

The Company may invest in various marketable securities and accounts for such investments in accordance with ASC 320-10.

Certain securities that the Company may invest in may be determined to be non-marketable. Non-marketable securities where the Company owns less than 20% of the investee are accounted for at cost pursuant to ASC 323-10.

Management determines the appropriate classification of its investments at the time of acquisition and reevaluates such determination at each balance sheet date. Trading securities that the Company may hold are treated in accordance with ASC 320-10 with any unrealized gains and losses included in earnings. Available-for-sale securities are carried at fair value, with unrealized gains and losses, net of tax, reported as a separate component of stockholders' equity. Investments classified as held-to-maturity are carried at amortized cost. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method.

F - 8

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

The Company periodically reviews its investments in marketable and non-marketable securities and records a reserve for impairment for any securities whose value is considered non-recoverable. The Company's determination of whether a security is other than temporarily impaired incorporates both quantitative and qualitative information. GAAP requires the exercise of judgment in making this assessment for qualitative information, rather than the application of fixed mathematical criteria. The Company considers a number of factors including, but not limited to, the length of time and the extent to which the fair value has been less than cost, the financial condition and near term prospects of the issuer, the reason for the decline in fair value, changes in fair value subsequent to the balance sheet date, and other factors specific to the individual investment. The Company's assessment involves a high degree of judgment and accordingly, actual results may differ materially from the Company's estimates and judgments.

Accounts Receivable

Accounts receivable are customer obligations due under normal trade terms. Senior management reviews accounts receivable on a monthly basis to determine if any receivables will potentially be uncollectible. The Company includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve, in its overall allowance for doubtful accounts. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.

Inventories

Inventories are stated at the lower of cost or market, with cost determined using a first-in, first-out method.

Property and Equipment and Depreciation

Property and equipment is recorded at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets of 3 to 7 years. Leasehold improvements are amortized over the lesser of the lease term or the useful life of the improvements. Expenditures for maintenance and repairs are expensed as incurred.

Impairment of Long-Lived Assets

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

Fair Value of Financial Instruments and Fair Value Measurements

We measure our financial assets and liabilities in accordance with ASC 820 "Fair Value Measurements and Disclosures". For certain of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued expenses, the carrying amounts approximate fair value due to their short maturities. The carrying amount of our convertible and other debt approximates the fair value because the interest rate on those debts do not vary materially from the market rate for similar debt instruments.

F - 9

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

We adopted accounting guidance for fair value measurements of financial assets and liabilities and adopted the same guidance for non-financial assets and liabilities effective July 1, 2009. The adoption did not have a material impact on our results of operations, financial position or liquidity. The standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

Level 1:

Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2:

Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.

The Company had no financial or non-financial assets or liabilities measured at fair value and subject to this accounting standard as of June 30, 2014 or 2013.

Revenue Recognition

Revenue from sales of products is recognized when persuasive evidence of an arrangement exists, products have been shipped to the customer, economic risk of loss has passed to the customer, the price is fixed or determinable, collection is reasonably assured, and any future obligations of the Company are insignificant. Revenue is shown net of returns and allowances. The Company does provide certain customers with the right of return for unsold product. Sales to these customers are recorded as the customer sells the product, thus removing the right of return.

Products shipped from either our third-party fulfillment companies or our Jupiter, Florida or Irwindale, California locations are shipped FOB shipping point. Normal payment terms are net 30 or net 60 days depending on the arrangement we have with the customer. As such, revenue is recognized when product has been shipped from either the third-party fulfillment company or from the Jupiter, Florida or Irwindale, California locations.

The Company follows the guidance of ASC 605-50-25, “Revenue Recognition, Customer Payments”. Accordingly, any incentives received from vendors are recognized as a reduction of the cost of products. Promotional products or samples given to customers or potential customers are recognized as a cost of goods sold. However, products we utilize to perform demonstrations for potential customers are recorded as a marketing expense in operations. During the fiscal years ended June 30, 2014 and 2013, these demonstration costs amounted to $4,195 and $10,889, respectively. Cash incentives provided to our customers are recognized as a reduction of the related sale price, and, therefore, are a reduction in sales.

Shipping and Handling Costs

Amounts invoiced to customers for shipping and handling are included in revenues. Shipping and handling costs related to sales of products are included in selling, general and administrative expenses and were $52,594 and $51,943 in 2014 and 2013, respectively.

Research and Development

In accordance with ASC 730-10 expenditures for research and development of the Company's products are expensed when incurred, and are included in operating expenses. The Company recognized research and development costs of $274,005 and $179,158 for the fiscal years ended June 30, 2014 and 2013, respectively.

F - 10

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Advertising

The Company conducts advertising for the promotion of its products and services. In accordance with ASC 720-35, advertising costs are charged to operations when incurred; such amounts aggregated $42,575 in fiscal 2014 and $26,931 in fiscal 2013.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management believes that the estimates utilized in preparing its consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Significant estimates in fiscal 2014 and fiscal 2013 include the allowance for doubtful accounts, depreciation and amortization, valuation of inventories, valuation of the beneficial conversion features associated with convertible notes, valuation of options and warrants granted for services or settlements, valuation of common stock granted for services or for debt conversion, accruals for litigation losses and the valuation of deferred tax assets.

Net Earnings (Loss) per Share

The Company computes net earnings (loss) per share in accordance with ASC 260-10. ASC 260-10 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. For the years ended June 30, 2014 and 2013, there was no separate computation of dilutive net loss per share since the common stock equivalents outstanding were anti-dilutive due to the net losses. At June 30, 2014 there were options to purchase 9,742,840 shares and warrants to purchase 3,387,121 shares of common stock outstanding which may dilute future earnings per share. In addition, there are 6,707,094 shares reserved for issuance related to convertible note agreements.

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718-10 “Compensation – Stock Compensation” which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options, restricted stock units, and stock appreciation rights are based on estimated fair values. Stock option compensation expense recognized under ASC 718-10 for the years ended June 30, 2014 and 2013 was $1,680,358 and $1,480,377, respectively, related to employee, director and advisory board stock options, and is included in selling, general and administrative expenses in the consolidated statements of operations. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. At June 30, 2014, the total compensation cost for stock options not yet recognized was $836,656. This cost will be amortized on a straight-line basis over the remaining vesting period of the options.

The Company accounts for non-employee stock based awards at fair value in accordance with the measurement and recognition criteria of ASC 505-50 "Equity Based payments to Non-Employees. Stock based compensation to non-employees recognized for the years ended June 30, 2014 and 2013 was $2,475 and $17,157, respectively.

2007 Equity Incentive Plan

In January 2007, the Company established the 2007 Equity Incentive Plan under which provided for the issuance of up to 1,500,000 stock options, stock appreciation rights, restricted stock or restricted stock units to our directors, employees and consultants. In September 2008, the Board of Directors approved an amendment to the Company’s 2007 Equity Incentive Plan to increase the number of shares authorized by the plan from 1,500,000 to 3,500,000. In fiscal 2012, Board of Directors increased the number of share authorized under the Plan to 4,500,000. In June 2013, the Board of Directors approved an amendment to increase the number of shares authorized by the plan to 15,000,000.

F - 11

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Under the Equity Incentive Plan, all directors who are not employees or own 10% or more of the Company’s outstanding stock at the time of grant shall automatically receive a grant of stock options as follows:

Initial Grants

A – Chairman of the Board

- 50,000 options

B – Director

- 30,000 options

C – Chair of a Committee

- 10,000 options

D – Member of a Committee

- 5,000 options

In June 2013, the Board of Directors increased the annual grants to the following amounts:

Annual Grants

A – Chairman of the Board

- 70,000 options

B – Director

- 100,000 options

C – Chair of a Committee

- 20,000 options

D – Member of a Committee

- 10,000 options

All initial grants of options to new non-employee directors and committee members vest annually over a three year period on the anniversary date of the grant, subject to continuing service as a director, Committee member, Chairman of the Board or Chairman of a Committee on the applicable vesting date. Options automatically granted annually under the 2007 Equity Incentive Plan vest the following June 30th, subject to continuing service as a director. The exercise price of options or stock appreciation rights granted under the 2007 Equity Incentive Plan shall not be less than the fair market value of the underlying common stock at the time of grant. In the case of incentive stock options, the exercise price may not be less than 110% of the fair market value in the case of 10% shareholders. Options and stock appreciation rights granted under the 2007 Equity Incentive Plan shall expire no later than ten years after the date of grant. The option price may be paid in United States dollars by check or wire transfer or, at the discretion of the Board of Directors or Compensation Committee, by delivery of shares of our common stock having fair market value equal as of the date of exercise to the cash exercise price, or a combination thereof.

The identification of individuals entitled to receive awards, the terms of the awards, and the number of shares subject to individual awards, are determined by the Board of Directors or the Compensation Committee, in their sole discretion. The purchase price per share, if applicable, shall be adjusted for any increase or decrease in the number of issued shares resulting from a recapitalization, reorganization, merger, consolidation, exchange of shares, stock dividend, stock split, reverse stock split, or other subdivision or consolidation of shares.

The Board of Directors or the Compensation Committee may from time to time alter, amend, suspend, or discontinue the Equity Incentive Plan with respect to any shares as to which awards of stock rights have not been granted. However no rights granted with respect to any awards under this Equity Incentive Plan before the amendment or alteration shall be impaired by any such amendment, except with the written consent of the grantee. Under the terms of the Equity Incentive Plan, the Board of Directors or the Compensation Committee may also grant awards which will be subject to vesting under certain conditions. The vesting may be time-based or based upon meeting performance standards, or both.

In April 2010, the Company amended the 2007 Equity Incentive Plan to increase the number of stock options granted annually to directors from 20,000 to 50,000. In June 2013, the Company amended the 2007 Equity Incentive Plan to increase the number of stock options granted annually to directors to 100,000.

All of our Stock Option Agreements provide for “clawback” provisions, which enable our Board of Directors to cancel stock awards and recover past profits if the person is dismissed for cause or commits certain acts which harm us.

Determining Fair Value under ASC 718-10

The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company’s determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables.

F - 12

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Income Taxes

The Company accounts for income taxes pursuant to the provisions of ASC 740-10, "Accounting for Income Taxes," which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

The Company follows the provisions of the ASC 740 -10 related to, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

Effective July 1, 2007, the Company adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of June 30, 2014, the fiscal tax years ended June 30, 2011, 2012 and 2013 are still subject to audit.

Legal Costs and Contingencies

In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received.

If a loss is considered probable and the amount can be reasonably estimated, the Company recognizes an expense for the estimated loss. If the Company has the potential to recover a portion of the estimated loss from a third party, the Company makes a separate assessment of recoverability and reduces the estimated loss, if recovery is also deemed probable.

New Accounting Pronouncements

Accounting Standards Updates (ASUs) which were not effective until after June 30, 2014 are not expected to have a significant effect on the Company's consolidated financial position or results of operations.

F - 13

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

2.

GOING CONCERN

These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize it assets and discharge its liabilities in the normal course of business. The Company has a net loss and net cash used in operating activities in fiscal 2014 of $7,111,945 and $5,132,019 respectively and has an accumulated deficit and stockholders’ deficit of $35,133,578 and $1,898,315, respectively, at June 30, 2014. In addition, the Company has not yet generated revenue sufficient to support ongoing operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders, the ability of the Company to obtain necessary debt or equity financing to continue operations, and the attainment of profitable operations. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

During the year ended June 30, 2014 the Company received $2,131,527 in exchange for common stock and $1,705,000 in exchange for common stock and warrants in connection with private placements, received $43,200 in connection with the exercise of options and warrants and received $1,000,000 in exchange for convertible notes. In addition, the Company received $570,000 under the stock purchase agreement with Lincoln Park Capital, signed in January 2012. This stock purchase agreement expired in July 2014.

Management believes that the actions presently being taken provide the opportunity for the Company to continue as a going concern.

3.

ACCOUNTS RECEIVABLE

Accounts receivable at June 30, 2014 and 2013 was as follows:

	2014			2013
Accounts receivable	$	95,869		$	77,802
Allowance for doubtful accounts		(60,593	)		(40,525	)
	$	35,276		$	37,277

Bad debt expense on trade accounts receivable for 2014 and 2013 was $20,068 and $-0-, respectively.

4.

INVENTORIES

Inventories consisted of the following at June 30, 2014 and 2013:

	2014		2013
Finished goods	$	491,409	$	333,987
Raw materials		352,455		254,716
	$	843,864	$	588,703

F - 14

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

5.

FURNITURE, FIXTURES AND EQUIPMENT

Furniture, fixtures and equipment consisted of the following as of June 30, 2014 and 2013:

	Estimated	June 30,
	Useful Life	2014			2013
Equipment	3 - 5 years	$	111,488		$	88,875
Storage facilities	3 years		20,802			20,802
Vehicles	5 - 7 years		214,470			164,232
Furniture and fixtures	5 years		20,420			20,420
			367,180			294,329
Accumulated depreciation			(191,429	)		(136,145	)
		$	175,751		$	158,184

Depreciation expense in 2014 and 2013 was $55,284 and $49,269, respectively.

6.

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS

On May 29, 2009, the Company received a line of credit (“Line of Credit”) from the Company’s principal stockholder (the “Lender”). In connection with this Line of Credit, the Company executed a Revolving Promissory Note which permitted the Company to borrow up to $2,500,000. Interest, at an annual rate of 5%, was due monthly on the 20th day of each month which commenced on July 20, 2009.

In February 2011, the Company renegotiated the Line of Credit Agreement with the Lender. As part of the renegotiation, the Company issued 892,857 shares of the Company’s common stock and five-year warrants to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $1.25 per share in exchange for a $1,000,000 reduction in the principal amount of the Line of Credit. In addition, the remaining principal amount due under the line of credit of $1,497,483 was replaced by a five-year convertible note of the same amount, convertible at $1.12 per share (fair market value on transaction date based upon the quoted trading price) and bearing annual interest of 5%, due on the maturity date of the note (the “2011 Note”). As an inducement for the Lender to enter into the convertible note agreement, the Company granted the Lender five-year warrants to purchase 300,000 shares of the Company’s common stock at an exercise price of $1.75 per share. These warrants were exercised in September 2012 in exchange for $150,000 in connection with the Company’s offer to all warrant holders to exercise warrants at $0.50 per share instead of the exercise price negotiated on the date of the grant. In February 2013, the 2011 Note, plus a $275,000 convertible original issue discount note were combined into one convertible note, see discussion below.

In December 2011, the Company received short term advances from its then Chief Executive Officer, former President and Chief Financial Officer in the amounts of $10,000, $29,380 and $50,000, respectively. The advances bear interest rates of 0.7%, 5.0% and 5.0%, respectively. In addition, as further inducement for the advance from the Chief Financial Officer, the Company approved the reduction in the exercise price of 150,000 options granted to the Chief Financial Officer from $1.95 to $0.60 per share. In connection with this repricing, the expense related to the vesting of these options was increased by $15,067 which will be recognized over the remaining service period. As of June 30, 2014, the Company has repaid all amounts due related to these advances.

F - 15

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

On March 9, 2012, the Company received $105,000 from third parties in exchange for nine month convertible original issue discount notes in the amount of $107,625. The notes bear an annual interest rate of 5% and are convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the notes, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $84,562 which will be amortized to interest expense over the life of the notes. In September 2012, the Company issued new one-year convertible original issue discount notes in the amount of $120,540, bearing annual interest of 12% and convertible at $0.50 per share in exchange for cancellation of the old notes. This modification was not considered a debt extinguishment. In accordance with ASC 470, the Company recognized a debt discount related to the change in fair value of the embedded conversion option in the amount of $35,138 which was amortized to interest expense over the life of the convertible notes. In August 2013, the Company paid one note in the amount of $34,440 by issuing 8,880 shares of common stock and a payment of $30,000. The remaining note in the amount of $86,100 was retired in August 2013 by the payment of $85,822.

On March 10, 2012, the Company received $75,000 from a director in exchange for a nine month convertible original issue discount note in the amount of $76,875. The note bears an annual interest rate of 5% and is convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the note, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $63,038 was amortized to interest expense over the life of the note. In September 2012, the Company issued a new one-year convertible original issue discount note in the amount of $86,100, bearing annual interest of 12% and convertible at $0.50 per share in exchange for cancellation of the old note. This modification was not considered a debt extinguishment. In accordance with ASC 470, the Company recognized a debt discount related to the change in fair value of the embedded conversion option in the amount of $24,971 which was amortized to interest expense over the life of the convertible note. In September 2013, the Company repaid the note.

In August 2012, the Company received $175,000 in exchange for six month convertible original issue discount notes in the amount of $179,375 with two accredited investors. The notes are convertible into common stock at $0.50 per share. The notes bear an annual interest rate of 5% and are convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the notes, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $106,600 and an original issue discount of $4,375 which are being amortized to interest expense over the life of the notes. In February 2013, one note holder was issued 205,000 shares of the Company’s common stock in exchange for a note in the amount of $102,500. In addition, the other note holder was issued a new one year original issue discount note for $86,100 convertible at $0.35 per share. The Company recorded an original issue discount of $9,225 and a beneficial conversion feature discount of $4,920 in connection with the new note. For the period February 2013 to August 2013, the Company recognized interest expense of $7,552 and $4,920, respectively, related to the amortization of the original issue discount and the beneficial conversion feature discount. In August 2013, the Company issued 234,663 shares of common stock valued at $82,132, in connection with the early conversion of this note.

On December 28, 2012, the Company received $250,000 from its principal stockholder in exchange for a one year convertible original issue discount note in the amount of $275,000 (the “2012 Note”). The note bears an annual interest rate of 10% and is convertible into the Company's common stock at the rate of $0.35 per share. In connection with the issuance of the note, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $23,571 and an original issue discount of $25,000 which is being amortized to interest expense over the life of the note.

F - 16

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

In February 2013, the Company entered into a new convertible note agreement in the amount of $1,997,483, convertible into common stock at a conversion price of $0.35 per share, bearing interest at an annual rate of 7.5% and due on December 31, 2016. This note was issued in exchange for the 2011 Note and the 2012 Note and receipt of $250,000. In connection with the transaction, the Company issued 210,226 shares of common stock in exchange for accrued interest of $73,579 due on the 2011 and 2012 notes resulting in a loss on conversion of interest of $4,204. The exchange of cash and the 2011 and 2012 notes was recorded as a debt extinguishment which resulted in a loss on extinguishment of debt in the amount of $21,311 for the year ended June 30, 2013. Because this convertible debt instrument contained an embedded beneficial conversion feature, and was extinguished before conversion, the amount of the reacquisition price to be allocated to the repurchased beneficial feature was measured using the intrinsic value of that conversion feature at the extinguishment date and was immaterial. In connection with the new note agreement, the Company recorded a note discount in the amount of $114,142 related to the beneficial conversion feature of the note calculated using the intrinsic value, of which $55,110 has been amortized as of June 30, 2014. The Company issued 428,032 shares of common stock in satisfaction of accrued interest in the amount $149,811. In connection with the issuance, the Company recorded a loss on conversion of interest of $201,175 representing the difference between the conversion rate of $0.35 per share and the market price of the stock of $0.82 per share.

In July 2013, the Company received $1 million from its Chief Operating Officer and principal stockholder in exchange for a five year, $1 million convertible note with a conversion rate of $1.00 per share and an annual interest of 7.5%, plus five year warrants to purchase 500,000 shares of the common stock at $1.30 per share. The Company estimated the relative fair market value of the warrants to be $311,949 using the Black-Scholes model using a volatility of 91.46% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 5 years (the term of the warrants) and a discount rate of 1.4%. In addition, the Company estimated the intrinsic value of the beneficial conversion feature of the note to be $601,949. For the year ended June 30, 2014, the Company recognized interest expense from the amortization of the debt discounts related to this note in the amount of $177,271. As of June 30, 2014, accrued interest due under the note amounted to $75,000.

A summary of notes payable and related discounts as of June 30, 2014 is as follows:

	Principal		Unamortized Discount			Debt, Net of Discount
Related parties
Convertible notes payable	$	2,997,483	$	(795,659	)	$	2,201,824
Less current portion		—		—			—
Convertible notes payable, net of current portion	$	2,997,483	$	(795,659	)	$	2,201,824

A summary of notes payable and related discounts as of June 30, 2013 is as follows:

	Principal		Unamortized Discount			Debt, Net of Discount
Third parties
Convertible notes payable	$	206,640	$	(14,477	)	$	192,163
Less current portion		206,640		(14,477	)		192,163
Convertible notes payable, net of current portion	$	—	$	—		$	—
Related parties
Convertible notes payable	$	2,083,583	$	(105,006	)	$	1,978,577
Less current portion		86,100		(6,839	)		79,261
Convertible and non-convertible note payable, net of current portion	$	1,997,483	$	(98,167	)	$	1,899,316

F - 17

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

7.

STOCKHOLDERS’ EQUITY (DEFICIT)

Preferred Stock

The Company has authorized 5,000,000 shares of preferred stock, par value $0.001 per share with such rights, preferences and limitations as may be set from time to time by resolution of the board of directors and the filing of a certificate of designation as required by Delaware law.

Common Stock Issued for Cash

On January 5, 2012, the Company signed a $5 million common stock purchase agreement with Lincoln Park Capital Fund, LLC (“LPC”), an Illinois limited liability company. Upon signing the agreement, the Company received $100,000 from LPC as an initial purchase under the $5 million commitment in exchange for 316,667 shares of the Company’s common stock.

The Company also entered into a registration rights agreement with LPC whereby it agreed to file a registration statement related to the transaction with the Securities and Exchange Commission (“SEC”) covering the shares issued to LPC under the purchase agreement. The Company filed a registration statement on January 6, 2012 which became effective on March 26, 2012. Under the registration statement, the Company registered 4.4 million shares of the Company’s common stock.

The Company had the right, in its sole discretion, over a 30-month period to sell shares of common stock to LPC in amounts up to $500,000 per sale, depending on certain conditions as set forth in the purchase agreement, which at the time of the purchase agreement was signed was up to an additional $4.9 million. During the year ended June 30, 2013, the Company issued 1,333,820 shares of common stock in exchange for $810,003 in connection with the purchase agreement. During the year ended June 30, 2014, the Company issued 577,428 shares of common stock in exchange for $570,000 in connection with the purchase agreement.

In consideration for entering into the purchase agreement, the Company issued to LPC 150,000 shares of common stock as a commitment fee and will issue up to 450,000 shares pro rata as LPC purchases additional shares. As of June 30, 2014, 320,810 “pro-rata” shares have been issued. The commitment shares are subject to a 30 month lock up restriction. The purchase agreement may be terminated by the Company at any time at our discretion without any cost to it. Except for a limitation on variable priced financings, there are no financial or business covenants, restrictions on future fundings, rights of first refusal, participation rights, penalties or liquidated damages in the agreement. In accordance with its terms, the purchase agreement expired in July 2014.

Issuances of Common Stock

Private Placements

During the year ended June 30, 2013, the Company issued 3,914,321 shares of common stock in exchange for $1,958,000 in connection with private placements with 13 accredited investors, including issuances of 1,910,714 shares to our Chief Operating Officer and principal stockholder in exchange for $950,000 and 241,379 shares each to our Chief Executive Officer and Chief Technology Officer in exchange for a total of $280,000.

During the year ended June 30, 2014, the Company issued 3,352,726 shares of common stock in exchange for $2,131,527 in connection with private placements with 15 accredited investors, including issuances of 1,434,060 shares to our Chief Operating Officer and principal stockholder in exchange for $925,000.

Issuances of Common Stock and Warrants for Cash

During the year ended June 30, 2014, the Company issued 2,575,579 shares of common stock and warrants to purchase 1,258,378 shares of common stock in exchange for $1,705,000 in connection with private placements with 6 accredited investors, including issuances of 1,817,932 shares and warrants to purchase 908,966 shares of common stock to our Chief Operating Officer and principal stockholder in exchange for $1,125,000 and 200,000 shares and warrants to purchase 100,000 shares of common stock to a director in exchange for $150,000.

F - 18

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Common Stock Issued for Interest

In February 2013, the Company issued 210,226 shares of common stock to its Chief Operating Officer and principal stockholder as payment of accrued interest in the amount of $73,579. The Company recorded a loss on conversion of interest of $4,204 in connection with this transaction representing the difference between the conversion price of $0.35 per share and the fair market value of the stock on the date of conversion, $0.37 per share.

In July 2013, the Company issued 8,880 shares of common stock as payment for accrued interest of $4,440 on a convertible note.

In April 2014, the Company issued 428,032 shares of common stock to its Chief Operating Officer and principal stockholder as payment of accrued interest of $149,811 which was due as of February 1, 2014, in accordance with the terms of the convertible note agreement. The Company recorded a loss on conversion of interest of $201,175 in connection with this transaction representing the difference between the conversion price of $0.35 per share and the fair market value of the stock on the date of conversion, $0.82 per share.

Common Stock Issued for Exercise of Options and Warrants and Cashless Exercise of Warrants

In September 2012, the Company issued 1,740,000 shares of common stock in exchange for $870,000 in connection with the exercise of 1,640,000 warrants and 100,000 options to purchase shares of the Company’s common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise prices of the warrants and options ranged from $1.25 to $1.75 per share. The cost of repricing warrants recognized by the Company amounted to $70,491 for the three months ended September 30, 2012. The cost represents the incremental increase in the fair value of the repriced warrants and options as compared to the original warrants and options granted, valued on the exercise date. The fair value of the warrants and options was determined using the Black-Scholes option pricing model.

In October 2012, the Company issued 80,000 shares of common in exchange for $40,000 in connection with the exercise of warrants at $0.50 per share.

In March 2013, the Company issued 9,171 shares of common stock related to the cashless exercise of 45,000 warrants to purchase common stock at an exercise price of $1.25 per share based upon a fair market value of our stock of $1.57 on the date of exercise.

In June 2013, the Company issued 11,667 shares of common stock in exchange for $6,534 in connection with the exercise of options by a director.

In July 2013, the Company issued 20,000 shares of common stock to a director in exchange for $18,200 in connection with the exercise of options at an exercise price of $0.91 per share.

In August 2013, the Company issued 20,000 shares of common stock in exchange for $25,000 in connection with the exercise of warrants with an exercise price of $1.25 per share.

Common Stock Issued for Conversion of Debt

In September 2012, our Chief Operating Officer and principal stockholder converted his $322,996 convertible original issue discount note which was due on September 28, 2012 into 665,992 shares of common stock.

In February 2013, the Company issued 205,000 shares of common stock in connection with the conversion of a convertible original issue discount note in the amount of $102,500.

In August 2013, the Company issued 234,663 shares of common stock in connection with the early conversion of a convertible note in the amount of $82,132.

F - 19

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Restricted Stock Units

On November 14, 2012 , the Compensation Committee of the Board of Directors granted its former Executive Chairman 800,000 restricted stock units (“RSU”), of which (i) 200,000 units vested immediately, (ii) 200,000 units vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 units vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 units vest upon the Company generating $6,000,000 in revenue in any 12-month period. Vested Units shall be paid in shares of the Company's common stock. The Company valued the 200,000 RSU's which vested immediately, at $0.45 per share based on the closing bid price on the vesting date and recorded stock compensation expense of $90,000 during the year ended June 30, 2013, resulting from the obligation to issue 200,000 shares of common stock.

In June 2013 the Executive Chairman was terminated for cause and the clawback provisions of the RSU agreement provided for the cancellation of the Company's obligation to issue these 200,000 shares of common stock. As the shares had not been delivered, the Company reduced its common stock issuable and recognized Other Income in fiscal 2013 for the grant date fair value of $90,000 for these shares in accordance with guidance in ASC 718-20-35, Awards Classified as Equity, Subsequent Measurement in conjunction with a clawback feature since the $196,000 fair value of the 200,000 shares at the cancellation date exceeds the grant date value of $90,000.

The fair value of stock option grants for the fiscal year ended June 30, 2014 and 2013 were estimated using the following weighted- average assumptions:

	2014	2013
Risk free interest rate	0.45% – 2.61%	0.53% – 2.49%
Expected term in years	2.5 – 6.5	2.5 – 10.0
Dividend yield	—	—
Volatility of common stock	89.98% – 91.94%	89.67% – 93.11%
Estimated annual forfeitures	—	—

The Black-Scholes option-pricing model was developed for use in estimating the fair value of non-traded options, which have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including the expected stock price volatility. Because the Company's stock options and warrants have characteristics different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of such stock options In fiscal 2014 and 2013, the Company used the Company’s trading prices in calculating the stock price volatility and based its volatility on historical volatility. The expected term was estimated using the simplified method for employee stock options since the Company does not have adequate historical exercise data to estimate the expected term.

F - 20

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Options to Purchase Common Stock

A summary of stock option transactions issued to employees under the 2007 Plan for the fiscal years ended June 30, 2014 and 2013 is as follows:

Employee Options and Stock Appreciation Rights

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		4,589,507		$	1.04		5.95
Granted		4,622,500		$	0.55		9.64
Exercised		—		$	—		—
Forfeited		(2,875,000	)	$	0.92		—
Expired		—		$	—		—
Outstanding at June 30, 2013		6,337,007		$	0.75		6.62	$	2,505,808
Exercisable at June 30, 2013		3,696,174		$	0.90		5.70	$	1,056,738
Weighted average fair value of options granted during the year ended June 30, 2013				$	0.41
Balance at June 30, 2013		6,337,007		$	0.75		6.62
Granted		1,425,500		$	1.34		7.81
Exercised		—		$	—		—
Forfeited		—		$	—		—
Expired		—		$	—		—
Outstanding at June 30, 2014		7,762,007		$	0.87		5.98	$	792,305
Exercisable at June 30, 2014		4,352,674		$	0.93		4.55	$	265,364
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.69

On September 21, 2012, the Company granted options to purchase 70,000 shares of the Company’s common stock at an exercise price of $0.63 per share to the father of the Company’s Chief Executive Officer and Chief Technology Officer in recognition of his service. Of the options granted, 35,000 vest immediately with the remainder vesting semi-annually each December 31 and June 30 over a three year period, subject to continued employment on the vesting date. The Company valued the options at $28,358 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 4 years, using the Simplified Method and a discount rate of 0.53%.

On September 21, 2012, the Company granted five-year options to purchase 265,000 shares of common stock at an exercise price of $0.60 per share to non-executive employees. The options vest 25% immediately with the remainder vesting annually over three years, subject to continued employment. The Company valued the options at $101,029 using the Black-Scholes option pricing model using a volatility of 89.93%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 4 years, using the Simplified Method and a discount rate of 0.53%. The resulting expense will be recognized 25% immediately and the remainder over the vesting period.

F - 21

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

On November 14, 2012, in connection with the signing of new employment agreements, the Compensation Committee of the Board of Directors granted its then Chief Executive Officer, Chief Financial Officer, Chief Technology Officer and former President, 800,000 stock settled stock appreciation rights (“SARS”) each, of which (i) 200,000 rights vested immediately, (ii) 200,000 rights vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 rights vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 rights vest upon the Company generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period. The Company valued the 3,200,000 SARS at $1,086,560 using the Black-Scholes option pricing model using a volatility of 89.67%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 6.5 years, using the Simplified Method and a discount rate of 0.93%. Compensation expense of $271,640 was recognized immediately relating to the 800,000 SARS that vested immediately. The remaining compensation expense will be recognized based on management’s assessment that the performance targets are likely to be met within 30 months of the grant date, resulting in the $814,920 of unrecognized compensation expense being expensed by June 30, 2015.

In connection with this grant, the Company’s then Chief Executive Officer, former President and Chief Technology Officer agreed to cancel 250,000 stock options granted to each of them in their prior employment agreements. Because the fair value of the options cancelled exceeded the fair value of the new options granted, no additional expense will be recognized relating to these options.

In connection with a Termination and Release Agreement (the “Release Agreement”) effective February 8, 2013, the Company issued its former President options to purchase 112,500 shares of common stock at an exercise price of $0.39 per share, subject to a lockup agreement for the option shares and the other shares he currently owns. The options are fully vested and have a ten year term. The Company valued the options at $43,875 using the Black-Scholes option pricing model using a volatility of 89.67%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 9.42 years, using the Simplified Method and a discount rate of 0.93%. Additionally, in connection with the Release Agreement the Company cancelled options to purchase 1,325,000 shares of common stock at exercise prices from $0.667 to $1.22 per share and under a clawback provision rescinded 800,000 stock appreciation rights. As a result of the clawback, the Company recorded other income of $67,920 representing the expense previously recognized for the vested portion of the Stock Appreciation Rights.

In June 2013, the Company granted its Chief Executive Officer, Chief Technology Officer and Chief Financial Officer 125,000 each ten-year options to purchase shares of common stock at an exercise price of $1.10 per share. The options vest in equal amounts annually on the anniversary date of the grant over three years, subject to continued employment. The Company valued the options at $317,963 using the Black-Scholes option pricing model using a volatility of 91.6%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 6.5 years, using the Simplified Method and a discount rate of 1.78%. The resulting expense will be recognized over the requisite service period of three years.

In July 2013, the Company issued ten year options to purchase 250,000 shares of common stock, each to its then Chief Executive Officer, Chief Technology Officer and Chief Financial Officer. The options have an exercise price of $1.30 per share and vest 50% upon the market value of the Company’s common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company’s common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period. The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 2.62%. The value of these options was estimated by management in accordance with ASC 718, which requires an estimate of the probability that these market conditions will occur and for the resulting discounted value be expensed immediately. Accordingly management has expensed $63,180 to stock compensation expense.

F - 22

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

In July 2013, the Company granted 100,000 options to a new employee in connection with his employment. Of the options granted, 50,000 are exercisable at $1.25 per share and 50,000 are exercisable at $1.75 per share. Both grants are for a five year term vest 25% immediately and 75% in equal amounts over three years. The options were valued using the Black-Scholes model using a volatility of 91.61% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 4.0 years (using the simplified method) and a discount rate of 1.14%. The value of these options, $80,413 will be recognized as an expense over the requisite service period.

In July 2013, the Company granted ten year options to purchase 25,000 shares of the Company’s common stock at an exercise price of $1.30 per share to the father of the Company’s CEO and CTO in recognition of his service. The options vest over a three year period. The Company valued the options at $25,272 using the Black-Scholes option pricing model using a volatility of 91.72%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 1.5 years, using the Simplified Method and a discount rate of 2.61%.

In July 2013, the Board of Directors approved a pool of 400,000 options to be granted to employees at the discretion of the executive management of the Company. In September 2013, management granted 100,000 of these options to employees. The options vested immediately, are exercisable for five years and have an exercise price of $1.30 per share, the market value of our common stock on the date of the grant. The Company valued the options at $69,452 using the Black-Scholes option pricing model using a volatility of 91.72%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.45%. In December 2013, management granted 90,500 of these options to employees. The options vested immediately, are exercisable for five years and have an exercise price of $0.72 per share, the market value of our common stock on the date of the grant. The Company valued the options at $34,610 using the Black-Scholes option pricing model using a volatility of 90.96%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.55%. In February 2014, the Company granted an additional 5,000 fully vested options to an employee at an exercise price of $0.77 per share. The options were valued at $2,044 using the Black-Scholes option pricing model using a volatility of 90.968% to 90.96%, based upon the historical price of the Company’s common stock since June 2008, estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.55%. The amount was recorded as expense during the year ended June 30, 2014. No additional grants from the pool were made during the year ended June 30, 2014.

In August 2013, the Company granted 150,000 stock settled Stock Appreciation Rights (SARS) to a new employee in connection with his employment. The SARS are exercisable at $1.52 per share, are for a five year term and vest 50,000 immediately and the remaining options will vest 33,334 upon the Company reaching $3 million in sales in any twelve month period, 33,333 upon the Company reaching sales of $5 million in any twelve month period and 33,333 upon the Company reaching sales of $6 million in any twelve month period. The SARS were valued using the Black-Scholes model using a volatility of 91.91% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 4.0 years (using the simplified method) and a discount rate of 1.97%. The value of these SARS, $176,413 will be recognized as expense over the period required to meet the performance criteria which is estimated to be approximately two years.

F - 23

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

A summary of options issued to directors under the 2007 Plan and changes during the period from June 30, 2012 to June 30, 2013 and from June 30, 2013 to June 30, 2014 is as follows:

Options Issued to Directors

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		857,500		$	1.36		7.96
Granted		610,000		$	0.95		10.00
Exercised		(11,667	)	$	0.56		—
Forfeited		(255,000	)	$	1.38		—
Expired		—		$	—		—
Outstanding at June 30, 2013		1,200,833		$	1.16		8.04	$	165,386
Exercisable at June 30, 2013		795,168		$	1.24		7.25	$	98,654
Weighted average fair value of options granted during the year ended June 30, 2013				$	0.72
Balance at June 30, 2013		1,200,833		$	1.16		8.04
Granted		495,000		$	1.19		10.00
Exercised		(20,000	)	$	0.91		10.00
Forfeited		—		$	—		—
Expired		—		$	—		—
Outstanding at June 30, 2014		1,675,833		$	1.12		7.62	$	8,337
Exercisable at June 30, 2014		1,389,168		$	1.14		7.36	$	8,404
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.76

On July 1, 2012, as an automatic grant under the Equity Incentive Plan, the Company issued options to purchase 230,000 shares of common stock to directors. The options have an exercise price of $0.91 per share, vest on June 30, 2013¸ subject to continuing service as a director and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 91.04% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 5.5 years (using the simplified method) and a discount rate of 0.82%. The value of these options will be recognized as expense over the requisite service period.

On December 6, 2012, the Company issued options to purchase 5,000 shares of common stock to a director upon his appointment to the audit committee. The options have an exercise price of $0.36 per share, and vest over three years, subject to continued service and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 89.86% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 0.90%. The value of these options, $1,360, will be recognized as expense over the requisite service period.

In March 2013, the Company granted each of its three non-employee directors ten year options to purchase 125,000 shares of common stock at an exercise price of $0.99 per share. The options vest annually over a three year period, subject to continued service as a director. The options were valued using the Black-Scholes model using a volatility of 93.11 (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.25%. The value of these options, $287,405, will be recognized as expense over the requisite service period.

In June 2013 in connection with the termination for cause of its former Executive Chairman, the Company clawed back options to purchase 255,000 shares of common stock with exercise prices from $0.91 to $1.95 per share previously granted to the Executive Chairman. In addition, the Company rescinded a grant of 800,000 restricted stock units with an exercise price of $0.45 per share, of which 200,000 had vested.

F - 24

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

In July 2013, the Company issued ten year options to purchase 50,000 shares of common stock to a director. The options have an exercise price of $1.30 per share and vested immediately. The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 2.67%. The value of these options was recognized as expense during the year ended June 30, 2014.

In September 2013, the Company issued ten year options to purchase 15,000 shares of common stock to a director. The options have an exercise price of $1.01 per share and vested immediately. The options were valued using the Black-Scholes model using a volatility of 91.6% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 5.0 years (using the simplified method) and a discount rate of 1.62%. The value of these options, $10,702, was recognized as expense during the year ended June 30, 2014.

In October 2013, the Company issued ten year options to purchase 60,000 shares of common stock at an exercise price of $1.17 per share to a new director. The options vest annually subject to continued service. The options were valued using the Black-Scholes model using a volatility of 91.94% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.89%. The value of these options, $54,285 will be recognized as expense over the vesting period.

A summary of options issued to non-employees, non-directors under the 2007 Plan and changes during the fiscal years ended June 30, 2014 and 2013 is as follows:

Non-Employee, Non-Director Options

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		540,000		$	1.16		3.14
Granted		275,000		$	1.23		10.00
Exercised		(100,000	)	$	0.50		—
Forfeited		—		$	—		—
Expired		(155,000	)	$	1.00		—
Outstanding at June 30, 2013		560,000		$	1.22		5.96	$	6,250
Exercisable at June 30, 2013		285,000		$	1.21		2.22	$	—
Weighted average fair value of options granted during the year ended June 30, 2013				$	1.00
Balance at June 30, 2013		560,000		$	1.22		5.96
Granted		25,000		$	1.11		5.00
Exercised		—		$	—		—
Forfeited		(275,000	)	$	1.23		—
Expired		(35,000	)	$	1.15		—
Outstanding at June 30, 2014		275,000		$	1.21		1.70	$	—
Exercisable at June 30, 2014		275,000		$	1.21		1.70	$	—
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.79

In September 2012, the Company issued 100,000 shares of common stock in exchange for $50,000 in connection with the exercise of 100,000 options to purchase shares of the Company’s common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise price of the options was $1.25 per share. The Company recognized a loss resulting from the reduction of the exercise price of the options exercised in the amount of $391 representing the difference in the fair market value of the repriced options as compared to the fair market value of the original options on the exercise date. The fair market value of the options was determined using the Black-Scholes options pricing model.

F - 25

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

In March 2013, the Company granted ten year options to purchase 150,000 shares of common stock at an exercise price of $1.33 per share to a consultant. The options vest annually over a three year period, subject to continued service as a consultant. The options were valued using the Black-Scholes model using a volatility of 93.11 (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.23%. The value of these options, $154,415, will be recognized as expense over the requisite service period.

In June 2013, the Company granted a consultant ten-year options to purchase 125,000 shares of common stock at an exercise price of $1.10 per share. The options vest in equal amounts annually on the anniversary date of the grant over three years, subject to continued engagement as a consultant. The Company valued the options at $119,618 using the Black-Scholes option pricing model using a volatility of 91.6%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 10.0 years, the term of the option and a discount rate of 2.49%. The resulting expense will be recognized over the requisite service period, three years.

In October 2013, the Company granted five-year options to purchase 20,000 shares of common stock at an exercise price of $1.18 per share to two consultants. The Company valued the options at $16,670 using the Black-Scholes option pricing model using a volatility of 91.94%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 5.0 years, the term of the options and a discount rate of 1.38%.

In March 2014, the Company granted five-year fully vested options to purchase 5,000 shares of common stock at an exercise price of $0.85 per share to a consultant. The Company valued the options at $2,962 using the Black-Scholes option pricing model using a volatility of 89.96%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 5.0 years, the term of the options and a discount rate of 1.76%. The expense was recognized during the three months ended March 31, 2014.

Warrants Issued as Settlements

	Number of Warrants			Weighted Average Exercise Price		Remaining Contractual Life
Balance at June 30, 2012		344,508		$	1.05		0.92
Granted		350,000		$	0.63		5.00
Exercised		—		$	—		—
Forfeited		—		$	—		—
Expired		(344,508	)	$	1.05		—
Outstanding at June 30, 2013		350,000		$	0.63		4.22
Exercisable at June 30, 2013		350,000		$	0.63		4.22
Weighted average fair value of warrants granted during the year ended June 30, 2013				$	0.33
Balance at June 30, 2013		350,000		$	0.63		4.22
Granted		—		$	—		—
Exercised		—		$	—		—
Forfeited		—		$	—		—
Expired		—		$	—		—
Outstanding at June 30, 2014		350,000		$	0.63		3.22
Exercisable at June 30, 2014		350,000		$	0.63		3.22
Weighted average fair value of warrants granted during the year ended June 30, 2014					N/A

F - 26

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

On September 21, 2012, the Company granted five year warrants to purchase 350,000 shares of the Company’s common stock at an exercise price of $0.63 per share to a director in recognition of his exemplary five years of service to the Company. The warrants vested immediately. The Company valued the warrants at $115,883 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.32%.

In May 2013, warrants to purchase 344,058 shares of common stock at an exercise price of $1.05 per share held by a director expired.

A summary of warrants issued for cash and changes during the periods June 30, 2012 to June 30, 2013 and from June 30, 2013 to June 30, 2014 is as follows:

Warrants issued for cash or services

	Number of Warrants			Weighted Average Exercise Price		Remaining Contractual Life
Balance at June 30, 2012		4,461,200		$	1.46		2.46
Granted		362,500		$	1.16		10.00
Exercised		(1,865,000	)	$	0.50		—
Forfeited		—		$	—		—
Expired		(1,425,000	)	$	1.60		—
Outstanding at June 30, 2013		1,533,700		$	1.25		2.06
Exercisable at June 30, 2013		1,533,700		$	1.25		2.06
Weighted average fair value of warrants granted during the year ended June 30, 2013				$	0.44
Balance at June 30, 2013		1,533,700		$	1.25		2.06
Granted		1,863,421		$	1.58		3.53
Exercised		(20,000	)	$	1.25		—
Forfeited		—		$	—		—
Expired		(340,000	)	$	1.60		—
Outstanding at June 30, 2014		3,037,121		$	1.45		2.73
Exercisable at June 30, 2014		3,037,121		$	1.45		2.73
Weighted average fair value of warrants granted during the year ended June 30, 2014					N/A

F - 27

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

On September 21, 2012, the Company granted five year warrants to purchase 50,000 shares of the Company’s common stock at an exercise price of $0.63 per share to the Company’s Investor Relations firm in recognition of their performance over the past year. The warrants vested immediately. The Company valued the warrants at $21,787 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company’s common stock since June 2008, an estimated term of 5 years, the term of the warrants, and a discount rate of 0.70%.

During the year ended June 30, 2013, the Company issued 1,820,000 shares of common stock in exchange for $910,000 in connection with the exercise of 1,820,000 warrants to purchase shares of the Company’s common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise prices of the warrants ranged from $1.25 to $1.75 per share. The cost of repricing warrants recognized by the Company amounted to $70,491 for the year ended June 30, 2013. The cost represents the incremental increase in the fair value of the repriced warrants as compared to the original warrants granted, valued on the exercise date. The fair value of the warrants was determined using the Black-Scholes option pricing model.

In March 2013, the Company issued 9,171 shares of common stock in connection with the cashless exercise of warrants to purchase 45,000 shares of common stock with an exercise price of $1.25 and a fair market value of the Company’s common stock of $1.57 on the date of exercise.

In May 2013, the Company issued five year warrants to purchase 312,500 shares of common stock at an exercise price of $1.25 per share in connection with two private placements with its Chief Operating Officer and principal stockholder.

During the year ended June 30, 2013, warrants to purchase 1,425,000 shares of the Company’s common stock at an exercise price of $1.60 per share expired unexercised.

In July 2013, the Company issued five year warrants to purchase 29,412 shares of common stock at an exercise price of $1.30 per share in connection with a private placement with an accredited investor.

In July 2013, the Company issued five year warrants to purchase 500,000 shares of common stock at an exercise price of $1.30 per share to its principal stockholder in connection with a $1.0 million convertible note agreement.

In August 2013, the Company issued 20,000 shares of common stock in exchange for $25,000 in connection with the exercise of warrants with an exercise price of $1.25 per share.

In October 2013, the Company issued five year warrants to purchase 100,000 shares of common stock at an exercise price of $1.00 per share in connection with a private placement with its principal shareholder.

In October 2013, the Company issued five year warrants to purchase 200,000 shares of common stock at an exercise price of $1.00 per share in connection with private placements with a director and his wife.

In October 2013, the Company issued five year warrants to purchase 120,000 shares of common stock at an exercise price of $1.00 per share in connection with private placements with three accredited investors.

During the year ended June 30, 2014, warrants to purchase 360,000 shares of common stock at an exercise price of $1.25 per share expired unexercised.

F - 28

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Options to Purchase Common Stock and Stock Appreciation Rights

Stock-based compensation expense recognized under ASC 718-10 for the fiscal years ended June 30, 2014 and 2013 was $1,682,833 and $1,497,534, respectively, for stock options and stock appreciation rights granted to employees, directors and a consultant. This expense is included in selling, general and administrative expenses in the consolidated statements of operations. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. At June 30, 2014, the total compensation cost for stock options and stock appreciation rights not yet recognized is $836,656. This cost will be recognized over the remaining vesting term of the options and stock appreciation rights of approximately five years.

8.

INCOME TAXES

Due to the net losses incurred, there was no income tax provision for the fiscal years ended June 30, 2014 and 2013. Deferred tax assets and liabilities as of June 30, 2014 and 2013, were as follows:

	June 30, 2014			June 30, 2013
Net operating loss carryforward	$	10,754,202		$	8,817,486
Allowance for bad debt		38,051			15,250
Stock-based compensation		1,493,004			1,304,426
Less: Deferred tax liability – depreciation		(2,627	)		(9,557	)
Net deferred tax assets		12,282,630			10,127,605
Less valuation allowance		(12,282,630	)		(10,127,605	)
Net deferred tax asset	$	—		$	—

The Company had available at June 30, 2014, net operating loss carryforwards for federal and state tax purposes of approximately $28,578,798 that could be applied against taxable income in subsequent years through June 30, 2034. The amount of net operating loss carryforward that can offset future taxable income may be limited in accordance with IRC Section 382 following certain ownership changes.

Based on the weight of available evidence, both positive and negative, a valuation allowance to fully provide for the net deferred tax assets has been recorded since it is more likely than not that the deferred tax assets will not be realized. The valuation allowance was increased by $2,155,025 during fiscal year ended June 30, 2014.

Reconciliation of the differences between income tax benefit computed at the federal and state statutory tax rates and the provision for income tax benefit for the fiscal years ended June 30, 2014 and 2013 was as follows:

	For the Fiscal Year Ended June 30,
	2014						2013
	Amount			%			Amount			%
Tax at U.S. statutory rate	$	(2,401,741	)		-34.00	%	$	(1,775,395	)		-34.00	%
State taxes, net of federal benefit		(255,305	)		-3.61	%		(188,025	)		-3.60	%
Other		502,021			7.10	%		(66,830	)		-1.28	%
Change in valuation allowance		2,155,025			30.51	%		2,030,250			38.88	%
	$	—			0.00	%	$	—			0.00	%

F - 29

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

9.

RELATED PARTY TRANSACTIONS

In addition to the acting Chief Executive Officer (CEO) and the Chief Technology Officer (CTO) the following related parties are employed at GelTech:

· The CEO’s sister–in-law is our Controller and her compensation is $1,092 per week,

· The CEO’s father is a researcher and his compensation is $2,123 per week, and

· The CEO’s mother is a receptionist and her compensation is $600 per week.

The Company has employment arrangements with its executive officers which are described in Note 10.

The Company has entered into a series of credit facilities with its largest principal stockholder as more fully described in Note 6.

In September 2012, the Company granted options to purchase 70,000 shares of the Company’s common stock to the father of the Company’s CEO as more fully described in Note 7.

In September 2012, the Company granted warrants to purchase 350,000 shares of the Company’s common stock to a director as more fully described in Note 7.

Effective February 8, 2013, the Company’s President and Director resigned from the Company to pursue other opportunities. In connection with his separation, the Company agreed to pay the former President $150,000 plus COBRA payments over 14 months. In addition, the Company agreed to issue the former President ten year fully vested options to purchase 112,500 shares of the Company’s common stock at an exercise price of $0.39 per share, subject to a lockup agreement for the option shares and the other shares he currently owns. In addition, options and stock appreciation rights to purchase 2,125,000 shares of the Company’s common stock at exercise prices from $0.45 to $1.22 per share, previously issued to him, were cancelled. The Company recognized a severance expense of $168,920 for the year ended June 30, 2013 representing the total liability to the Company under the severance agreement. As of June 30, 2014, there is no remaining liability under the agreement.

10.

COMMITMENTS AND CONTINGENCIES

The Company leases office and warehouse space located in Jupiter, Florida and rents space in an industrial yard in Irvine, California under a month-to-month lease. In February 2013, the Company entered into a one year lease agreement for a support facility in Brooklyn, New York at a monthly rent of $3,600. In February 2014, the Company extended the lease at a monthly rent of $4,000. Effective August 31, 2014 the Company terminated the lease. Rent expense for the fiscal year ended June 30, 2014 and 2013 was $169,547 and $143,614, respectively.

On November 14, 2012, the Compensation Committee approved new employment agreements for the Company’s then Chief Executive Officer, then President, Chief Technology Officer and Chief Financial Officer. The employment agreements each provide for base salaries of $150,000 and 800,000 stock settled stock appreciation rights (“SARS”) of which (i) 200,000 vested immediately, (ii) 200,000 vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 vest upon the Company generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period. The Company’s then Chief Executive Officer, then President and Chief Technology Officer agreed to cancel the 250,000 stock options granted to each of them in their prior employment agreements. These executives’ base salary will increase to: (i) $170,000 upon the Company generating $3,000,000 in revenue in any 12-month period, (ii) $190,000 upon the Company generating $5,000,000 in any 12-month period and (iii) $200,000 upon the Company generating $6,000,000 in any 12-month period.

F - 30

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

Additionally, the Compensation Committee approved a four-year employment agreement for the Company’s Executive Chairman. Prior to his employment agreement being terminated for cause, the Executive Chairman received a base salary of $200,000 per year and was granted 800,000 restricted stock units vesting on identical terms as the SARs (which have been cancelled). All of the five senior executives receive (or were to receive prior to the terminations of their employment) a monthly car allowance of $600 per month. The Compensation Committee has the discretion to award each of the employed executives a bonus based upon job performance, revenue growth or any other factors determined by the Compensation Committee.

In August 2011, the Company entered into a settlement agreement with a former shareholder of Dyn-O-Mat, the Company's predecessor. At the time of the Company's formation, the Company was unable to contact the investor in order to offer the investor shares of GelTech in exchange for the investor's shares of Dyn-O-Mat. The investor came forward in May 2011 seeking to receive the same offer made to Dyn-O-Mat shareholders in 2007. Under the settlement agreement, the Company paid the investor $50,000, which has been recorded as a loss on settlement as of June 30, 2011. In addition, the Company's Chief Technology Officer and his father agreed to pay the investor an additional $125,000 prior to December 31, 2011. As of June 30, 2013, this amount has not yet been paid.

The Company was sued by a former employee on June 23, 2008, alleging breach of a consulting agreement and an employment agreement entered into in May and June 2007, respectively. In addition, the plaintiff seeks to recover certain of his personal property, which was used or stored in the Company’s offices, and alleges the Company invaded his privacy by looking at his personal computer (which was used in the Company’s business) in the Company’s offices. A jury trial was held for the lawsuit in July 2012. At the conclusion of the trial, the plaintiff was awarded $200,000 under his invasion of privacy and fraudulent misrepresentation claim, $5,000 on the trespass claim,$841,000 on the breach of consulting agreement claim and $200,000 against the Company’s CEO on a claim of civil theft, which by law results in an award of $600,000 for the plaintiff. The Company’s board of directors approved the indemnification of the Company’s CEO for the $600,000. The Company filed a post-trial motion for Judgment Notwithstanding Verdict, New Trial and Remittitur, requesting that the judge set aside or reduce the amounts of the jury verdict.

Based upon the verdicts, the Company recorded a litigation accrual of $1,646,000 as of June 30, 2012. In November 2012, the insurance carrier paid the plaintiff $200,000 in settlement of the invasion of privacy and fraudulent misrepresentation awards. As a result, the Company reduced the amounts accrued for these awards resulting in other income of $200,000 for the period ended December 31, 2012.

In January 2013, the court ruled on the Company’s post-trial motions in this litigation dismissing the $200,000 civil theft verdict (which was subject to triple damages) against the CEO and reducing the $841,000 breach of the consulting agreement award to $500,000. The Company then filed a motion seeking a new trial on damages. The Company received a favorable ruling on this motion and received a new trial on the damages. As a result of the reduction in the award for breach of the consulting agreement from $841,000 to $500,000 and the vacating of the award for civil theft which the Company had previously accrued $600,000, the Company recorded other income of $941,000 for the year ended June 30, 2013. The Company expects the trial to determine damages took place in September 2014. Each side has until October 14, 2014 to file briefs and proposed orders to the court, after which the judge will review the briefs and consider the trial testimony in rendering a decision.

F - 31

GELTECH SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2014 AND 2013

11.

CONCENTRATIONS

The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through June 30, 2013. As of June 30, 2014, the Company had no cash equivalent balances that were not insured.

At June 30, 2014, there were accounts receivable from three customers that each exceeded 10% of the total gross accounts receivable at 24.4%, 16.1% and 10.4%. At June 30, 2013, there were accounts receivable from three customers that each exceeded 10% of the total gross accounts receivable at 39.2%, 13.9% and 11.6%.

During fiscal 2014, one customer accounted for 60.7% of sales. No other customer had sales in excess of 10% of revenues. During fiscal 2013, two customers accounted for 36.3% and 32.4% of sales. No other customer had sales in excess of 10% of revenues.

During fiscal 2014, sales resulted from three products, EMFIDS, FireIce and Soil₂O® and from paid for research and development which made up 52.2%, 27.4%, 19.2% and 1.27% of total sales, respectively. During fiscal 2013, sales resulted from two products, FireIce and Soil₂O® and from paid for research and development which made up 38.8%, 43.5% and 17.7% of total sales, respectively.

During the year ended June 30, 2014, the Company’s made inventory purchases from three vendors amounting to approximately $226,000, $81,000 and $64,000 representing 35.3%, 12.6% and 10.0%, respectively, of inventory purchases for the fiscal year. During the year ended June 30, 2013, the Company purchased approximately $142,000 of raw material from one vendor and approximately $32,000 from another vendor which amounted to 50.8% and 11.5%, respectively, of the inventory purchases in fiscal 2013.

12.

SUBSEQUENT EVENTS

In July 2014, the Company issued 107,143 shares of common stock to its chief operating officer and principal stockholder in payment of accrued interest in the amount of $75,000 related to a convertible note.

In accordance with the 2007 Equity Incentive Plan, on July 1, 2014, the Company issued options to purchase 470,000 shares of common stock to directors. The options have an exercise price of $0.70 per share, vest on June 30, 2015¸ subject to continuing service as a director and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 88.55% (derived using the historical market price for the Company’s common stock since it began trading in June 2008), an expected term of 5.5 years (using the simplified method) and a discount rate of 1.79%. The value of these options will be recognized as expense over the requisite service period.

Since July 1, 2014, the Company has issued 1,855,188 shares of common stock and two year warrants to purchase 906,586 shares of common stock at an exercise price of $2.00 per share in exchange for $1,025,000 in connection with private placements with accredited investors, including 1,603,087 shares and 801,544 warrants to our chief operating officer and principal stockholder in exchange for $850,000.

F - 32

EX-10.34

EXHIBIT 10.34

NON-QUALIFIED STOCK OPTION AGREEMENT

THIS NON-QUALIFIED STOCK OPTION AGREEMENT (the “Agreement”) entered into as of July 1, 2014 (the “Grant Date”) between GelTech Solutions, Inc. (the “Company”) and __________ (the “Optionee”).

WHEREAS, by action taken by the Board of Directors (the “Board”) it has adopted the 2007 Equity Incentive Plan (the “Plan”); and

WHEREAS, pursuant to the Plan, it has been determined that in order to enhance the ability of the Company to attract and retain qualified employees, consultants and directors, the Company has granted the Optionee the right to purchase the common stock of the Company pursuant to stock options.

NOW THEREFORE, in consideration of the mutual covenants and promises hereafter set forth and for other good and valuable consideration, receipt of which is acknowledged, the parties hereto agree as follows:

1.

Grant of Non-Qualified Options.  The Company irrevocably granted to the Optionee, as a matter of separate agreement and not in lieu of salary or other compensation for services, the right and option to purchase all or any part of _________ shares of authorized but unissued or treasury common stock of the Company (the “Options”) on the terms and conditions herein set forth.  The Options are not intended to be Incentive Stock Options as defined by Section 422 of the Internal Revenue Code of 1986 (the “Code”).  Of the Options: (i) ________ were granted for service as a director and (ii) _______ were granted for service as a committee member.  The Optionee acknowledges receipt of a copy of the Plan, as amended.

2.

Price.  The exercise price of the Options is $0.73 per share.

3.

Vesting - When Exercisable.  

(a)

The Options shall vest on June 30, 2015,subject to the Optionee’s continued service with the Company in the capacity for which the Options were granted on the applicable vesting date.  Any fractional vesting shall be rounded up to the extent necessary.  Notwithstanding any other provision in this Agreement, the Options shall vest immediately on the occurrence of a Change of Control as defined under the Plan (a “Triggering Event”); provided, however, that there shall be no immediate vesting under romanette (ii) of the definition of Change of Control if the directors serving just prior to the Triggering Event remain the majority of the Board after the Triggering Event. Additionally, all Options shall vest immediately (subject to the preceding sentence) on the date the Company publicly announces, by press release, by disclosure in a filing with the Securities and Exchange Commission or otherwise (the “Public Announcement”), its intention to sell substantially all of the Company’s assets or to enter into a merger or

consolidation as described in clauses (i) and (ii) under the definition of Change of Control in the Plan.  If the Optionee exercises the Options within 10 calendar days from the date of the Public Announcement, the Optionee shall be deemed a record holder of the shares underlying the Options as of the record date of the Change of Control.

(b)

Subject to Sections 3(c) and 4 of this Agreement, the vested Options may be exercised until 6:00 p.m. New York time for 10 years from the Grant Date (the “Expiration Date”).

(c)

Notwithstanding any other provision of this Agreement, at the discretion of the Board, all Options, whether vested or unvested, shall be immediately forfeited and no longer exercisable if any of the following events occur:

(1)

The Optionee purchases or sells securities of the Company in violation of the Company’s insider trading guidelines then in effect;

(2)

The Optionee breaches any duty of confidentiality including that required by the Company’s insider trading guidelines then in effect;

(3)

The Optionee competes with the Company; or

(4)

The Optionee recruits Company personnel for another entity or business within 24 months following termination of services.

4.

Termination of Relationship.

(a)

If for any reason, except death or disability as provided below, the Optionee ceases to perform services in the capacity for which the Options were granted, all vested Options as of the date of the termination of services may be exercised by the Optionee at any time within three months following termination of services.

(b)

If the Optionee’s services in the capacity for which the Options were granted are terminated as a result of his death, the Optionee’s estate or any Transferee, as defined herein, shall have the right to exercise the Optionee’s vested Options within the time provided in the Plan subject to Section 3(c).  For the purpose of this Agreement, “Transferee” shall mean a person to whom such shares are transferred by will or by the laws of descent and distribution.

(c)

If the Optionee is unable to perform services in the capacity for which the Options were granted as a result of becoming disabled, within the meaning of Section 22(e)(3) of the Code, the Optionee shall have the right to exercise the Optionee’s vested options within the time provided in the Plan.

(d)

Notwithstanding anything contained in this Section 4, the Options may not be exercised after the Expiration Date.

(e)

Any of the Options that were not vested immediately prior to ceasing to perform the services for which the Options were granted shall terminate at that time.  

For purposes of this Section 4 “Company” shall include subsidiaries and/or affiliates of the Company.

5.

Profits on the Sale of Certain Shares; Redemption.  If any of the events specified in Section 3(c) of this Agreement occur within one year following the date the Optionee last performed services in the capacity for which the Options were granted (the “Termination Date”) (or such longer period required by any written agreement), all profits earned from the sale of the Company’s securities, including the sale of shares of common stock underlying the Options, during the two-year period commencing one year prior to the Termination Date shall be forfeited and immediately paid by the Optionee to the Company.  Further, in such event, the Company may at its option redeem shares of common stock acquired upon exercise of the Options by payment of the exercise price to the Optionee.  The Company’s rights under this Section 5 do not lapse one year from the Termination Date but are a contract right subject to any appropriate statutory limitation period.

6.

Method of Exercise.  The Options shall be exercisable by a written notice which shall:

(a)  

state the election to exercise the Options, the number of shares to be exercised, the person in whose name the stock certificate or certificates for such shares of common stock is to be registered, address and social security number of such person (or if more than one, the names, addresses and social security numbers of such persons);

(b)  

if applicable, contain such representations and agreements as to the holder’s investment intent with respect to such shares of common stock as set forth in Section 11 hereof;

(c)  

be signed by the person or persons entitled to exercise the Options and, if the Options are being exercised by any person or persons other than the Optionee, be accompanied by proof, satisfactory to counsel for the Company, of the right of such person or persons to exercise the Options;

(d)

be accompanied by full payment of the exercise price by tender to the Company of an amount equal to the exercise price multiplied by the number of underlying shares being purchased either in cash, by wire transfer, or by certified check or bank cashier’s check, payable to the order of the Company; and  

(e)

be accompanied by payment of any amount that the Company, in its sole discretion, deems necessary to comply with any federal, state or local withholding requirements for income and employment tax purposes.  If the Optionee fails to make such payment in a timely manner, the Company may: (i) decline to permit exercise of the Options or (ii) withhold and set-off against compensation and any other amounts payable to the Optionee the amount of

such required payment. Such withholding may be in the shares underlying the Options at the sole discretion of the Company.

The certificate or certificates for shares of common stock as to which the Options shall be exercised shall be registered in the name of the person or persons exercising the Options.

7.

Sale of Shares Acquired Upon Exercise of Options.  If the Optionee is an officer (as defined by Section 16(b) of the Securities Exchange Act of 1934 (“Section 16(b)”)) or a director of the Company, any shares of the Company’s common stock acquired pursuant to the Options cannot be sold by the Optionee until at least six months elapse from the Grant Date except in case of death or disability or if the grant was exempt from the short-swing profit provisions of Section 16(b).

8.

Anti-Dilution Provisions.  The Options shall have the anti-dilution rights set forth in the Plan.

9.  

Necessity to Become Holder of Record.  Neither the Optionee, the Optionee’s estate, nor any Transferee shall have any rights as a shareholder with respect to any of the shares underlying the Options until such person shall have become the holder of record of such shares.  No cash dividends or cash distributions, ordinary or extraordinary, shall be provided to the holder if the record date is prior to the date on which such person became the holder of record thereof.

10.  

Reservation of Right to Terminate Relationship.  Nothing contained in this Agreement shall restrict the right of the Company to terminate the relationship of the Optionee at any time, with or without cause.  The termination of the relationship of the Optionee by the Company, regardless of the reason therefor, shall have the results provided for in Sections 3 and 4 of this Agreement.  

11.  

Conditions to Exercise of Options.  If a Registration Statement on Form S-8 (or any other successor form) is not effective as to the shares of common stock issuable upon exercise of the Options, the remainder of this Section 11 is applicable as to federal law.  In order to enable the Company to comply with the Securities Act of 1933 (the “Securities Act”) and relevant state law, the Company may require the Optionee, the Optionee’s estate, or any Transferee as a condition of the exercising of the Options granted hereunder, to give written assurance satisfactory to the Company that the shares underlying the Options are being acquired for such persons own account, for investment only, with no view to the distribution of same, and that any subsequent resale of any such shares either shall be made pursuant to a registration statement under the Securities Act and applicable state law which has become effective and is current with regard to the shares being sold, or shall be pursuant to an exemption from registration under the Securities Act and applicable state law.

The Options are subject to the requirement that, if at any time the Board shall determine, in its discretion, that the listing, registration, or qualification of the shares of common stock underlying the Options upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body, is necessary as a condition of, or in connection with

the issue or purchase of the shares underlying the Options, the Options may not be exercised in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected.  

12.  

Transfer.  No transfer of the Options by the Optionee by will or by the laws of descent and distribution shall be effective to bind the Company unless the Company shall have been furnished with written notice thereof and a copy of the letters testamentary or such other evidence as the Board may deem necessary to establish the authority of the estate and the acceptance by the Transferee or Transferees of the terms and conditions of the Options.

13.  

Duties of the Company.  The Company will at all times during the term of the Options:

(a)  

Reserve and keep available for issue such number of shares of its authorized and unissued common stock as will be sufficient to satisfy the requirements of this Agreement;

(b)  

Pay all original issue taxes with respect to the issuance of shares pursuant hereto and all other fees and expenses necessarily incurred by the Company in connection therewith;

(c)  

Use its best efforts to comply with all laws and regulations which, in the opinion of counsel for the Company, shall be applicable thereto.

14.

Parties Bound by Plan.  The Plan and each determination, interpretation or other action made or taken pursuant to the provisions of the Plan shall be final and shall be binding and conclusive for all purposes on the Company and the Optionee and the Optionee’s respective successors in interest.

15.

Severability.  In the event any parts of this Agreement are found to be void, the remaining provisions of this Agreement shall nevertheless be binding with the same effect as though the void parts were deleted.

16.

Arbitration.  Any controversy, dispute or claim arising out of or relating to this Agreement, or its interpretation, application, implementation, breach or enforcement which the parties are unable to resolve by mutual agreement, shall be settled by submission by either party of the controversy, claim or dispute to binding arbitration in Palm Beach County, Florida (unless the parties agree in writing to a different location), before a single arbitrator in accordance with the rules of the American Arbitration Association then in effect.  The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof.  Any arbitration proceeding brought under this Agreement shall be subject to all statutes of limitation in the same manner as if an action were filed in court.  

17.

Benefit.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their legal representatives, successors and assigns.

18.

Notices and Addresses.  All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently given if delivered to the addressees in person, by FedEx or similar receipted delivery as follows:

The Optionee:

To the Optionee at the address on the signature page

of this Agreement

The Company:

GelTech Solutions, Inc.

1460 Park Lane South, Suite 1

Jupiter, FL 33458

Attention: Michael Hull

Facsimile: (561) 427-6182

with a copy to:

Michael D. Harris, Esq.

Nason, Yeager, Gerson, White & Lioce P.A.

1645 Palm Beach Lakes Blvd., Suite 1200

West Palm Beach, FL 33401

Facsimile:  (561) 471-0894

or to such other address as either of them, by notice to the other may designate from time to time.  

19.

Attorney’s Fees.  In the event that there is any controversy or claim arising out of or relating to this Agreement, or to the interpretation, breach or enforcement thereof, and any action or proceeding is commenced to enforce the provisions of this Agreement, the prevailing party shall be entitled to a reasonable attorneys’ fees, costs and expenses.

20.

Governing Law.  This Agreement and any dispute, disagreement, or issue of construction or interpretation arising hereunder whether relating to its execution, its validity, the obligations provided herein or performance shall be governed or interpreted according to the laws of the State of Delaware without regard to choice of law considerations.  

21.

Oral Evidence.  This Agreement constitutes the entire Agreement between the parties and supersedes all prior oral and written agreements between the parties hereto with respect to the subject matter hereof.  Neither this Agreement nor any provision hereof may be changed, waived, discharged or terminated orally, except by a statement in writing signed by the party or parties against whom enforcement or the change, waiver discharge or termination is sought.

22.

Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  The execution of this Agreement may be by actual, pdf, electronic or facsimile signature.

23.

Section or Paragraph Headings.  Section headings herein have been inserted for reference only and shall not be deemed to limit or otherwise affect, in any matter, or be deemed to interpret in whole or in part any of the terms or provisions of this Agreement.

24.

Stop-Transfer Orders.  

(a)

The Optionee agrees that, in order to ensure compliance with the restrictions set forth in the Plan and this Agreement, the Company may issue appropriate “stop transfer” instructions to its duly authorized transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

(b)

The Company shall not be required (i) to transfer on its books any shares of the Company’s common stock that have been sold or otherwise transferred in violation of any of the provisions of the Plan or the Agreement or (ii) to treat the owner of such shares of common stock or to accord the right to vote or pay dividends to any purchaser or other Transferee to whom such shares of common stock shall have been so transferred.

[Signature Page to Follow]

IN WITNESS WHEREOF the parties hereto have set their hand and seals the day and year first above written.

GELTECH SOLUTIONS, INC.
By:
	Michael Hull
	Chief Financial Officer
	OPTIONEE:
	Address of the Optionee:

EX-23.1

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of GelTech Solutions, Inc. filed on September 29, 2008, and Form S-1 of GelTech Solutions, Inc. filed on March 13, 2012 of our report dated September 29, 2014 on the consolidated financial statements of GelTech Solutions, Inc. and Subsidiaries, as of June 30, 2014 and 2013 and for each of the two years in the period ended June 30, 2014.

/s/ Salberg & Company, P.A.

SALBERG & COMPANY, P.A.

Boca Raton, Florida

September 29, 2014

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Peter Cordani, certify that:

1.

I have reviewed this annual report on Form 10-K of GelTech Solutions, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 29, 2014

/s/ Peter Cordani

Peter Cordani

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Michael Hull, certify that:

1.

I have reviewed this annual report on Form 10-K of GelTech Solutions, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 29, 2014

/s/ Michael Hull

Michael Hull

Chief Financial Officer

(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of GelTech Solutions, Inc. (the “Company”) on Form 10-K for the year ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof, I, Peter Cordani, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.

The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

2.

The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Peter Cordani

Peter Cordani

Chief Executive Officer

(Principal Executive Officer)

Dated: September 29, 2014

In connection with the annual report of GelTech Solutions, Inc. (the “Company”) on Form 10-K for the year ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof, I, Michael Hull, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.

The annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

2.

The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Michael Hull

Michael Hull

Chief Financial Officer

(Principal Financial Officer)

Dated: September 29, 2014

EX-99.1

EXHIBIT 99.1

Audit Committee Charter

Adopted on September 26, 2014

Purpose.  The purpose of the Audit Committee (the “Committee”) of GelTech Solutions, Inc. (the “Company”) is to:

·

oversee the Company’s accounting and financial reporting processes, internal systems of control and audits of the Company’s consolidated financial statements.

·

oversee the Company’s relationship with its independent auditors (the “Auditors”), including appointing or changing the Auditors and ensuring their independence.

·

provide oversight regarding significant financial matters.

·

oversee compliance with legal and regulatory requirements.

Appointment and Membership Requirements.  The Committee will comply with all applicable provisions of the Sarbanes-Oxley Act of 2002, the rules and regulations of the Securities and Exchange Commission (“SEC”) and the NASDAQ Stock Market.  The Committee shall be made up of at least three members of the Board of Directors (the “Board”) appointed by the Board.  Each member shall have been determined by the Board to be “independent” for purposes of audit committee membership in accordance with applicable listing standards of NASDAQ and under the rules and regulations of the SEC. Each member of the Committee must meet the financial literacy requirements of NASDAQ and at least one member shall be an “audit committee financial expert” as such term is defined under applicable SEC rules.  The Board will make all determinations regarding the satisfaction of all membership requirements described in this paragraph. The Committee can appoint a chair of the Committee, unless a chair is appointed by the Board.  

Responsibilities.  The following list includes the Committee’s main recurring processes in carrying out its responsibilities. This list is intended as a guide, with the understanding that the Committee can supplement it as appropriate, consistent with the requirements of the SEC and NASDAQ.

1.

Communication. The Committee must maintain free and open communication with the Auditors and management.

2.

Hiring and Selection of the Auditors. The Committee will directly appoint, retain and compensate the Auditors. The Auditors will report directly to the Committee.

3.

Approval of Audit and Non-Audit Services. The Committee is responsible for overseeing services provided by the Auditors, including establishing a policy to decide what services will be performed and the approval requirements for these services.  The Committee will approve, in advance, any and all permissible non-audit services, and require the provision of any such non-audit services be disclosed in periodic reports filed by the Company as required under SEC rules and regulations.

4.

Auditor Independence. The Committee is responsible for making sure it reviews at least annually a formal written statement explaining all relationships between the Auditors and the Company and any subsidiaries, consistent with the applicable requirements of the Public Company Accounting Oversight Board regarding the Auditors’ communications with the Committee concerning independence. The Committee will maintain an active dialogue with the Auditors, covering any disclosed relationships or services that may impact their objectivity and independence.  The Committee will review all proposed hires by the Company or its subsidiaries of management level or higher individuals formerly employed by the Auditors. The Committee will take, or recommend to the Board that it take, appropriate actions to oversee the independence of the Auditors.

5.

Oversight of Auditors; Audit Plan. The Committee will be responsible for the Company’s relationship with the Auditors. The Committee will discuss with the Auditors and management the overall scope and plans for the audits and other financial reviews. The Committee will oversee the rotation of the audit partners of the Auditors as required by the Sarbanes-Oxley Act and the rules of the SEC. The Committee will be responsible for reviewing and resolving any disagreements between management and the Auditors regarding financial controls or financial reporting.

6.

Auditor Reports and Difficulties in Audit. The Committee will review any reports of the Auditors mandated by Section 10A of the Securities Exchange Act of 1934 and obtain from the Auditors any information with respect to illegal acts in accordance with Section 10A.  The Committee will also discuss with the Auditors and then disclose those matters whose disclosure is required by SAS 61 (or any successor provision), including any difficulties the Auditors encountered in the course of the audit work, any restrictions on the scope of the Auditors’ activities or on their access to requested information, and any significant disagreements with management.

7.

Risks.  The Committee will (i) inquire of management and the Auditors about significant risks or exposures facing the Company (ii) assess the steps management has taken or proposes to take to minimize such risks to the Company and (iii) periodically review compliance with such steps.

8.

Internal Controls. The Committee will discuss with management and the Auditors the design, implementation, adequacy and effectiveness of the Company’s internal controls. The Committee will also meet separately with the Auditors, with and without management present, to discuss the results of their examinations. The Committee will provide oversight over the system of internal controls, relying upon management’s and the Auditors’ representations and assessments of, and recommendations regarding, these controls. The Committee will review any required disclosures regarding the Company’s internal controls. Particular emphasis should be given to the adequacy of such internal controls to expose any payments, transactions or procedures that might be deemed illegal or otherwise improper.

9.

Financial Statements. The Committee will review and discuss the annual audited financial statements and quarterly financial statements with management and the Auditors, including the disclosures made in management’s discussion and analysis. The Committee will be responsible for making a recommendation to the Board as to whether the annual audited financial statements should be included in the Company’s Form 10-K.  

10.

Proxy Report. The Committee will prepare any report required to be prepared by it for inclusion in any proxy statement under SEC rules and regulations.

11.

Earnings Announcements. The Committee will review and discuss with management The Company’s quarterly earnings announcements and other public announcements regarding results of operations.

12.

Critical Accounting Policies. The Committee will obtain, review and discuss reports from the Auditors about: (i) all critical accounting policies and practices which the Company will use, and the qualities of those policies and practices; (ii) all alternative treatments of financial information within generally accepted accounting principles that the Auditors have discussed with management, the ramifications of the use of these alternative disclosures and treatments, the treatment preferred by the independent auditors and the reasons for favoring that treatment; and (iii) other material written communications between the Auditors and management, such as any management letter or schedule of unadjusted differences.

13.

CEO and CFO Certifications. The Committee will review the CEO and CFO disclosure and certifications under Sections 302 and 906 of the Sarbanes-Oxley Act.

14.

Related Party Transactions. The Committee will review and approve all related party transactions as described under SEC rules and regulations.

15.

Complaints. The Committee will have responsibility for establishment and oversight of processes and procedures for (a) the receipt, retention and treatment of complaints about accounting, internal accounting controls or audit matters and (b) confidential and anonymous submissions by employees concerning questionable accounting, auditing and internal control matters.

16.

Ability to Investigate; Retention of Advisors. The Committee has the power to investigate any matter brought to its attention, with full access to all of the Company’s books, records, facilities and employees. The Committee also has the power to retain independent counsel or other experts and advisors, and will have funding sufficient for this purpose and the power to use such funding to compensate its counsel, experts and advisors.

17.

Review of Code of Ethics. The Committee will review the Company’s Code of Ethics and review the Company’s compliance therewith.

18.

Review of Charter. The Committee will review and reassess the adequacy of this charter at least once a year.

19.

Self-Evaluate.  The Committee will conduct an annual self-evaluation of the performance of the Committee, including its effectiveness and compliance with this charter.

20.

Legal Matters. On at least an annual basis, the Committee will review with the Company’s counsel, any legal matters that could have a significant impact on the Company's financial statements, the Company’s compliance with applicable laws and regulations, inquiries received from regulators or governmental agencies.

21.

Second Opinion.  Discuss with management any second opinions sought from an accounting firm other than the Auditors, including the substance and reasons for seeking any such opinion.

It is NOT the Committee’s responsibility to prepare and certify the Company’s financial statements, to guarantee the independent auditors’ report, or to guarantee other disclosures by the Company. These are the fundamental responsibilities of management and the Auditors.

Meetings and Minutes.  The Committee shall meet at least on a quarterly basis to discuss with management the annual audited financial statements and quarterly financial statements.  The Committee will submit the minutes of all meetings of the Committee to, or discuss the matters discussed at each committee meeting with, the Board.

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Narrative) (Options) (Details) (USD $)	1 Months Ended	12 Months Ended					12 Months Ended	1 Months Ended					12 Months Ended		1 Months Ended	12 Months Ended		1 Months Ended	12 Months Ended		1 Months Ended													1 Months Ended						1 Months Ended
	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2008	Jan. 31, 2007	Jun. 30, 2014 Maximum [Member]	Sep. 30, 2012 Father of CEO and CTO [Member]	Feb. 28, 2013 Former President [Member]	Jul. 31, 2013 Director [Member]	Jun. 30, 2013 Director [Member]	Feb. 28, 2013 Stock Options [Member]	Jun. 30, 2014 Stock Options [Member]	Jun. 30, 2013 Stock Options [Member]	Feb. 28, 2013 Stock Options [Member] Minimum [Member]	Jun. 30, 2014 Stock Options [Member] Minimum [Member]	Jun. 30, 2013 Stock Options [Member] Minimum [Member]	Feb. 28, 2013 Stock Options [Member] Maximum [Member]	Jun. 30, 2014 Stock Options [Member] Maximum [Member]	Jun. 30, 2013 Stock Options [Member] Maximum [Member]	Sep. 30, 2012 Stock Options [Member] Common Stock [Member]	Jul. 31, 2013 Stock Options [Member] Father of CEO and CTO [Member]	Sep. 30, 2012 Stock Options [Member] Father of CEO and CTO [Member]	Sep. 30, 2012 Stock Options [Member] Non-executive Employees [Member]	Jul. 31, 2013 Stock Options [Member] Chief Executive Officer [Member]	Jun. 30, 2013 Stock Options [Member] Chief Executive Officer [Member]	Jul. 31, 2013 Stock Options [Member] Chief Financial Officer [Member]	Jun. 30, 2013 Stock Options [Member] Chief Financial Officer [Member]	Jul. 31, 2013 Stock Options [Member] Chief Technology Officer [Member]	Jun. 30, 2013 Stock Options [Member] Chief Technology Officer [Member]	Feb. 28, 2013 Stock Options [Member] Former President [Member]	Jul. 31, 2013 Stock Options [Member] New Employee [Member]	Jun. 30, 2013 Stock Options [Member] New Employee [Member]	Jul. 31, 2013 Stock Options [Member] New Employee [Member] Equity Transaction One [Member]	Jul. 31, 2013 Stock Options [Member] New Employee [Member] Equity Transaction Two [Member]	Feb. 28, 2014 Stock Options [Member] Employees [Member]	Dec. 31, 2013 Stock Options [Member] Employees [Member]	Sep. 30, 2013 Stock Options [Member] Employees [Member]	Jul. 31, 2013 Stock Options [Member] Employees [Member]	Oct. 31, 2013 Stock Options [Member] Director [Member]	Sep. 30, 2013 Stock Options [Member] Director [Member]	Jul. 31, 2013 Stock Options [Member] Director [Member]	Mar. 31, 2013 Stock Options [Member] Director [Member]	Dec. 31, 2012 Stock Options [Member] Director [Member]	Jul. 31, 2012 Stock Options [Member] Director [Member]	Jun. 30, 2013 Stock Options [Member] Former Executive Chairman [Member]	Jun. 30, 2013 Stock Options [Member] Former Executive Chairman [Member] Minimum [Member]	Jun. 30, 2013 Stock Options [Member] Former Executive Chairman [Member] Maximum [Member]	Mar. 31, 2014 Stock Options [Member] Consultant [Member]	Oct. 31, 2013 Stock Options [Member] Consultant [Member]	Jun. 30, 2013 Stock Options [Member] Consultant [Member]	Mar. 31, 2013 Stock Options [Member] Consultant [Member]	Feb. 28, 2013 Stock Appreciation Rights (SARs) [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Chief Executive Officer [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Chief Financial Officer [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Chief Technology Officer [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Former President [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Chief Executive Officer, Chief Technology Officer, Chief Financial Officer and Former President [Member]	Aug. 31, 2013 Stock Appreciation Rights (SARs) [Member] New Employee [Member]	Jun. 30, 2013 Stock Appreciation Rights (SARs) [Member] Former Executive Chairman [Member]	Mar. 31, 2013 Stock Appreciation Rights (SARs) [Member] Former Executive Chairman [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted								70,000	112,500				1,425,500	4,622,500								25,000	70,000	265,000	250,000	125,000	250,000	125,000	250,000	125,000	112,500	100,000		50,000	50,000	5,000	90,500	100,000		60,000	15,000	50,000	125,000	5,000	230,000				5,000	20,000	125,000	150,000		800,000	800,000	800,000	800,000	3,200,000	150,000
Options granted, exercise price													$ 1.34	$ 0.55								$ 1.30	$ 0.63	$ 0.60	$ 1.30	$ 1.10	$ 1.30	$ 1.10	$ 1.30	$ 1.10	$ 0.39			$ 1.25	$ 1.75	$ 0.77	$ 0.72	$ 1.30		$ 1.17	$ 1.01	$ 1.30	$ 0.99	$ 0.36	$ 0.91				$ 0.85	$ 1.18	$ 1.10	$ 1.33		$ 0.45	$ 0.45	$ 0.45	$ 0.45		$ 1.52
Immediately vested shares																							35,000																															200,000	200,000	200,000	200,000	800,000	50,000
Vesting period																						3 years	3 years	3 years		3 years		3 years		3 years				3 years	3 years								3 years	3 years							3 years	3 years
Fair value of options																						$ 25,272	$ 28,358	$ 101,029		$ 317,963		$ 317,963		$ 317,963	$ 43,875					$ 2,044	$ 34,610	$ 69,452											$ 2,962	$ 16,670	$ 119,618							$ 1,086,560
Volatility																						91.72%	90.09%	89.93%	93.11%	91.60%	93.11%	91.60%	93.11%	91.60%	89.67%			91.61%	91.61%		90.96%	91.72%		91.94%	91.60%	93.11%	93.11%	89.86%	91.04%				89.96%	91.94%	91.60%	93.11%						89.67%	91.91%
Expected term																2 years 6 months	2 years 6 months		6 years 6 months	10 years		1 year 6 months	4 years	4 years	6 years 6 months	6 years 6 months	6 years 6 months	6 years 6 months	6 years 6 months	6 years 6 months	9 years 5 months 1 day			4 years	4 years	2 years 6 months	2 years 6 months	2 years 6 months		6 years 6 months	5 years	6 years 6 months	6 years 6 months	6 years 6 months	5 years 6 months				5 years	5 years	10 years	6 years 6 months						6 years 6 months	4 years
Discount rate																						2.61%	0.53%	0.53%	2.62%	1.78%	2.62%	1.78%	2.62%	1.78%	0.93%			1.14%	1.14%	0.55%	0.55%	0.45%		1.89%	1.62%	2.67%	1.25%	0.90%	0.82%				1.76%	1.38%	2.49%	1.23%						0.93%	1.97%
Term							10 years															10 years		5 years	10 years	10 years	10 years	10 years	10 years	10 years	10 years			5 years	5 years		5 years	5 years		10 years	10 years	10 years	10 years	10 years	10 years				5 years	5 years	10 years	10 years		10 years	10 years	10 years	10 years		5 years
Percentage of shares immediately vested																								25.00%										25.00%	25.00%
Percentage expensed immediately																								25.00%
Vested shares upon generating $3,000,000 in revenue in any 12-month period																																																						200,000	200,000	200,000	200,000	170,000	33,334
Vested shares upon generating $5,000,000 in revenue in any 12-month period																																																						200,000	200,000	200,000	200,000	190,000	33,333
Vested shares upon generating $6,000,000 in revenue in any 12-month period																																																						200,000	200,000	200,000	200,000	200,000	33,333
Equity compensation expense		1,682,833	1,497,534										1,680,358	1,480,377											63,180		63,180		63,180																													271,640
Unrecognized compensation expense, period for recognition		5 years																								3 years		3 years		3 years																					3 years							18 months	2 years
Unrecognized compensation expense		836,656																															80,413								10,702		287,405	1,360								154,415						814,920	176,413
Cancelled options									2,125,000			1,325,000		2,875,000																																255,000								250,000		250,000	250,000	250,000
Cancelled options, exercise price														$ 0.92	$ 0.667			$ 1.22																													$ 0.91	$ 1.95
Cancellation of stock appreciation rights grant under clawback provision, shares																																																					800,000							800,000
Other income																																																					67,920
Terms of Award																									vest 50% upon the market value of the Company's common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company's common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period		vest 50% upon the market value of the Company's common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company's common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period		vest 50% upon the market value of the Company's common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company's common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period
Shares authorized			15,000,000	4,500,000	3,500,000	1,500,000																																	400,000
Volatility, minimum													89.98%	89.67%																						90.968%
Volatility, maximum													91.94%	93.11%																						90.96%
Vested shares																																																												200,000
Exercised options	100,000									20,000	11,667										100,000
Cash received from stock options exercised		18,200	6,534							18,200	6,534										50,000
Exercise price										$ 0.91											$ 0.50
Options exercisable, exercise price													$ 0.93	$ 0.90							$ 1.25																																								$ 0.45
Loss on stock option repricing																					$ 391

XML

CONCENTRATIONS (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Concentration Risk [Line Items]
Cash balance not insured by the FDIC
Accounts Receivable [Member] | Customer One Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	24.40%	39.20%
Accounts Receivable [Member] | Customer Two Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	16.10%	13.90%
Accounts Receivable [Member] | Customer Three Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	10.40%	11.60%
Sales Revenue [Member] | Emergency Manhole Fire Ice Delivery System [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	52.20%
Sales Revenue [Member] | Fire Ice Products [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	27.40%	38.80%
Sales Revenue [Member] | Soil Twoo Dust Control Products [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	19.20%	43.50%
Sales Revenue [Member] | Paid For Research And Development [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	1.27%	17.70%
Sales Revenue [Member] | Customer One Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	60.70%	36.30%
Sales Revenue [Member] | Customer Two Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		32.40%
Inventory purchases [Member] | Supplier One Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	35.30%	50.80%
Total EMFIDS parts, raw material and packaging purchases made during the period	226,000	142,000
Inventory purchases [Member] | Supplier Two Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	12.60%	11.50%
Total EMFIDS parts, raw material and packaging purchases made during the period	81,000	32,000
Inventory purchases [Member] | Supplier Three Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%
Total EMFIDS parts, raw material and packaging purchases made during the period	$ 64,000

XML

RELATED PARTY TRANSACTIONS (Details) (USD $)			12 Months Ended		1 Months Ended				1 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014 Warrant [Member]	Jun. 30, 2013 Warrant [Member]	Sep. 30, 2012 CEO and CTO's Father [Member]	Jun. 30, 2014 CEO and CTO's Father [Member]	Jun. 30, 2014 CEO's sister-in-law [Member]	Jun. 30, 2014 CEO and CTO's Mother [Member]	Sep. 30, 2012 Director [Member] Warrant [Member]	Feb. 28, 2013 President [Member]	Jun. 30, 2013 President [Member]	Feb. 28, 2013 President [Member] Minimum [Member]	Feb. 28, 2013 President [Member] Maximum [Member]
Related Party Transaction [Line Items]
Weekly salary amount						$ 2,123	$ 1,092	$ 600
Severance expense										150,000	168,920
Exercise price per share										$ 0.39		$ 0.45	$ 1.22
Options granted					70,000					112,500
Granted, number of warrants			1,863,421	362,500					350,000
Forfeited, shares										2,125,000
Accrual for severance agreement		$ 102,056
Number of shares callable by warrants									350,000

XML

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS (Schedule of Debt) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Third Party
Convertible notes payable, principal		$ 206,640
Convertible notes payable, unamortized discount		(14,477)
Convertible notes payable, net		192,163
Less current portion, principal		206,640
Less current portion, unamortized discount		(14,477)
Less current portion, net		192,163
Convertible notes payable, net of current portion, principal
Convertible notes payable, net of current portion, unamortized discount
Convertible notes payable, net of current portion, net
Related Party
Convertible notes payable, related, principal	2,997,483	2,083,583
Convertible notes payable, related, unamortized discount	(795,659)	(105,006)
Convertible notes payable, related, net	2,201,824	1,978,577
Less current portion, related, principal		86,100
Less current portion, related, unamortized portion		(6,839)
Less current portion, related, net		79,261
Convertible and nonconvertible note payable, net of current portion, principal	2,997,483	1,997,483
Convertible and nonconvertible note payable, net of current portion, unamortized discount	(795,659)	(98,167)
Convertible and nonconvertible note payable, net of current portion, net	$ 2,201,824	$ 1,899,316

XML

INCOME TAXES (Tables)

12 Months Ended

Jun. 30, 2014

INCOME TAXES [Abstract]

Schedule of Deferred Income Tax Assets and Liabilities

Deferred tax assets and liabilities as of June 30, 2014 and 2013, were as follows:

	June 30, 2014			June 30, 2013
Net operating loss carryforward	$	10,754,202		$	8,817,486
Allowance for bad debt		38,051			15,250
Stock-based compensation		1,493,004			1,304,426
Less: Deferred tax liability - depreciation		(2,627	)		(9,557	)
Net deferred tax assets		12,282,630			10,127,605
Less valuation allowance		(12,282,630	)		(10,127,605	)
Net deferred tax asset	$	-		$	-

Schedule of Reconciliation of Provision (Benefit) for Income Taxes

Reconciliation of the differences between income tax benefit computed at the federal and state statutory tax rates and the provision for income tax benefit for the fiscal years ended June 30, 2014 and 2013 was as follows:

	For the Fiscal Year Ended June 30,
	2014						2013
	Amount			%			Amount			%
Tax at U.S. statutory rate	$	(2,401,741	)		-34.00	%	$	(1,775,395	)		-34.00	%
State taxes, net of federal benefit		(255,305	)		-3.61	%		(188,025	)		-3.60	%
Other		502,021			7.10	%		(66,830	)		-1.28	%
Change in valuation allowance		2,155,025			30.51	%		2,030,250			38.88	%
	$	-			0.00	%	$	-			0.00	%

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Options to Purchase Common Stock and Stock Appreciation Rights) (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]
Share-based compensation expense	$ 1,682,833	$ 1,497,534
Unrecognized compensation expense	$ 836,656
Unrecognized compensation cost, period for recognition	5 years

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Schedule of Assumptions) (Details) (Stock Options [Member])	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate, minimum	0.45%	0.53%
Risk-free interest rate, maximum	2.61%	2.49%
Dividend yield
Expected volatility, minimum	89.98%	89.67%
Expected volatility, maximum	91.94%	93.11%
Estimated annual forfeitures
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	2 years 6 months	2 years 6 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	6 years 6 months	10 years

XML

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	12 Months Ended		1 Months Ended		1 Months Ended														12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Nov. 30, 2012 Executive Chairman [Member]	Nov. 14, 2012 Executive Chairman [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Chief Executive Officer, Chief Technology Officer, Chief Financial Officer and Former President [Member]	Nov. 30, 2012 Stock Appreciation Rights (SARs) [Member] Chief Financial Officer [Member]	Nov. 30, 2012 Restricted Stock Units (RSUs) [Member] Executive Chairman [Member]	Jul. 31, 2012 Loss Contingency Invasion Of Privacy And Misrepresentation [Member]	Jun. 30, 2012 Loss Contingency Invasion Of Privacy And Misrepresentation [Member]	Jan. 31, 2013 Loss Contingency Breach Of Agreement [Member]	Jul. 31, 2012 Loss Contingency Breach Of Agreement [Member]	Jul. 31, 2012 Loss Contingency Trespass Claim [Member]	Jan. 31, 2013 Loss Contingency Civil Theft [Member]	Jul. 31, 2012 Loss Contingency Civil Theft [Member]	Jul. 31, 2012 Loss Contingency Civil Theft Law Enforced Settlement [Member]	Aug. 31, 2011 Settlement Agreement With Former Shareholder [Member]	Feb. 28, 2014 Juniper, Florida Office and Warehouse [Member]	Feb. 28, 2013 Juniper, Florida Office and Warehouse [Member]	Jun. 30, 2014 Juniper, Florida Office and Warehouse [Member]	Jun. 30, 2013 Juniper, Florida Office and Warehouse [Member]
Operating Leased Assets [Line Items]
Rent expense																			$ 169,547	$ 143,614
Monthly rent payment																	4,000	3,600
Lease terms																		1 year
Lease expiration date																	Aug. 31, 2014
Loss Contingencies [Line Items]
Litigation accrual		1,646,000
Litigation, damages awarded								200,000		500,000	841,000	5,000		200,000	600,000
Litigation, provision																125,000
Damages paid to plaintiff by insurance carrier									200,000
Portion of litigation expense that was dismissed													200,000
Loss contingency accrual, period increase (decrease)									(200,000)
Other income	941,000
Loss Contingency, Loss in Period																50,000
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Immediately vested shares					800,000	200,000
Vested shares upon generating $3,000,000 in revenue in any 12-month period					170,000	200,000
Vested shares upon generating $6,000,000 in revenue in any 12-month period					200,000	200,000
Vested shares upon generating $5,000,000 in revenue in any 12-month period					190,000	200,000
Granted					3,200,000	800,000	800,000
Cancelled options					250,000
Monthly car allowance			600
Annual base salary per executive				$ 200,000
Employment agreement term			4 years
Options granted, exercise price						$ 0.45
Term						10 years

XML

ACCOUNTS RECEIVABLE

12 Months Ended

Jun. 30, 2014

ACCOUNTS RECEIVABLE [Abstract]

ACCOUNTS RECEIVABLE

3.

ACCOUNTS RECEIVABLE

Accounts receivable at June 30, 2014 and 2013 was as follows:

	2014			2013
Accounts receivable	$	95,869		$	77,802
Allowance for doubtful accounts		(60,593	)		(40,525	)
	$	35,276		$	37,277

Bad debt expense on trade accounts receivable for 2014 and 2013 was $20,068 and $-0-, respectively.

XML

INCOME TAXES (Narrative) (Details) (USD $)	12 Months Ended
	Jun. 30, 2014
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 28,578,798
Increase in valuation allowance	$ 2,155,025
Maximum [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carry-forward expiration date	Jun. 30, 2034

XML

ACCOUNTS RECEIVABLE (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
ACCOUNTS RECEIVABLE [Abstract]
Accounts receivable	$ 95,869	$ 77,802
Allowance for doubtful accounts	(60,593)	(40,525)
Accounts receivable, net	35,276	37,277
Bad debt expense	$ 20,068

XML

GOING CONCERN (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
GOING CONCERN [Abstract]
Net cash used in operating activities	$ 5,132,019	$ 4,195,655
Loss from operations	7,111,945	5,221,747
Accumulated deficit	35,133,578	28,021,633
Stockholders' deficit	1,898,315	2,270,386	2,965,902
Proceeds from issuance of common stock	2,131,527	1,658,000
Proceeds from the sale of stock and warrants through private placements	1,705,000	300,000
Proceeds from exercise of options and warrants	43,200
Proceeds from convertible notes with related parties	1,000,000	500,000
Proceeds from sale of stock under stock purchase agreement	$ 570,000	$ 810,003

XML

INCOME TAXES (Schedule of Deferred Tax Assets and Liabilities) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Net operating loss carryforward	$ 10,754,202	$ 8,817,486
Allowance for bad debt	38,051	15,250
Stock-based compensation	1,493,004	1,304,426
Less: Deferred tax liability - depreciation	(2,627)	(9,557)
Net deferred tax assets	12,282,630	10,127,605
Less valuation allowance	(12,282,630)	(10,127,605)
Net deferred tax assets

XML

INVENTORIES (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
INVENTORIES [Abstract]
Finished goods	$ 491,409	$ 333,987
Raw materials	352,455	254,716
Total inventory	$ 843,864	$ 588,703

XML

FURNITURE, FIXTURES AND EQUIPMENT (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Property, Plant and Equipment [Line Items]
Furniture, fixtures, and equipment	$ 367,180	$ 294,329
Accumulated depreciation	(191,429)	(136,145)
Total furniture, fixtures, and equipment, net	175,751	158,184
Depreciation	55,284	49,269
Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Equipment [Member]
Property, Plant and Equipment [Line Items]
Furniture, fixtures, and equipment	111,488	88,875
Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years	3 years
Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years	5 years
Storage Facilities [Member]
Property, Plant and Equipment [Line Items]
Furniture, fixtures, and equipment	20,802	20,802
Estimated useful life	3 years	3 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Furniture, fixtures, and equipment	214,470	164,232
Vehicles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years	5 years
Vehicles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years	7 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Furniture, fixtures, and equipment	$ 20,420	$ 20,420
Estimated useful life	5 years	5 years

XML

GOING CONCERN

12 Months Ended

Jun. 30, 2014

GOING CONCERN [Abstract]

GOING CONCERN

2.

GOING CONCERN

These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize it assets and discharge its liabilities in the normal course of business. The Company has a net loss and net cash used in operating activities in fiscal 2014 of $7,111,945 and $5,132,019 respectively and has an accumulated deficit and stockholders' deficit of $35,133,578 and $1,898,315, respectively, at June 30, 2014. In addition, the Company has not yet generated revenue sufficient to support ongoing operations. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders, the ability of the Company to obtain necessary debt or equity financing to continue operations, and the attainment of profitable operations. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

During the year ended June 30, 2014 the Company received $2,131,527 in exchange for common stock and $1,705,000 in exchange for common stock and warrants in connection with private placements, received $43,200 in connection with the exercise of options and warrants and received $1,000,000 in exchange for convertible notes. In addition, the Company received $570,000 under the stock purchase agreement with Lincoln Park Capital, signed in January 2012. This stock purchase agreement expired in July 2014.

Management believes that the actions presently being taken provide the opportunity for the Company to continue as a going concern.

XML

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS (Narrative) (Details) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended		1 Months Ended				1 Months Ended																	12 Months Ended	1 Months Ended
	Oct. 31, 2012	Jun. 30, 2014	Jun. 30, 2013	May 31, 2009 Principal Stockholder [Member] Line of Credit [Member]	May 29, 2009 Principal Stockholder [Member] Line of Credit [Member]	Feb. 28, 2013 Former President [Member]	Dec. 31, 2011 Short Term Advances [Member] Chief Executive Officer [Member]	Dec. 31, 2011 Short Term Advances [Member] Former President [Member]	Dec. 31, 2011 Short Term Advances [Member] Chief Financial Officer [Member]	Aug. 31, 2013 Convertible Original Discount Note From Third Parties Dated March 2012 [Member] Third Party [Member]	Sep. 30, 2012 Convertible Original Discount Note From Third Parties Dated March 2012 [Member] Third Party [Member]	Mar. 31, 2012 Convertible Original Discount Note From Third Parties Dated March 2012 [Member] Third Party [Member]	Aug. 31, 2013 Convertible Original Discount Note From Third Parties Dated September 2012 [Member] Third Party [Member]	Mar. 31, 2012 Convertible Original Discount Note From Director Dated March 2012 [Member] Director [Member]	Sep. 30, 2012 Convertible Original Discount Note From Director Dated September 2012 [Member] Director [Member]	Aug. 31, 2013 Convertible Original Discount Note From Accredited Investor Dated August 2012 [Member] Accredited Investor [Member]	Feb. 28, 2013 Convertible Original Discount Note From Accredited Investor Dated August 2012 [Member] Accredited Investor [Member]	Aug. 31, 2012 Convertible Original Discount Note From Accredited Investor Dated August 2012 [Member] Accredited Investor [Member]	Aug. 31, 2013 Convertible Original Discount Note From Accredited Investor Dated February 2013 [Member] Accredited Investor [Member]	Feb. 28, 2013 Convertible Original Discount Note From Accredited Investor Dated February 2013 [Member] Accredited Investor [Member]	Dec. 31, 2012 Convertible Original Discount Note From Principal Stockholder Dated December 2012 [Member] Principal Stockholder [Member]	Sep. 30, 2012 2011 Convertible Note [Member] Principal Stockholder [Member]	Feb. 28, 2011 2011 Convertible Note [Member] Principal Stockholder [Member]	Feb. 28, 2013 Convertible Note Payable Dated February 2013 [Member]	Feb. 28, 2014 Convertible Note Payable Dated July 2013 [Member]	Jul. 31, 2013 Convertible Note Payable Dated July 2013 [Member] Chief Operating Officer and Principal Stockholder [Member]	Jun. 30, 2014 Convertible Note Payable Dated July 2013 [Member] Chief Operating Officer and Principal Stockholder [Member]	Feb. 28, 2011 Reduction In Principal Amount Of Line Of Credit [Member] Principal Stockholder [Member]
Debt Instrument [Line Items]
Proceeds from issuance of debt												$ 105,000		$ 75,000				$ 175,000			$ 250,000					$ 1,000,000
Debt instrument, face amount							10,000	29,380	50,000		120,540	107,625		76,875	86,100			179,375		86,100	275,000		1,497,483	1,997,483		1,000,000
Debt instrument, term											1 year	9 months		9 months	1 year			6 months		1 year	1 year		5 years			5 years
Debt instrument, interest rate							0.70%	5.00%	5.00%		12.00%	5.00%		5.00%	12.00%			5.00%			10.00%		5.00%	7.50%		7.50%
Debt instrument, maturity date																								Dec. 31, 2016
Convertible note, conversion price											$ 0.50	$ 0.50		$ 0.50	$ 0.50			$ 0.50		$ 0.35	$ 0.35		$ 1.12	$ 0.35		$ 1.00
Unamortized beneficial conversion feature												84,562						106,600		4,920	23,571			114,142		601,949
Unamortized discount on notes payable											35,138				24,971			4,375		9,225	25,000
Amortization of beneficial conversion feature of convertible notes														63,038										55,110
Accrued interest																								73,579	149,811		75,000
Interest expense		462,760	473,605													4,920	7,552										177,271
Convertible note payable			79,261										86,100
Repayment of convertible note with third party		115,822											85,822
Line of credit, commencement date				Jul. 20, 2009
Line of credit, annual interest rate				5.00%
Line of credit, borrowing capacity					2,500,000
Shares issued from conversion of convertible debt										8,880									234,663						428,032
Number of shares callable by warrants																							300,000			500,000		1,000,000
Exercise price of shares called by warrants	$ 0.50																					$ 0.50	$ 1.75			$ 1.30		$ 1.25
Proceeds from exercise of warrants	40,000	25,000	910,000																			150,000
Debt conversion, cash payment amount										30,000
Value of convertible original issue discount note										34,440						82,132												1,000,000
Loss on extinguishment of debt			25,515
Loss on conversion of interest		201,175																						(4,204)
Additional stock compensation expense to be recognized due to repricing of stock options							15,067
Granted						112,500	150,000
Options granted, exercise price							$ 1.95
Common shares issued																								210,226				892,857
Granted shares, reduced exercise price							$ 0.60
Fair value																										$ 311,949
Volatility rate																										91.46%
Expected term																										5 years
Risk free interest rate																										1.40%

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Schedule of Warrant Activity) (Details) (USD $)	1 Months Ended		12 Months Ended
	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Warrants Issued as Settlements [Member]
Number of Warrants
Balance			350,000	344,508
Granted				350,000
Exercised
Forfeited
Expired				(344,508)
Outstanding			350,000	350,000	344,508
Exercisable			350,000	350,000
Weighted Average Exercise Price
Balance			$ 0.63	$ 1.05
Granted				$ 0.63
Exercised
Forfeited
Expired				$ 1.05
Outstanding			$ 0.63	$ 0.63	$ 1.05
Exercisable			$ 0.63	$ 0.63
Weighted average fair value of warrants granted				$ 0.33
Remaining Contractual Life
Granted				5 years
Outstanding			3 years 2 months 19 days	4 years 2 months 19 days	11 months 1 day
Exercisable			3 years 2 months 19 days	4 years 2 months 19 days
Warrants Issued for Cash or Services [Member]
Number of Warrants
Balance			1,533,700	4,461,200
Granted			1,863,421	362,500
Exercised	(45,000)	(1,640,000)	(20,000)	(1,865,000)
Forfeited
Expired			(340,000)	(1,425,000)
Outstanding			3,037,121	1,533,700	4,461,200
Exercisable			3,037,121	1,533,700
Weighted Average Exercise Price
Balance			$ 1.25	$ 1.46
Granted			$ 1.58	$ 1.16
Exercised			$ 1.25	$ 0.50
Forfeited
Expired			$ 1.60	$ 1.60
Outstanding			$ 1.45	$ 1.25	$ 1.46
Exercisable			$ 1.45	$ 1.25
Weighted average fair value of warrants granted				$ 0.44
Remaining Contractual Life
Granted			3 years 6 months 11 days	10 years
Outstanding			2 years 8 months 23 days	2 years 22 days	2 years 5 months 16 days
Exercisable			2 years 8 months 23 days	2 years 22 days

XML

CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2014	Jun. 30, 2013
Current assets
Cash and cash equivalents	$ 66,266	$ 90,275
Accounts receivable trade, net	35,276	37,277
Inventories	843,864	588,703
Prepaid expenses and other current assets	88,836	66,756
Total current assets	1,034,242	783,011
Furniture, fixtures, and equipment, net	175,751	158,184
Deposits	30,086	26,886
Total assets	1,240,079	968,081
Current liabilities
Accounts payable	228,063	265,122
Accrued expenses	189,933	176,734
Litigation accrual	505,000	505,000
Accrual for severance agreement		102,056
Convertible notes - related parties, net of discount		79,261
Convertible notes - third parties, net of discount		192,163
Insurance premium finance contract	13,574	11,796
Deferred revenue		7,019
Total current liabilities	936,570	1,339,151
Convertible notes - related party, net of discounts	2,201,824	1,899,316
Total liabilities	3,138,394	3,238,467
Commitments and contingencies (Note 10)
Stockholders' deficit
Preferred stock: $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Common stock: $0.001 par value; 50,000,000 shares authorized; 40,301,979 and 33,084,671 shares issued and outstanding as of June 30, 2014 and 2013, respectively.	40,302	33,084
Additional paid in capital	33,194,961	25,718,163
Accumulated deficit	(35,133,578)	(28,021,633)
Total stockholders' deficit	(1,898,315)	(2,270,386)
Total liabilities and stockholders' deficit	$ 1,240,079	$ 968,081

XML

INCOME TAXES (Schedule of Reconciliation of Provision (Benefit) for Income Taxes) (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Amount
Tax at U.S. statutory rate	$ (2,401,741)	$ (1,775,395)
State taxes, net of federal benefit	(255,305)	(188,025)
Other	502,021	(66,830)
Change in valuation allowance	2,155,025	2,030,250
Total income tax expense (benefit)
Percentage
Tax at U.S. statutory rate	(34.00%)	(34.00%)
State taxes, net of federal benefit	(3.61%)	(3.60%)
Other	7.10%	(1.28%)
Change in valuation allowance	30.51%	38.88%
Total effective income tax rate	0.00%	0.00%

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities
Net loss	$ (7,111,945)	$ (5,221,747)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	55,284	49,269
Bad debt expense	20,068
Amortization of beneficial conversion feature of convertible notes	223,025
Amortization of original issue discounts related to convertible notes	5,791	385,650
Equity compensation expense	1,682,833	1,497,534
Cost of repricing warrants to induce exercise		70,491
Loss on disposal of assets	11,413	9,822
Loss on stock issued for interest	201,175	4,205
Other income from the clawback of equity compensation		(157,920)
Reversal of litigation accrual		(941,000)
Payment by insurance company of prior period litigation expense		(200,000)
Changes in assets and liabilities:
Accounts receivable	(18,067)	17,883
Inventories	(266,574)	(42,585)
Prepaid expenses and other current assets	46,862	26,500
Other assets	(3,200)	(11,255)
Accounts payable	(37,059)	30,748
Accrual for severance agreement	(102,056)	102,056
Deferred revenue	(7,019)	7,019
Accrued expenses	167,450	177,675
Net cash used in operating activities	(5,132,019)	(4,195,655)
Cash flows from Investing Activities
Proceeds from sale of asset		15,000
Purchases of equipment	(72,851)	(43,496)
Net cash used in investing activities	(72,851)	(28,496)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements	2,131,527	1,658,000
Proceeds from the sale of stock and warrants through private placements	1,705,000	300,000
Proceeds from sale of stock under stock purchase agreement	570,000	810,003
Proceeds from exercise of warrants	25,000	910,000
Proceeds from exercise of stock options	18,200	6,534
Repayments of convertible notes from third parties	(115,822)
Payments on notes with related parties	(85,880)	(84,380)
Proceeds from convertible notes with third parties		175,000
Proceeds from convertible notes with related parties	1,000,000	500,000
Payments on insurance finance contract	(67,164)	(44,925)
Net cash provided by financing activities	5,180,861	4,230,232
Net increase (decrease) in cash and cash equivalents	(24,009)	6,081
Cash and cash equivalents - beginning	90,275	84,194
Cash and cash equivalents - ending	66,266	90,275
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	2,736	2,702
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	68,942	47,471
Beneficial conversion feature of convertible notes	913,898	309,342
Conversion of notes for common stock	82,132	435,495
Common stock issued for accrued interest	$ 154,251	$ 77,784

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Common Stock) (Details) (USD $)	1 Months Ended		3 Months Ended	12 Months Ended		1 Months Ended			12 Months Ended		1 Months Ended				1 Months Ended			12 Months Ended	1 Months Ended	12 Months Ended				1 Months Ended	12 Months Ended		1 Months Ended			1 Months Ended			12 Months Ended					1 Months Ended
	Oct. 31, 2012	Sep. 30, 2012	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Aug. 31, 2013 Warrant [Member]	Mar. 31, 2013 Warrant [Member]	Sep. 30, 2012 Warrant [Member]	Jun. 30, 2014 Warrant [Member]	Jun. 30, 2013 Warrant [Member]	Aug. 31, 2013 Convertible Note [Member]	Feb. 28, 2013 Convertible Note [Member]	Sep. 30, 2012 Minimum [Member]	Sep. 30, 2012 Maximum [Member]	Aug. 31, 2013 Common Stock [Member]	Sep. 30, 2012 Common Stock [Member]	Mar. 31, 2013 Common Stock [Member]	Jun. 30, 2013 Common Stock [Member] Warrant [Member]	Jul. 31, 2013 Common Stock [Member] Convertible Note [Member]	Jun. 30, 2014 Private Placement [Member]	Jun. 30, 2014 Private Placement [Member] Common Stock [Member]	Jun. 30, 2013 Private Placement [Member] Common Stock [Member]	Jun. 30, 2014 Lincoln Park Capital Fund, LLC ("LPC") [Member] Common Stock Purchase Agreement [Member]	Jan. 31, 2012 Lincoln Park Capital Fund, LLC ("LPC") [Member] Common Stock Purchase Agreement [Member] Common Stock [Member]	Jun. 30, 2014 Lincoln Park Capital Fund, LLC ("LPC") [Member] Common Stock Purchase Agreement [Member] Common Stock [Member]	Jun. 30, 2013 Lincoln Park Capital Fund, LLC ("LPC") [Member] Common Stock Purchase Agreement [Member] Common Stock [Member]	Jan. 31, 2012 Lincoln Park Capital Fund, LLC ("LPC") [Member] Common Stock Purchase Agreement [Member] Scenario, Plan [Member]	Jun. 30, 2014 Lincoln Park Capital Fund, LLC ("LPC") [Member] Common Stock Purchase Agreement [Member] Scenario, Plan [Member]	May 31, 2013 COO and Principal Shareholder [Member] Warrant [Member]	Sep. 30, 2012 COO and Principal Shareholder [Member] Convertible Note [Member]	Feb. 28, 2013 COO and Principal Shareholder [Member] Common Stock [Member]	Apr. 30, 2014 COO and Principal Shareholder [Member] Common Stock [Member] Convertible Note [Member]	Jun. 30, 2014 COO and Principal Shareholder [Member] Private Placement [Member]	Jun. 30, 2014 COO and Principal Shareholder [Member] Private Placement [Member] Common Stock [Member]	Jun. 30, 2013 COO and Principal Shareholder [Member] Private Placement [Member] Common Stock [Member]	Jun. 30, 2014 Chief Executive Officer [Member] Private Placement [Member]	Jun. 30, 2013 Chief Executive Officer [Member] Private Placement [Member] Common Stock [Member]	Jul. 31, 2013 Director [Member]	Jun. 30, 2013 Director [Member]	Sep. 30, 2012 Director [Member] Warrant [Member]
Class of Stock [Line Items]
Proceeds from issuance of common stock per agreement																											$ 5,000,000
Common stock issued in connection with stock purchase agreement				570,000	810,003																			100,000	570,000	810,003
Common stock issued in connection with stock purchase agreement, shares																								316,667	577,428	1,333,820
Number of shares registered																								4,400,000
Maximum proceeds from issuance of common stock per sale																											500,000
Proceeds from issuance of common stock				2,131,527	1,658,000																2,131,527	1,958,000					4,900,000							925,000	950,000		280,000
Shares of stock issued as a commitment fee																									150,000
Pro-rata shares issued																							320,810					450,000
Common stock issued, shares																					3,352,726	3,914,321												1,434,060	1,910,714		241,379
Number of accredited investors																				6	15	13
Common stock and warrants issued for cash, shares																				2,575,579													1,817,932			200,000
Number of shares callable by warrants																	45,000			1,258,378									312,500				908,966			100,000				350,000
Proceeds from the sale of stock and warrants through private placements				1,705,000	300,000															1,705,000													1,125,000			150,000
Common stock issued for interest, shares																			8,880												210,226	428,032
Accrued interest																			4,440												73,579	149,811
Debt instrument, maturity date																														Sep. 28, 2012		Feb. 01, 2014
Loss on conversion of interest				201,175																											(4,204)	(201,175)
Conversion price																															$ 0.35	$ 0.35
Fair market value, price per share							$ 1.57										$ 1.57														$ 0.37	$ 0.82
Number of shares issued upon exercise of warrants and options																1,740,000
Proceeds from exercise of warrants and stock options		870,000
Exercised warrants							45,000	1,640,000	20,000	1,865,000								1,820,000
Exercise of stock options, shares		100,000																																				20,000	11,667
Reduced exercise price of warrants and options		$ 0.50	$ 0.50
Original exercise price of warrants and options													$ 1.25	$ 1.75
Cost of repricing warrants to induce exercise			70,491		70,491
Common stock issued upon exercise of warrants, shares	80,000					20,000	9,171
Proceeds from exercise of warrants	40,000			25,000	910,000	25,000									25,000
Exercise price of shares called by warrants	$ 0.50					$ 1.25	$ 1.25								$ 1.25		$ 1.25												$ 1.25											$ 0.63
Proceeds from exercise of stock options				18,200	6,534																																	18,200	6,534
Exercise price																																						$ 0.91
Convertible notes payable											$ 82,132	$ 102,500																		$ 322,996
Convertible note conversions, shares											234,663	205,000																		665,992

XML

FURNITURE, FIXTURES AND EQUIPMENT (Tables)

12 Months Ended

Jun. 30, 2014

FURNITURE, FIXTURES AND EQUIPMENT [Abstract]

Schedule of Property and Equipment

Furniture, fixtures and equipment consisted of the following as of June 30, 2014 and 2013:

	Estimated	June 30,
	Useful Life	2014			2013
Equipment	3 - 5 years	$	111,488		$	88,875
Storage facilities	3 years		20,802			20,802
Vehicles	5 - 7 years		214,470			164,232
Furniture and fixtures	5 years		20,420			20,420
			367,180			294,329
Accumulated depreciation			(191,429	)		(136,145	)
		$	175,751		$	158,184

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Restricted Stock Units) (Details) (Restricted Stock Units (RSUs) [Member], Former Executive Chairman [Member], USD $)	1 Months Ended		12 Months Ended
	Jun. 30, 2013	Nov. 30, 2012	Jun. 30, 2013
Restricted Stock Units (RSUs) [Member] | Former Executive Chairman [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments granted		800,000
Immediately vested shares		200,000
Vested shares upon generating $3,000,000 in revenue in any 12-month period		200,000
Vested shares upon generating $5,000,000 in revenue in any 12-month period		200,000
Vested shares upon generating $6,000,000 in revenue in any 12-month period		200,000
Fair market value, price per share	$ 0.45		$ 0.45
Vesting of restricted stock units			$ 90,000
Cancelled shares	200,000
Cancelled shares, grant date fair value	$ 196,000	$ 90,000	$ 196,000

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)

12 Months Ended

Jun. 30, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Fair Value Assumptions for Stock Options

The fair value of stock option grants for the fiscal year ended June 30, 2014 and 2013 were estimated using the following weighted- average assumptions:

	2014	2013
Risk free interest rate	0.45% - 2.61%	0.53% - 2.49%
Expected term in years	2.5 - 6.5	2.5 - 10.0
Dividend yield	-	-
Volatility of common stock	89.98% - 91.94%	89.67% - 93.11%
Estimated annual forfeitures	-	-

Employee Options and Stock Appreciation Rights [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Options Activity

A summary of stock option transactions issued to employees under the 2007 Plan for the fiscal years ended June 30, 2014 and 2013 is as follows:

Employee Options and Stock Appreciation Rights

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		4,589,507		$	1.04		5.95
Granted		4,622,500		$	0.55		9.64
Exercised		-		$	-		-
Forfeited		(2,875,000	)	$	0.92		-
Expired		-		$	-		-
Outstanding at June 30, 2013		6,337,007		$	0.75		6.62	$	2,505,808
Exercisable at June 30, 2013		3,696,174		$	0.90		5.70	$	1,056,738
Weighted average fair value of options granted during the year ended June 30, 2013				$	0.41
Balance at June 30, 2013		6,337,007		$	0.75		6.62
Granted		1,425,500		$	1.34		7.81
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at June 30, 2014		7,762,007		$	0.87		5.98	$	792,305
Exercisable at June 30, 2014		4,352,674		$	0.93		4.55	$	265,364
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.69

Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Options Activity

A summary of options issued to directors under the 2007 Plan and changes during the period from June 30, 2012 to June 30, 2013 and from June 30, 2013 to June 30, 2014 is as follows:

Options Issued to Directors

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		857,500		$	1.36		7.96
Granted		610,000		$	0.95		10.00
Exercised		(11,667	)	$	0.56		-
Forfeited		(255,000	)	$	1.38		-
Expired		-		$	-		-
Outstanding at June 30, 2013		1,200,833		$	1.16		8.04	$	165,386
Exercisable at June 30, 2013		795,168		$	1.24		7.25	$	98,654
Weighted average fair value of options granted during the year ended June 30, 2013				$	0.72
Balance at June 30, 2013		1,200,833		$	1.16		8.04
Granted		495,000		$	1.19		10.00
Exercised		(20,000	)	$	0.91		10.00
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at June 30, 2014		1,675,833		$	1.12		7.62	$	8,337
Exercisable at June 30, 2014		1,389,168		$	1.14		7.36	$	8,404
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.76

Non-Employee, Non-Director Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Options Activity

A summary of options issued to non-employees, non-directors under the 2007 Plan and changes during the fiscal years ended June 30, 2014 and 2013 is as follows:

Non-Employee, Non-Director Options

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		540,000		$	1.16		3.14
Granted		275,000		$	1.23		10.00
Exercised		(100,000	)	$	0.50		-
Forfeited		-		$	-		-
Expired		(155,000	)	$	1.00		-
Outstanding at June 30, 2013		560,000		$	1.22		5.96	$	6,250
Exercisable at June 30, 2013		285,000		$	1.21		2.22	$	-
Weighted average fair value of options granted during the year ended June 30, 2013				$	1.00
Balance at June 30, 2013		560,000		$	1.22		5.96
Granted		25,000		$	1.11		5.00
Exercised		-		$	-		-
Forfeited		(275,000	)	$	1.23		-
Expired		(35,000	)	$	1.15		-
Outstanding at June 30, 2014		275,000		$	1.21		1.70	$	-
Exercisable at June 30, 2014		275,000		$	1.21		1.70	$	-
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.79

Warrants Issued for Cash or Services [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Warrant Activity

Warrants issued for cash or services

	Number of Warrants			Weighted Average Exercise Price		Remaining Contractual Life
Balance at June 30, 2012		4,461,200		$	1.46		2.46
Granted		362,500		$	1.16		10.00
Exercised		(1,865,000	)	$	0.50		-
Forfeited		-		$	-		-
Expired		(1,425,000	)	$	1.60		-
Outstanding at June 30, 2013		1,533,700		$	1.25		2.06
Exercisable at June 30, 2013		1,533,700		$	1.25		2.06
Weighted average fair value of warrants granted during the year ended June 30, 2013				$	0.44
Balance at June 30, 2013		1,533,700		$	1.25		2.06
Granted		1,863,421		$	1.58		3.53
Exercised		(20,000	)	$	1.25		-
Forfeited		-		$	-		-
Expired		(340,000	)	$	1.60		-
Outstanding at June 30, 2014		3,037,121		$	1.45		2.73
Exercisable at June 30, 2014		3,037,121		$	1.45		2.73
Weighted average fair value of warrants granted during the year ended June 30, 2014					N/A

Warrants Issued as Settlements [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Warrant Activity

Warrants Issued as Settlements

	Number of Warrants			Weighted Average Exercise Price		Remaining Contractual Life
Balance at June 30, 2012		344,508		$	1.05		0.92
Granted		350,000		$	0.63		5.00
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		(344,508	)	$	1.05		-
Outstanding at June 30, 2013		350,000		$	0.63		4.22
Exercisable at June 30, 2013		350,000		$	0.63		4.22
Weighted average fair value of warrants granted during the year ended June 30, 2013				$	0.33
Balance at June 30, 2013		350,000		$	0.63		4.22
Granted		-		$	-		-
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at June 30, 2014		350,000		$	0.63		3.22
Exercisable at June 30, 2014		350,000		$	0.63		3.22
Weighted average fair value of warrants granted during the year ended June 30, 2014					N/A

XML

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Jun. 30, 2014

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1.

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

GelTech Solutions, Inc., or GelTech or the Company, generates revenue primarily from marketing the following three products: (1) FireIce®, a water enhancing powder that can be utilized both as a fire suppressant in urban firefighting, including underground utility fires, and in wildland firefighting and as a medium-term fire retardant to protect wildlands, structures and firefighters; (2) Soil₂O® "Dust Control", our application which is used for dust mitigation in the aggregate, road construction, mining, as well as, other industries that deal with daily dust control issues and (3) Emergency Manhole FireIce Delivery System, or EMFIDS, an innovative system designed to deliver FireIce® into a manhole in the event of a fire. Other products currently being marketed include (1) FireIce® Home Defense Unit, a system for applying FireIce® to structures to protect them from wildfires; and (2) Soil₂O®, a product which reduces the use of water and is primarily marketed to golf courses, commercial landscapers and the agriculture market. During the fourth quarter of fiscal 2014, the Company developed and began marketing two new products, (1) GT-W14, an industrial absorbent powder used to contain and clean up industrial liquid spills; and (2) Soil₂O® Soil Cap, a dust suppressant technology designed to stabilize stockpile dust and reduce soil erosion. Our consolidated financial statements have been prepared on a going concern basis, and we need to generate sufficient material revenues to support the ongoing business of GelTech.

The corporate office is located in Jupiter, Florida.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its three wholly-owned subsidiaries: FireIce Gel, Inc., GelTech International, Inc. and Weather Tech Innovations, Inc. There has been no activity in Weather Tech Innovations, Inc. and GelTech International, Inc. All intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

For the purposes of the statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company's cash equivalents consist of a brokerage money market account.

Investments in Marketable Securities

The Company may invest in various marketable securities and accounts for such investments in accordance with ASC 320-10.

Certain securities that the Company may invest in may be determined to be non-marketable. Non-marketable securities where the Company owns less than 20% of the investee are accounted for at cost pursuant to ASC 323-10.

Management determines the appropriate classification of its investments at the time of acquisition and reevaluates such determination at each balance sheet date. Trading securities that the Company may hold are treated in accordance with ASC 320-10 with any unrealized gains and losses included in earnings. Available-for-sale securities are carried at fair value, with unrealized gains and losses, net of tax, reported as a separate component of stockholders' equity. Investments classified as held-to-maturity are carried at amortized cost. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method.

The Company periodically reviews its investments in marketable and non-marketable securities and records a reserve for impairment for any securities whose value is considered non-recoverable. The Company's determination of whether a security is other than temporarily impaired incorporates both quantitative and qualitative information. GAAP requires the exercise of judgment in making this assessment for qualitative information, rather than the application of fixed mathematical criteria. The Company considers a number of factors including, but not limited to, the length of time and the extent to which the fair value has been less than cost, the financial condition and near term prospects of the issuer, the reason for the decline in fair value, changes in fair value subsequent to the balance sheet date, and other factors specific to the individual investment. The Company's assessment involves a high degree of judgment and accordingly, actual results may differ materially from the Company's estimates and judgments.

Accounts Receivable

Accounts receivable are customer obligations due under normal trade terms. Senior management reviews accounts receivable on a monthly basis to determine if any receivables will potentially be uncollectible. The Company includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve, in its overall allowance for doubtful accounts. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.

Inventories

Inventories are stated at the lower of cost or market, with cost determined using a first-in, first-out method.

Property and Equipment and Depreciation

Property and equipment is recorded at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets of 3 to 7 years. Leasehold improvements are amortized over the lesser of the lease term or the useful life of the improvements. Expenditures for maintenance and repairs are expensed as incurred.

Impairment of Long-Lived Assets

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

Fair Value of Financial Instruments and Fair Value Measurements

We measure our financial assets and liabilities in accordance with ASC 820 "Fair Value Measurements and Disclosures". For certain of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued expenses, the carrying amounts approximate fair value due to their short maturities. The carrying amount of our convertible and other debt approximates the fair value because the interest rate on those debts do not vary materially from the market rate for similar debt instruments.

We adopted accounting guidance for fair value measurements of financial assets and liabilities and adopted the same guidance for non-financial assets and liabilities effective July 1, 2009. The adoption did not have a material impact on our results of operations, financial position or liquidity. The standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

Level 1:

Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2:

Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.

The Company had no financial or non-financial assets or liabilities measured at fair value and subject to this accounting standard as of June 30, 2014 or 2013.

Revenue Recognition

Revenue from sales of products is recognized when persuasive evidence of an arrangement exists, products have been shipped to the customer, economic risk of loss has passed to the customer, the price is fixed or determinable, collection is reasonably assured, and any future obligations of the Company are insignificant. Revenue is shown net of returns and allowances. The Company does provide certain customers with the right of return for unsold product. Sales to these customers are recorded as the customer sells the product, thus removing the right of return.

Products shipped from either our third-party fulfillment companies or our Jupiter, Florida or Irwindale, California locations are shipped FOB shipping point. Normal payment terms are net 30 or net 60 days depending on the arrangement we have with the customer. As such, revenue is recognized when product has been shipped from either the third-party fulfillment company or from the Jupiter, Florida or Irwindale, California locations.

The Company follows the guidance of ASC 605-50-25, "Revenue Recognition, Customer Payments". Accordingly, any incentives received from vendors are recognized as a reduction of the cost of products. Promotional products or samples given to customers or potential customers are recognized as a cost of goods sold. However, products we utilize to perform demonstrations for potential customers are recorded as a marketing expense in operations. During the fiscal years ended June 30, 2014 and 2013, these demonstration costs amounted to $4,195 and $10,889, respectively. Cash incentives provided to our customers are recognized as a reduction of the related sale price, and, therefore, are a reduction in sales.

Shipping and Handling Costs

Amounts invoiced to customers for shipping and handling are included in revenues. Shipping and handling costs related to sales of products are included in selling, general and administrative expenses and were $52,594 and $51,943 in 2014 and 2013, respectively.

Research and Development

In accordance with ASC 730-10 expenditures for research and development of the Company's products are expensed when incurred, and are included in operating expenses. The Company recognized research and development costs of $274,005 and $179,158 for the fiscal years ended June 30, 2014 and 2013, respectively.

Advertising

The Company conducts advertising for the promotion of its products and services. In accordance with ASC 720-35, advertising costs are charged to operations when incurred; such amounts aggregated $42,575 in fiscal 2014 and $26,931 in fiscal 2013.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management believes that the estimates utilized in preparing its consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Significant estimates in fiscal 2014 and fiscal 2013 include the allowance for doubtful accounts, depreciation and amortization, valuation of inventories, valuation of the beneficial conversion features associated with convertible notes, valuation of options and warrants granted for services or settlements, valuation of common stock granted for services or for debt conversion, accruals for litigation losses and the valuation of deferred tax assets.

Net Earnings (Loss) per Share

The Company computes net earnings (loss) per share in accordance with ASC 260-10. ASC 260-10 requires presentation of both basic and diluted earnings per share ("EPS") on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. For the years ended June 30, 2014 and 2013, there was no separate computation of dilutive net loss per share since the common stock equivalents outstanding were anti-dilutive due to the net losses. At June 30, 2014 there were options to purchase 9,742,840 shares and warrants to purchase 3,387,121 shares of common stock outstanding which may dilute future earnings per share. In addition, there are 6,707,094 shares reserved for issuance related to convertible note agreements.

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718-10 "Compensation - Stock Compensation" which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options, restricted stock units, and stock appreciation rights are based on estimated fair values. Stock option compensation expense recognized under ASC 718-10 for the years ended June 30, 2014 and 2013 was $1,680,358 and $1,480,377, respectively, related to employee, director and advisory board stock options, and is included in selling, general and administrative expenses in the consolidated statements of operations. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. At June 30, 2014, the total compensation cost for stock options not yet recognized was $836,656. This cost will be amortized on a straight-line basis over the remaining vesting period of the options.

The Company accounts for non-employee stock based awards at fair value in accordance with the measurement and recognition criteria of ASC 505-50 "Equity Based payments to Non-Employees. Stock based compensation to non-employees recognized for the years ended June 30, 2014 and 2013 was $2,475 and $17,157, respectively.

2007 Equity Incentive Plan

In January 2007, the Company established the 2007 Equity Incentive Plan under which provided for the issuance of up to 1,500,000 stock options, stock appreciation rights, restricted stock or restricted stock units to our directors, employees and consultants. In September 2008, the Board of Directors approved an amendment to the Company's 2007 Equity Incentive Plan to increase the number of shares authorized by the plan from 1,500,000 to 3,500,000. In fiscal 2012, Board of Directors increased the number of share authorized under the Plan to 4,500,000. In June 2013, the Board of Directors approved an amendment to increase the number of shares authorized by the plan to 15,000,000.

Under the Equity Incentive Plan, all directors who are not employees or own 10% or more of the Company's outstanding stock at the time of grant shall automatically receive a grant of stock options as follows:

Initial Grants

A - Chairman of the Board

- 50,000 options

B - Director

- 30,000 options

C - Chair of a Committee

- 10,000 options

D - Member of a Committee

- 5,000 options

In June 2013, the Board of Directors increased the annual grants to the following amounts:

Annual Grants

A - Chairman of the Board

- 70,000 options

B - Director

- 100,000 options

C - Chair of a Committee

- 20,000 options

D - Member of a Committee

- 10,000 options

All initial grants of options to new non-employee directors and committee members vest annually over a three year period on the anniversary date of the grant, subject to continuing service as a director, Committee member, Chairman of the Board or Chairman of a Committee on the applicable vesting date. Options automatically granted annually under the 2007 Equity Incentive Plan vest the following June 30th, subject to continuing service as a director. The exercise price of options or stock appreciation rights granted under the 2007 Equity Incentive Plan shall not be less than the fair market value of the underlying common stock at the time of grant. In the case of incentive stock options, the exercise price may not be less than 110% of the fair market value in the case of 10% shareholders. Options and stock appreciation rights granted under the 2007 Equity Incentive Plan shall expire no later than ten years after the date of grant. The option price may be paid in United States dollars by check or wire transfer or, at the discretion of the Board of Directors or Compensation Committee, by delivery of shares of our common stock having fair market value equal as of the date of exercise to the cash exercise price, or a combination thereof.

The identification of individuals entitled to receive awards, the terms of the awards, and the number of shares subject to individual awards, are determined by the Board of Directors or the Compensation Committee, in their sole discretion. The purchase price per share, if applicable, shall be adjusted for any increase or decrease in the number of issued shares resulting from a recapitalization, reorganization, merger, consolidation, exchange of shares, stock dividend, stock split, reverse stock split, or other subdivision or consolidation of shares.

The Board of Directors or the Compensation Committee may from time to time alter, amend, suspend, or discontinue the Equity Incentive Plan with respect to any shares as to which awards of stock rights have not been granted. However no rights granted with respect to any awards under this Equity Incentive Plan before the amendment or alteration shall be impaired by any such amendment, except with the written consent of the grantee. Under the terms of the Equity Incentive Plan, the Board of Directors or the Compensation Committee may also grant awards which will be subject to vesting under certain conditions. The vesting may be time-based or based upon meeting performance standards, or both.

In April 2010, the Company amended the 2007 Equity Incentive Plan to increase the number of stock options granted annually to directors from 20,000 to 50,000. In June 2013, the Company amended the 2007 Equity Incentive Plan to increase the number of stock options granted annually to directors to 100,000.

All of our Stock Option Agreements provide for "clawback" provisions, which enable our Board of Directors to cancel stock awards and recover past profits if the person is dismissed for cause or commits certain acts which harm us.

Determining Fair Value under ASC 718-10

The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company's determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables.

Income Taxes

The Company accounts for income taxes pursuant to the provisions of ASC 740-10, "Accounting for Income Taxes," which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

The Company follows the provisions of the ASC 740 -10 related to, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

Effective July 1, 2007, the Company adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of June 30, 2014, the fiscal tax years ended June 30, 2011, 2012 and 2013 are still subject to audit.

Legal Costs and Contingencies

In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received.

If a loss is considered probable and the amount can be reasonably estimated, the Company recognizes an expense for the estimated loss. If the Company has the potential to recover a portion of the estimated loss from a third party, the Company makes a separate assessment of recoverability and reduces the estimated loss, if recovery is also deemed probable.

New Accounting Pronouncements

Accounting Standards Updates (ASUs) which were not effective until after June 30, 2014 are not expected to have a significant effect on the Company's consolidated financial position or results of operations.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jun. 30, 2014	Jun. 30, 2013
CONSOLIDATED BALANCE SHEETS [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	40,301,979	33,084,671
Common stock, shares outstanding	40,301,979	33,084,671

XML

CONCENTRATIONS

12 Months Ended

Jun. 30, 2014

CONCENTRATIONS [Abstract]

CONCENTRATIONS

11.

CONCENTRATIONS

The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through June 30, 2013. As of June 30, 2014, the Company had no cash equivalent balances that were not insured.

At June 30, 2014, there were accounts receivable from three customers that each exceeded 10% of the total gross accounts receivable at 24.4%, 16.1% and 10.4%. At June 30, 2013, there were accounts receivable from three customers that each exceeded 10% of the total gross accounts receivable at 39.2%, 13.9% and 11.6%.

During fiscal 2014, one customer accounted for 60.7% of sales. No other customer had sales in excess of 10% of revenues. During fiscal 2013, two customers accounted for 36.3% and 32.4% of sales. No other customer had sales in excess of 10% of revenues.

During fiscal 2014, sales resulted from three products, EMFIDS, FireIce and Soil₂O® and from paid for research and development which made up 52.2%, 27.4%, 19.2% and 1.27% of total sales, respectively. During fiscal 2013, sales resulted from two products, FireIce and Soil₂O® and from paid for research and development which made up 38.8%, 43.5% and 17.7% of total sales, respectively.

During the year ended June 30, 2014, the Company's made inventory purchases from three vendors amounting to approximately $226,000, $81,000 and $64,000 representing 35.3%, 12.6% and 10.0%, respectively, of inventory purchases for the fiscal year. During the year ended June 30, 2013, the Company purchased approximately $142,000 of raw material from one vendor and approximately $32,000 from another vendor which amounted to 50.8% and 11.5%, respectively, of the inventory purchases in fiscal 2013.

XML

Document and Entity Information (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2014	Sep. 26, 2014	Dec. 31, 2013
Document and Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2014
Entity Registrant Name	GelTech Solutions, Inc.
Entity Central Index Key	0001403676
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		42,264,310
Entity Public Float			$ 13.7
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes

XML

SUBSEQUENT EVENTS

12 Months Ended

Jun. 30, 2014

SUBSEQUENT EVENTS [Abstract]

SUBSEQUENT EVENTS

12.

SUBSEQUENT EVENTS

In July 2014, the Company issued 107,143 shares of common stock to its chief operating officer and principal stockholder in payment of accrued interest in the amount of $75,000 related to a convertible note.

In accordance with the 2007 Equity Incentive Plan, on July 1, 2014, the Company issued options to purchase 470,000 shares of common stock to directors. The options have an exercise price of $0.70 per share, vest on June 30, 2015¸ subject to continuing service as a director and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 88.55% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5.5 years (using the simplified method) and a discount rate of 1.79%. The value of these options will be recognized as expense over the requisite service period.

Since July 1, 2014, the Company has issued 1,855,188 shares of common stock and two year warrants to purchase 906,586 shares of common stock at an exercise price of $2.00 per share in exchange for $1,025,000 in connection with private placements with accredited investors, including 1,603,087 shares and 801,544 warrants to our chief operating officer and principal stockholder in exchange for $850,000.

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Sales	$ 814,587	$ 526,010
Cost of goods sold	393,102	180,427
Gross profit	421,485	345,583
Operating expenses:
Selling, general and administrative expenses	6,601,353	6,103,435
Research and development	274,005	179,158
Total operating expenses	6,875,358	6,282,593
Loss from operations	(6,453,873)	(5,937,010)
Other income (expense)
Interest income	276	864
Loss on settlement		(5,088)
Loss on sale of assets	(11,413)	(9,822)
Loss on extinguishment of debt		(25,515)
Loss on conversion of interest	(201,175)
Other income (loss)	17,000	1,298,920
Cost of repricing warrants to induce exercise		(70,491)
Interest expense	(462,760)	(473,605)
Total other income (expense)	(658,072)	715,263
Net loss	$ (7,111,945)	$ (5,221,747)
Net loss per common share - basic and diluted	$ (0.20)	$ (0.18)
Weighted average shares outstanding - basic and diluted	36,410,142	29,479,048

XML

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS

12 Months Ended

Jun. 30, 2014

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS [Abstract]

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS

6.

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS

On May 29, 2009, the Company received a line of credit ("Line of Credit") from the Company's principal stockholder (the "Lender"). In connection with this Line of Credit, the Company executed a Revolving Promissory Note which permitted the Company to borrow up to $2,500,000. Interest, at an annual rate of 5%, was due monthly on the 20th day of each month which commenced on July 20, 2009.

In February 2011, the Company renegotiated the Line of Credit Agreement with the Lender. As part of the renegotiation, the Company issued 892,857 shares of the Company's common stock and five-year warrants to purchase 1,000,000 shares of the Company's common stock at an exercise price of $1.25 per share in exchange for a $1,000,000 reduction in the principal amount of the Line of Credit. In addition, the remaining principal amount due under the line of credit of $1,497,483 was replaced by a five-year convertible note of the same amount, convertible at $1.12 per share (fair market value on transaction date based upon the quoted trading price) and bearing annual interest of 5%, due on the maturity date of the note (the "2011 Note"). As an inducement for the Lender to enter into the convertible note agreement, the Company granted the Lender five-year warrants to purchase 300,000 shares of the Company's common stock at an exercise price of $1.75 per share. These warrants were exercised in September 2012 in exchange for $150,000 in connection with the Company's offer to all warrant holders to exercise warrants at $0.50 per share instead of the exercise price negotiated on the date of the grant. In February 2013, the 2011 Note, plus a $275,000 convertible original issue discount note were combined into one convertible note, see discussion below.

In December 2011, the Company received short term advances from its then Chief Executive Officer, former President and Chief Financial Officer in the amounts of $10,000, $29,380 and $50,000, respectively. The advances bear interest rates of 0.7%, 5.0% and 5.0%, respectively. In addition, as further inducement for the advance from the Chief Financial Officer, the Company approved the reduction in the exercise price of 150,000 options granted to the Chief Financial Officer from $1.95 to $0.60 per share. In connection with this repricing, the expense related to the vesting of these options was increased by $15,067 which will be recognized over the remaining service period. As of June 30, 2014, the Company has repaid all amounts due related to these advances.

On March 9, 2012, the Company received $105,000 from third parties in exchange for nine month convertible original issue discount notes in the amount of $107,625. The notes bear an annual interest rate of 5% and are convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the notes, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $84,562 which will be amortized to interest expense over the life of the notes. In September 2012, the Company issued new one-year convertible original issue discount notes in the amount of $120,540, bearing annual interest of 12% and convertible at $0.50 per share in exchange for cancellation of the old notes. This modification was not considered a debt extinguishment. In accordance with ASC 470, the Company recognized a debt discount related to the change in fair value of the embedded conversion option in the amount of $35,138 which was amortized to interest expense over the life of the convertible notes. In August 2013, the Company paid one note in the amount of $34,440 by issuing 8,880 shares of common stock and a payment of $30,000. The remaining note in the amount of $86,100 was retired in August 2013 by the payment of $85,822.

On March 10, 2012, the Company received $75,000 from a director in exchange for a nine month convertible original issue discount note in the amount of $76,875. The note bears an annual interest rate of 5% and is convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the note, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $63,038 was amortized to interest expense over the life of the note. In September 2012, the Company issued a new one-year convertible original issue discount note in the amount of $86,100, bearing annual interest of 12% and convertible at $0.50 per share in exchange for cancellation of the old note. This modification was not considered a debt extinguishment. In accordance with ASC 470, the Company recognized a debt discount related to the change in fair value of the embedded conversion option in the amount of $24,971 which was amortized to interest expense over the life of the convertible note. In September 2013, the Company repaid the note.

In August 2012, the Company received $175,000 in exchange for six month convertible original issue discount notes in the amount of $179,375 with two accredited investors. The notes are convertible into common stock at $0.50 per share. The notes bear an annual interest rate of 5% and are convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the notes, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $106,600 and an original issue discount of $4,375 which are being amortized to interest expense over the life of the notes. In February 2013, one note holder was issued 205,000 shares of the Company's common stock in exchange for a note in the amount of $102,500. In addition, the other note holder was issued a new one year original issue discount note for $86,100 convertible at $0.35 per share. The Company recorded an original issue discount of $9,225 and a beneficial conversion feature discount of $4,920 in connection with the new note. For the period February 2013 to August 2013, the Company recognized interest expense of $7,552 and $4,920, respectively, related to the amortization of the original issue discount and the beneficial conversion feature discount. In August 2013, the Company issued 234,663 shares of common stock valued at $82,132, in connection with the early conversion of this note.

On December 28, 2012, the Company received $250,000 from its principal stockholder in exchange for a one year convertible original issue discount note in the amount of $275,000 (the "2012 Note"). The note bears an annual interest rate of 10% and is convertible into the Company's common stock at the rate of $0.35 per share. In connection with the issuance of the note, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $23,571 and an original issue discount of $25,000 which is being amortized to interest expense over the life of the note.

In February 2013, the Company entered into a new convertible note agreement in the amount of $1,997,483, convertible into common stock at a conversion price of $0.35 per share, bearing interest at an annual rate of 7.5% and due on December 31, 2016. This note was issued in exchange for the 2011 Note and the 2012 Note and receipt of $250,000. In connection with the transaction, the Company issued 210,226 shares of common stock in exchange for accrued interest of $73,579 due on the 2011 and 2012 notes resulting in a loss on conversion of interest of $4,204. The exchange of cash and the 2011 and 2012 notes was recorded as a debt extinguishment which resulted in a loss on extinguishment of debt in the amount of $21,311 for the year ended June 30, 2013. Because this convertible debt instrument contained an embedded beneficial conversion feature, and was extinguished before conversion, the amount of the reacquisition price to be allocated to the repurchased beneficial feature was measured using the intrinsic value of that conversion feature at the extinguishment date and was immaterial. In connection with the new note agreement, the Company recorded a note discount in the amount of $114,142 related to the beneficial conversion feature of the note calculated using the intrinsic value, of which $55,110 has been amortized as of June 30, 2014. The Company issued 428,032 shares of common stock in satisfaction of accrued interest in the amount $149,811. In connection with the issuance, the Company recorded a loss on conversion of interest of $201,175 representing the difference between the conversion rate of $0.35 per share and the market price of the stock of $0.82 per share.

In July 2013, the Company received $1 million from its Chief Operating Officer and principal stockholder in exchange for a five year, $1 million convertible note with a conversion rate of $1.00 per share and an annual interest of 7.5%, plus five year warrants to purchase 500,000 shares of the common stock at $1.30 per share. The Company estimated the relative fair market value of the warrants to be $311,949 using the Black-Scholes model using a volatility of 91.46% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5 years (the term of the warrants) and a discount rate of 1.4%. In addition, the Company estimated the intrinsic value of the beneficial conversion feature of the note to be $601,949. For the year ended June 30, 2014, the Company recognized interest expense from the amortization of the debt discounts related to this note in the amount of $177,271. As of June 30, 2014, accrued interest due under the note amounted to $75,000.

A summary of notes payable and related discounts as of June 30, 2014 is as follows:

	Principal		Unamortized Discount			Debt, Net of Discount
Related parties
Convertible notes payable	$	2,997,483	$	(795,659	)	$	2,201,824
Less current portion		-		-			-
Convertible notes payable, net of current portion	$	2,997,483	$	(795,659	)	$	2,201,824

A summary of notes payable and related discounts as of June 30, 2013 is as follows:

	Principal		Unamortized Discount			Debt, Net of Discount
Third parties
Convertible notes payable	$	206,640	$	(14,477	)	$	192,163
Less current portion		206,640		(14,477	)		192,163
Convertible notes payable, net of current portion	$	-	$	-		$	-
Related parties
Convertible notes payable	$	2,083,583	$	(105,006	)	$	1,978,577
Less current portion		86,100		(6,839	)		79,261
Convertible and non-convertible note payable, net of current portion	$	1,997,483	$	(98,167	)	$	1,899,316

XML

FURNITURE, FIXTURES AND EQUIPMENT

12 Months Ended

Jun. 30, 2014

FURNITURE, FIXTURES AND EQUIPMENT [Abstract]

FURNITURE, FIXTURES AND EQUIPMENT

5.

FURNITURE, FIXTURES AND EQUIPMENT

Furniture, fixtures and equipment consisted of the following as of June 30, 2014 and 2013:

	Estimated	June 30,
	Useful Life	2014			2013
Equipment	3 - 5 years	$	111,488		$	88,875
Storage facilities	3 years		20,802			20,802
Vehicles	5 - 7 years		214,470			164,232
Furniture and fixtures	5 years		20,420			20,420
			367,180			294,329
Accumulated depreciation			(191,429	)		(136,145	)
		$	175,751		$	158,184

Depreciation expense in 2014 and 2013 was $55,284 and $49,269, respectively.

XML

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS (Tables)

12 Months Ended

Jun. 30, 2014

CONVERTIBLE AND NON-CONVERTIBLE NOTE AGREEMENTS [Abstract]

Schedule of Notes Payable and Related Discounts

A summary of notes payable and related discounts as of June 30, 2014 is as follows:

	Principal		Unamortized Discount			Debt, Net of Discount
Related parties
Convertible notes payable	$	2,997,483	$	(795,659	)	$	2,201,824
Less current portion		-		-			-
Convertible notes payable, net of current portion	$	2,997,483	$	(795,659	)	$	2,201,824

A summary of notes payable and related discounts as of June 30, 2013 is as follows:

	Principal		Unamortized Discount			Debt, Net of Discount
Third parties
Convertible notes payable	$	206,640	$	(14,477	)	$	192,163
Less current portion		206,640		(14,477	)		192,163
Convertible notes payable, net of current portion	$	-	$	-		$	-
Related parties
Convertible notes payable	$	2,083,583	$	(105,006	)	$	1,978,577
Less current portion		86,100		(6,839	)		79,261
Convertible and non-convertible note payable, net of current portion	$	1,997,483	$	(98,167	)	$	1,899,316

XML

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)

12 Months Ended

Jun. 30, 2014

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Principles of Consolidation

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its three wholly-owned subsidiaries: FireIce Gel, Inc., GelTech International, Inc. and Weather Tech Innovations, Inc. There has been no activity in Weather Tech Innovations, Inc. and GelTech International, Inc. All intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and Cash Equivalents

For the purposes of the statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company's cash equivalents consist of a brokerage money market account.

Investments in Marketable Securities

Investments in Marketable Securities

The Company may invest in various marketable securities and accounts for such investments in accordance with ASC 320-10.

Certain securities that the Company may invest in may be determined to be non-marketable. Non-marketable securities where the Company owns less than 20% of the investee are accounted for at cost pursuant to ASC 323-10.

Management determines the appropriate classification of its investments at the time of acquisition and reevaluates such determination at each balance sheet date. Trading securities that the Company may hold are treated in accordance with ASC 320-10 with any unrealized gains and losses included in earnings. Available-for-sale securities are carried at fair value, with unrealized gains and losses, net of tax, reported as a separate component of stockholders' equity. Investments classified as held-to-maturity are carried at amortized cost. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method.

The Company periodically reviews its investments in marketable and non-marketable securities and records a reserve for impairment for any securities whose value is considered non-recoverable. The Company's determination of whether a security is other than temporarily impaired incorporates both quantitative and qualitative information. GAAP requires the exercise of judgment in making this assessment for qualitative information, rather than the application of fixed mathematical criteria. The Company considers a number of factors including, but not limited to, the length of time and the extent to which the fair value has been less than cost, the financial condition and near term prospects of the issuer, the reason for the decline in fair value, changes in fair value subsequent to the balance sheet date, and other factors specific to the individual investment. The Company's assessment involves a high degree of judgment and accordingly, actual results may differ materially from the Company's estimates and judgments.

Accounts Receivable

Accounts Receivable

Accounts receivable are customer obligations due under normal trade terms. Senior management reviews accounts receivable on a monthly basis to determine if any receivables will potentially be uncollectible. The Company includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve, in its overall allowance for doubtful accounts. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.

Inventories

Inventories

Inventories are stated at the lower of cost or market, with cost determined using a first-in, first-out method.

Property and Equipment and Depreciation

Property and Equipment and Depreciation

Property and equipment is recorded at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets of 3 to 7 years. Leasehold improvements are amortized over the lesser of the lease term or the useful life of the improvements. Expenditures for maintenance and repairs are expensed as incurred.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

Fair Value of Financial Instruments and Fair Value Measurements

Fair Value of Financial Instruments and Fair Value Measurements

We measure our financial assets and liabilities in accordance with ASC 820 "Fair Value Measurements and Disclosures". For certain of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued expenses, the carrying amounts approximate fair value due to their short maturities. The carrying amount of our convertible and other debt approximates the fair value because the interest rate on those debts do not vary materially from the market rate for similar debt instruments.

We adopted accounting guidance for fair value measurements of financial assets and liabilities and adopted the same guidance for non-financial assets and liabilities effective July 1, 2009. The adoption did not have a material impact on our results of operations, financial position or liquidity. The standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

Level 1:

Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2:

Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.

The Company had no financial or non-financial assets or liabilities measured at fair value and subject to this accounting standard as of June 30, 2014 or 2013.

Revenue Recognition

Revenue Recognition

Revenue from sales of products is recognized when persuasive evidence of an arrangement exists, products have been shipped to the customer, economic risk of loss has passed to the customer, the price is fixed or determinable, collection is reasonably assured, and any future obligations of the Company are insignificant. Revenue is shown net of returns and allowances. The Company does provide certain customers with the right of return for unsold product. Sales to these customers are recorded as the customer sells the product, thus removing the right of return.

Products shipped from either our third-party fulfillment companies or our Jupiter, Florida or Irwindale, California locations are shipped FOB shipping point. Normal payment terms are net 30 or net 60 days depending on the arrangement we have with the customer. As such, revenue is recognized when product has been shipped from either the third-party fulfillment company or from the Jupiter, Florida or Irwindale, California locations.

The Company follows the guidance of ASC 605-50-25, "Revenue Recognition, Customer Payments". Accordingly, any incentives received from vendors are recognized as a reduction of the cost of products. Promotional products or samples given to customers or potential customers are recognized as a cost of goods sold. However, products we utilize to perform demonstrations for potential customers are recorded as a marketing expense in operations. During the fiscal years ended June 30, 2014 and 2013, these demonstration costs amounted to $4,195 and $10,889, respectively. Cash incentives provided to our customers are recognized as a reduction of the related sale price, and, therefore, are a reduction in sales.

Shipping and Handling Costs

Shipping and Handling Costs

Amounts invoiced to customers for shipping and handling are included in revenues. Shipping and handling costs related to sales of products are included in selling, general and administrative expenses and were $52,594 and $51,943 in 2014 and 2013, respectively.

Research and Development

Research and Development

In accordance with ASC 730-10 expenditures for research and development of the Company's products are expensed when incurred, and are included in operating expenses. The Company recognized research and development costs of $274,005 and $179,158 for the fiscal years ended June 30, 2014 and 2013, respectively.

Advertising

Advertising

The Company conducts advertising for the promotion of its products and services. In accordance with ASC 720-35, advertising costs are charged to operations when incurred; such amounts aggregated $42,575 in fiscal 2014 and $26,931 in fiscal 2013.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management believes that the estimates utilized in preparing its consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Significant estimates in fiscal 2014 and fiscal 2013 include the allowance for doubtful accounts, depreciation and amortization, valuation of inventories, valuation of the beneficial conversion features associated with convertible notes, valuation of options and warrants granted for services or settlements, valuation of common stock granted for services or for debt conversion, accruals for litigation losses and the valuation of deferred tax assets.

Net Earnings (Loss) per Share

Net Earnings (Loss) per Share

The Company computes net earnings (loss) per share in accordance with ASC 260-10. ASC 260-10 requires presentation of both basic and diluted earnings per share ("EPS") on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. For the years ended June 30, 2014 and 2013, there was no separate computation of dilutive net loss per share since the common stock equivalents outstanding were anti-dilutive due to the net losses. At June 30, 2014 there were options to purchase 9,742,840 shares and warrants to purchase 3,387,121 shares of common stock outstanding which may dilute future earnings per share. In addition, there are 6,707,094 shares reserved for issuance related to convertible note agreements.

Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718-10 "Compensation - Stock Compensation" which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options, restricted stock units, and stock appreciation rights are based on estimated fair values. Stock option compensation expense recognized under ASC 718-10 for the years ended June 30, 2014 and 2013 was $1,680,358 and $1,480,377, respectively, related to employee, director and advisory board stock options, and is included in selling, general and administrative expenses in the consolidated statements of operations. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. At June 30, 2014, the total compensation cost for stock options not yet recognized was $836,656. This cost will be amortized on a straight-line basis over the remaining vesting period of the options.

The Company accounts for non-employee stock based awards at fair value in accordance with the measurement and recognition criteria of ASC 505-50 "Equity Based payments to Non-Employees. Stock based compensation to non-employees recognized for the years ended June 30, 2014 and 2013 was $2,475 and $17,157, respectively.

2007 Equity Incentive Plan

In January 2007, the Company established the 2007 Equity Incentive Plan under which provided for the issuance of up to 1,500,000 stock options, stock appreciation rights, restricted stock or restricted stock units to our directors, employees and consultants. In September 2008, the Board of Directors approved an amendment to the Company's 2007 Equity Incentive Plan to increase the number of shares authorized by the plan from 1,500,000 to 3,500,000. In fiscal 2012, Board of Directors increased the number of share authorized under the Plan to 4,500,000. In June 2013, the Board of Directors approved an amendment to increase the number of shares authorized by the plan to 15,000,000.

Under the Equity Incentive Plan, all directors who are not employees or own 10% or more of the Company's outstanding stock at the time of grant shall automatically receive a grant of stock options as follows:

Initial Grants

A - Chairman of the Board

- 50,000 options

B - Director

- 30,000 options

C - Chair of a Committee

- 10,000 options

D - Member of a Committee

- 5,000 options

In June 2013, the Board of Directors increased the annual grants to the following amounts:

Annual Grants

A - Chairman of the Board

- 70,000 options

B - Director

- 100,000 options

C - Chair of a Committee

- 20,000 options

D - Member of a Committee

- 10,000 options

All initial grants of options to new non-employee directors and committee members vest annually over a three year period on the anniversary date of the grant, subject to continuing service as a director, Committee member, Chairman of the Board or Chairman of a Committee on the applicable vesting date. Options automatically granted annually under the 2007 Equity Incentive Plan vest the following June 30th, subject to continuing service as a director. The exercise price of options or stock appreciation rights granted under the 2007 Equity Incentive Plan shall not be less than the fair market value of the underlying common stock at the time of grant. In the case of incentive stock options, the exercise price may not be less than 110% of the fair market value in the case of 10% shareholders. Options and stock appreciation rights granted under the 2007 Equity Incentive Plan shall expire no later than ten years after the date of grant. The option price may be paid in United States dollars by check or wire transfer or, at the discretion of the Board of Directors or Compensation Committee, by delivery of shares of our common stock having fair market value equal as of the date of exercise to the cash exercise price, or a combination thereof.

The identification of individuals entitled to receive awards, the terms of the awards, and the number of shares subject to individual awards, are determined by the Board of Directors or the Compensation Committee, in their sole discretion. The purchase price per share, if applicable, shall be adjusted for any increase or decrease in the number of issued shares resulting from a recapitalization, reorganization, merger, consolidation, exchange of shares, stock dividend, stock split, reverse stock split, or other subdivision or consolidation of shares.

The Board of Directors or the Compensation Committee may from time to time alter, amend, suspend, or discontinue the Equity Incentive Plan with respect to any shares as to which awards of stock rights have not been granted. However no rights granted with respect to any awards under this Equity Incentive Plan before the amendment or alteration shall be impaired by any such amendment, except with the written consent of the grantee. Under the terms of the Equity Incentive Plan, the Board of Directors or the Compensation Committee may also grant awards which will be subject to vesting under certain conditions. The vesting may be time-based or based upon meeting performance standards, or both.

In April 2010, the Company amended the 2007 Equity Incentive Plan to increase the number of stock options granted annually to directors from 20,000 to 50,000. In June 2013, the Company amended the 2007 Equity Incentive Plan to increase the number of stock options granted annually to directors to 100,000.

All of our Stock Option Agreements provide for "clawback" provisions, which enable our Board of Directors to cancel stock awards and recover past profits if the person is dismissed for cause or commits certain acts which harm us.

Determining Fair Value under ASC 718-10

The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company's determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables.

Income Taxes

Income Taxes

The Company accounts for income taxes pursuant to the provisions of ASC 740-10, "Accounting for Income Taxes," which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

The Company follows the provisions of the ASC 740 -10 related to, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

Effective July 1, 2007, the Company adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of June 30, 2014, the fiscal tax years ended June 30, 2011, 2012 and 2013 are still subject to audit.

Legal Costs and Contingencies

Legal Costs and Contingencies

In the normal course of business, the Company incurs costs to hire and retain external legal counsel to advise it on regulatory, litigation and other matters. The Company expenses these costs as the related services are received.

If a loss is considered probable and the amount can be reasonably estimated, the Company recognizes an expense for the estimated loss. If the Company has the potential to recover a portion of the estimated loss from a third party, the Company makes a separate assessment of recoverability and reduces the estimated loss, if recovery is also deemed probable.

New Accounting Pronouncements

New Accounting Pronouncements

Accounting Standards Updates (ASUs) which were not effective until after June 30, 2014 are not expected to have a significant effect on the Company's consolidated financial position or results of operations.

XML

RELATED PARTY TRANSACTIONS

12 Months Ended

Jun. 30, 2014

RELATED PARTY TRANSACTIONS [Abstract]

RELATED PARTY TRANSACTIONS

9.

RELATED PARTY TRANSACTIONS

In addition to the acting Chief Executive Officer (CEO) and the Chief Technology Officer (CTO) the following related parties are employed at GelTech:

· The CEO's sister-in-law is our Controller and her compensation is $1,092 per week,

· The CEO's father is a researcher and his compensation is $2,123 per week, and

· The CEO's mother is a receptionist and her compensation is $600 per week.

The Company has employment arrangements with its executive officers which are described in Note 10.

The Company has entered into a series of credit facilities with its largest principal stockholder as more fully described in Note 6.

In September 2012,  the Company granted options to purchase 70,000 shares of the Company's common stock to the father of the Company's CEO as more fully described in Note 7.

In September 2012, the Company granted warrants to purchase 350,000 shares of the Company's common stock to a director as more fully described in Note 7.

Effective February 8, 2013, the Company's President and Director resigned from the Company to pursue other opportunities. In connection with his separation, the Company agreed to pay the former President $150,000 plus COBRA payments over 14 months. In addition, the Company agreed to issue the former President ten year fully vested options to purchase 112,500 shares of the Company's common stock at an exercise price of $0.39 per share, subject to a lockup agreement for the option shares and the other shares he currently owns. In addition, options and stock appreciation rights to purchase 2,125,000 shares of the Company's common stock at exercise prices from $0.45 to $1.22 per share, previously issued to him, were cancelled. The Company recognized a severance expense of $168,920 for the year ended June 30, 2013 representing the total liability to the Company under the severance agreement. As of June 30, 2014, there is no remaining liability under the agreement.

XML

STOCKHOLDERS' EQUITY (DEFICIT)

12 Months Ended

Jun. 30, 2014

STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]

STOCKHOLDERS' EQUITY (DEFICIT)

7.

STOCKHOLDERS' EQUITY (DEFICIT)

Preferred Stock

The Company has authorized 5,000,000 shares of preferred stock, par value $0.001 per share with such rights, preferences and limitations as may be set from time to time by resolution of the board of directors and the filing of a certificate of designation as required by Delaware law.

Common Stock Issued for Cash

On January 5, 2012, the Company signed a $5 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"), an Illinois limited liability company. Upon signing the agreement, the Company received $100,000 from LPC as an initial purchase under the $5 million commitment in exchange for 316,667 shares of the Company's common stock.

The Company also entered into a registration rights agreement with LPC whereby it agreed to file a registration statement related to the transaction with the Securities and Exchange Commission ("SEC") covering the shares issued to LPC under the purchase agreement. The Company filed a registration statement on January 6, 2012 which became effective on March 26, 2012. Under the registration statement, the Company registered 4.4 million shares of the Company's common stock.

The Company had the right, in its sole discretion, over a 30-month period to sell shares of common stock to LPC in amounts up to $500,000 per sale, depending on certain conditions as set forth in the purchase agreement, which at the time of the purchase agreement was signed was up to an additional $4.9 million. During the year ended June 30, 2013, the Company issued 1,333,820 shares of common stock in exchange for $810,003 in connection with the purchase agreement. During the year ended June 30, 2014, the Company issued 577,428 shares of common stock in exchange for $570,000 in connection with the purchase agreement.

In consideration for entering into the purchase agreement, the Company issued to LPC 150,000 shares of common stock as a commitment fee and will issue up to 450,000 shares pro rata as LPC purchases additional shares. As of June 30, 2014, 320,810 "pro-rata" shares have been issued. The commitment shares are subject to a 30 month lock up restriction. The purchase agreement may be terminated by the Company at any time at our discretion without any cost to it. Except for a limitation on variable priced financings, there are no financial or business covenants, restrictions on future fundings, rights of first refusal, participation rights, penalties or liquidated damages in the agreement. In accordance with its terms, the purchase agreement expired in July 2014.

Issuances of Common Stock

Private Placements

During the year ended June 30, 2013, the Company issued 3,914,321 shares of common stock in exchange for $1,958,000 in connection with private placements with 13 accredited investors, including issuances of 1,910,714 shares to our Chief Operating Officer and principal stockholder in exchange for $950,000 and 241,379 shares each to our Chief Executive Officer and Chief Technology Officer in exchange for a total of $280,000.

During the year ended June 30, 2014, the Company issued 3,352,726 shares of common stock in exchange for $2,131,527 in connection with private placements with 15 accredited investors, including issuances of 1,434,060 shares to our Chief Operating Officer and principal stockholder in exchange for $925,000.

Issuances of Common Stock and Warrants for Cash

During the year ended June 30, 2014, the Company issued 2,575,579 shares of common stock and warrants to purchase 1,258,378 shares of common stock in exchange for $1,705,000 in connection with private placements with 6 accredited investors, including issuances of 1,817,932 shares and warrants to purchase 908,966 shares of common stock to our Chief Operating Officer and principal stockholder in exchange for $1,125,000 and 200,000 shares and warrants to purchase 100,000 shares of common stock to a director in exchange for $150,000.

Common Stock Issued for Interest

In February 2013, the Company issued 210,226 shares of common stock to its Chief Operating Officer and principal stockholder as payment of accrued interest in the amount of $73,579. The Company recorded a loss on conversion of interest of $4,204 in connection with this transaction representing the difference between the conversion price of $0.35 per share and the fair market value of the stock on the date of conversion, $0.37 per share.

In July 2013, the Company issued 8,880 shares of common stock as payment for accrued interest of $4,440 on a convertible note.

In April 2014, the Company issued 428,032 shares of common stock to its Chief Operating Officer and principal stockholder as payment of accrued interest of $149,811 which was due as of February 1, 2014, in accordance with the terms of the convertible note agreement. The Company recorded a loss on conversion of interest of $201,175 in connection with this transaction representing the difference between the conversion price of $0.35 per share and the fair market value of the stock on the date of conversion, $0.82 per share.

Common Stock Issued for Exercise of Options and Warrants and Cashless Exercise of Warrants

In September 2012, the Company issued 1,740,000 shares of common stock in exchange for $870,000 in connection with the exercise of 1,640,000 warrants and 100,000 options to purchase shares of the Company's common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise prices of the warrants and options ranged from $1.25 to $1.75 per share. The cost of repricing warrants recognized by the Company amounted to $70,491 for the three months ended September 30, 2012. The cost represents the incremental increase in the fair value of the repriced warrants and options as compared to the original warrants and options granted, valued on the exercise date. The fair value of the warrants and options was determined using the Black-Scholes option pricing model.

In October 2012, the Company issued 80,000 shares of common in exchange for $40,000 in connection with the exercise of warrants at $0.50 per share.

In March 2013, the Company issued 9,171 shares of common stock related to the cashless exercise of 45,000 warrants to purchase common stock at an exercise price of $1.25 per share based upon a fair market value of our stock of $1.57 on the date of exercise.

In June 2013, the Company issued 11,667 shares of common stock in exchange for $6,534 in connection with the exercise of options by a director.

In July 2013, the Company issued 20,000 shares of common stock to a director in exchange for $18,200 in connection with the exercise of options at an exercise price of $0.91 per share.

In August 2013, the Company issued 20,000 shares of common stock in exchange for $25,000 in connection with the exercise of warrants with an exercise price of $1.25 per share.

Common Stock Issued for Conversion of Debt

In September 2012, our Chief Operating Officer and principal stockholder converted his $322,996 convertible original issue discount note which was due on September 28, 2012 into 665,992 shares of common stock.

In February 2013, the Company issued 205,000 shares of common stock in connection with the conversion of a convertible original issue discount note in the amount of $102,500.

In August 2013, the Company issued 234,663 shares of common stock in connection with the early conversion of a convertible note in the amount of $82,132.

Restricted Stock Units

On November 14, 2012 , the Compensation Committee of the Board of Directors granted its former Executive Chairman 800,000 restricted stock units ("RSU"), of which (i) 200,000 units vested immediately, (ii) 200,000 units vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 units vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 units vest upon the Company generating $6,000,000 in revenue in any 12-month period. Vested Units shall be paid in shares of the Company's common stock. The Company valued the 200,000 RSU's which vested immediately, at $0.45 per share based on the closing bid price on the vesting date and recorded stock compensation expense of $90,000 during the year ended June 30, 2013, resulting from the obligation to issue 200,000 shares of common stock.

In June 2013 the Executive Chairman was terminated for cause and the clawback provisions of the RSU agreement provided for the cancellation of the Company's obligation to issue these 200,000 shares of common stock. As the shares had not been delivered, the Company reduced its common stock issuable and recognized Other Income in fiscal 2013 for the grant date fair value of $90,000 for these shares in accordance with guidance in ASC 718-20-35, Awards Classified as Equity, Subsequent Measurement in conjunction with a clawback feature since the $196,000 fair value of the 200,000 shares at the cancellation date exceeds the grant date value of $90,000.

The fair value of stock option grants for the fiscal year ended June 30, 2014 and 2013 were estimated using the following weighted- average assumptions:

	2014	2013
Risk free interest rate	0.45% - 2.61%	0.53% - 2.49%
Expected term in years	2.5 - 6.5	2.5 - 10.0
Dividend yield	-	-
Volatility of common stock	89.98% - 91.94%	89.67% - 93.11%
Estimated annual forfeitures	-	-

The Black-Scholes option-pricing model was developed for use in estimating the fair value of non-traded options, which have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including the expected stock price volatility. Because the Company's stock options and warrants have characteristics different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of such stock options In fiscal 2014 and 2013, the Company used the Company's trading prices in calculating the stock price volatility and based its volatility on historical volatility. The expected term was estimated using the simplified method for employee stock options since the Company does not have adequate historical exercise data to estimate the expected term.

Options to Purchase Common Stock

A summary of stock option transactions issued to employees under the 2007 Plan for the fiscal years ended June 30, 2014 and 2013 is as follows:

Employee Options and Stock Appreciation Rights

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		4,589,507		$	1.04		5.95
Granted		4,622,500		$	0.55		9.64
Exercised		-		$	-		-
Forfeited		(2,875,000	)	$	0.92		-
Expired		-		$	-		-
Outstanding at June 30, 2013		6,337,007		$	0.75		6.62	$	2,505,808
Exercisable at June 30, 2013		3,696,174		$	0.90		5.70	$	1,056,738
Weighted average fair value of options granted during the year ended June 30, 2013				$	0.41
Balance at June 30, 2013		6,337,007		$	0.75		6.62
Granted		1,425,500		$	1.34		7.81
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at June 30, 2014		7,762,007		$	0.87		5.98	$	792,305
Exercisable at June 30, 2014		4,352,674		$	0.93		4.55	$	265,364
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.69

On September 21, 2012, the Company granted options to purchase 70,000 shares of the Company's common stock at an exercise price of $0.63 per share to the father of the Company's Chief Executive Officer and Chief Technology Officer in recognition of his service. Of the options granted, 35,000 vest immediately with the remainder vesting semi-annually each December 31 and June 30 over a three year period, subject to continued employment on the vesting date. The Company valued the options at $28,358 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 4 years, using the Simplified Method and a discount rate of 0.53%.

On September 21, 2012, the Company granted five-year options to purchase 265,000 shares of common stock at an exercise price of $0.60 per share to non-executive employees. The options vest 25% immediately with the remainder vesting annually over three years, subject to continued employment. The Company valued the options at $101,029 using the Black-Scholes option pricing model using a volatility of 89.93%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 4 years, using the Simplified Method and a discount rate of 0.53%. The resulting expense will be recognized 25% immediately and the remainder over the vesting period.

On November 14, 2012, in connection with the signing of new employment agreements, the Compensation Committee of the Board of Directors granted its then Chief Executive Officer, Chief Financial Officer, Chief Technology Officer and former President, 800,000 stock settled stock appreciation rights ("SARS") each, of which (i) 200,000 rights vested immediately, (ii) 200,000 rights vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 rights vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 rights vest upon the Company generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period. The Company valued the 3,200,000 SARS at $1,086,560 using the Black-Scholes option pricing model using a volatility of 89.67%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 6.5 years, using the Simplified Method and a discount rate of 0.93%. Compensation expense of $271,640 was recognized immediately relating to the 800,000 SARS that vested immediately. The remaining compensation expense will be recognized based on management's assessment that the performance targets are likely to be met within 30 months of the grant date, resulting in the $814,920 of unrecognized compensation expense being expensed by June 30, 2015.

In connection with this grant, the Company's then Chief Executive Officer, former President and Chief Technology Officer agreed to cancel 250,000 stock options granted to each of them in their prior employment agreements. Because the fair value of the options cancelled exceeded the fair value of the new options granted, no additional expense will be recognized relating to these options.

In connection with a Termination and Release Agreement (the "Release Agreement") effective February 8, 2013, the Company issued its former President options to purchase 112,500 shares of common stock at an exercise price of $0.39 per share, subject to a lockup agreement for the option shares and the other shares he currently owns. The options are fully vested and have a ten year term. The Company valued the options at $43,875 using the Black-Scholes option pricing model using a volatility of 89.67%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 9.42 years, using the Simplified Method and a discount rate of 0.93%. Additionally, in connection with the Release Agreement the Company cancelled options to purchase 1,325,000 shares of common stock at exercise prices from $0.667 to $1.22 per share and under a clawback provision rescinded 800,000 stock appreciation rights. As a result of the clawback, the Company recorded other income of $67,920 representing the expense previously recognized for the vested portion of the Stock Appreciation Rights.

In June 2013, the Company granted its Chief Executive Officer, Chief Technology Officer and Chief Financial Officer 125,000 each ten-year options to purchase shares of common stock at an exercise price of $1.10 per share. The options vest in equal amounts annually on the anniversary date of the grant over three years, subject to continued employment. The Company valued the options at $317,963 using the Black-Scholes option pricing model using a volatility of 91.6%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 6.5 years, using the Simplified Method and a discount rate of 1.78%. The resulting expense will be recognized over the requisite service period of three years.

In July 2013, the Company issued ten year options to purchase 250,000 shares of common stock, each to its then Chief Executive Officer, Chief Technology Officer and Chief Financial Officer. The options have an exercise price of $1.30 per share and vest 50% upon the market value of the Company's common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company's common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period. The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 2.62%. The value of these options was estimated by management in accordance with ASC 718, which requires an estimate of the probability that these market conditions will occur and for the resulting discounted value be expensed immediately. Accordingly management has expensed $63,180 to stock compensation expense.

In July 2013, the Company granted 100,000 options to a new employee in connection with his employment. Of the options granted, 50,000 are exercisable at $1.25 per share and 50,000 are exercisable at $1.75 per share. Both grants are for a five year term vest 25% immediately and 75% in equal amounts over three years. The options were valued using the Black-Scholes model using a volatility of 91.61% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 4.0 years (using the simplified method) and a discount rate of 1.14%. The value of these options, $80,413 will be recognized as an expense over the requisite service period.

In July 2013, the Company granted ten year options to purchase 25,000 shares of the Company's common stock at an exercise price of $1.30 per share to the father of the Company's CEO and CTO in recognition of his service. The options vest over a three year period. The Company valued the options at $25,272 using the Black-Scholes option pricing model using a volatility of 91.72%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 1.5 years, using the Simplified Method and a discount rate of 2.61%.

In July 2013, the Board of Directors approved a pool of 400,000 options to be granted to employees at the discretion of the executive management of the Company. In September 2013, management granted 100,000 of these options to employees. The options vested immediately, are exercisable for five years and have an exercise price of $1.30 per share, the market value of our common stock on the date of the grant. The Company valued the options at $69,452 using the Black-Scholes option pricing model using a volatility of 91.72%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.45%. In December 2013, management granted 90,500 of these options to employees. The options vested immediately, are exercisable for five years and have an exercise price of $0.72 per share, the market value of our common stock on the date of the grant. The Company valued the options at $34,610 using the Black-Scholes option pricing model using a volatility of 90.96%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.55%. In February 2014, the Company granted an additional 5,000 fully vested options to an employee at an exercise price of $0.77 per share. The options were valued at $2,044 using the Black-Scholes option pricing model using a volatility of 90.968% to 90.96%, based upon the historical price of the Company's common stock since June 2008, estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.55%. The amount was recorded as expense during the year ended June 30, 2014. No additional grants from the pool were made during the year ended June 30, 2014.

In August 2013, the Company granted 150,000 stock settled Stock Appreciation Rights (SARS) to a new employee in connection with his employment. The SARS are exercisable at $1.52 per share, are for a five year term and vest 50,000 immediately and the remaining options will vest 33,334 upon the Company reaching $3 million in sales in any twelve month period, 33,333 upon the Company reaching sales of $5 million in any twelve month period and 33,333 upon the Company reaching sales of $6 million in any twelve month period. The SARS were valued using the Black-Scholes model using a volatility of 91.91% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 4.0 years (using the simplified method) and a discount rate of 1.97%. The value of these SARS, $176,413 will be recognized as expense over the period required to meet the performance criteria which is estimated to be approximately two years.

A summary of options issued to directors under the 2007 Plan and changes during the period from June 30, 2012 to June 30, 2013 and from June 30, 2013 to June 30, 2014 is as follows:

Options Issued to Directors

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		857,500		$	1.36		7.96
Granted		610,000		$	0.95		10.00
Exercised		(11,667	)	$	0.56		-
Forfeited		(255,000	)	$	1.38		-
Expired		-		$	-		-
Outstanding at June 30, 2013		1,200,833		$	1.16		8.04	$	165,386
Exercisable at June 30, 2013		795,168		$	1.24		7.25	$	98,654
Weighted average fair value of options granted during the year ended June 30, 2013				$	0.72
Balance at June 30, 2013		1,200,833		$	1.16		8.04
Granted		495,000		$	1.19		10.00
Exercised		(20,000	)	$	0.91		10.00
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at June 30, 2014		1,675,833		$	1.12		7.62	$	8,337
Exercisable at June 30, 2014		1,389,168		$	1.14		7.36	$	8,404
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.76

On July 1, 2012, as an automatic grant under the Equity Incentive Plan, the Company issued options to purchase 230,000 shares of common stock to directors. The options have an exercise price of $0.91 per share, vest on June 30, 2013¸ subject to continuing service as a director and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 91.04% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5.5 years (using the simplified method) and a discount rate of 0.82%. The value of these options will be recognized as expense over the requisite service period.

On December 6, 2012, the Company issued options to purchase 5,000 shares of common stock to a director upon his appointment to the audit committee. The options have an exercise price of $0.36 per share, and vest over three years, subject to continued service and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 89.86% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 0.90%. The value of these options, $1,360, will be recognized as expense over the requisite service period.

In March 2013, the Company granted each of its three non-employee directors ten year options to purchase 125,000 shares of common stock at an exercise price of $0.99 per share. The options vest annually over a three year period, subject to continued service as a director. The options were valued using the Black-Scholes model using a volatility of 93.11 (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.25%. The value of these options, $287,405, will be recognized as expense over the requisite service period.

In June 2013 in connection with the termination for cause of its former Executive Chairman, the Company clawed back options to purchase 255,000 shares of common stock with exercise prices from $0.91 to $1.95 per share previously granted to the Executive Chairman. In addition, the Company rescinded a grant of 800,000 restricted stock units with an exercise price of $0.45 per share, of which 200,000 had vested.

In July 2013, the Company issued ten year options to purchase 50,000 shares of common stock to a director. The options have an exercise price of $1.30 per share and vested immediately. The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 2.67%. The value of these options was recognized as expense during the year ended June 30, 2014.

In September 2013, the Company issued ten year options to purchase 15,000 shares of common stock to a director. The options have an exercise price of $1.01 per share and vested immediately. The options were valued using the Black-Scholes model using a volatility of 91.6% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5.0 years (using the simplified method) and a discount rate of 1.62%. The value of these options, $10,702, was recognized as expense during the year ended June 30, 2014.

In October 2013, the Company issued ten year options to purchase 60,000 shares of common stock at an exercise price of $1.17 per share to a new director. The options vest annually subject to continued service. The options were valued using the Black-Scholes model using a volatility of 91.94% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.89%. The value of these options, $54,285 will be recognized as expense over the vesting period.

A summary of options issued to non-employees, non-directors under the 2007 Plan and changes during the fiscal years ended June 30, 2014 and 2013 is as follows:

Non-Employee, Non-Director Options

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at June 30, 2012		540,000		$	1.16		3.14
Granted		275,000		$	1.23		10.00
Exercised		(100,000	)	$	0.50		-
Forfeited		-		$	-		-
Expired		(155,000	)	$	1.00		-
Outstanding at June 30, 2013		560,000		$	1.22		5.96	$	6,250
Exercisable at June 30, 2013		285,000		$	1.21		2.22	$	-
Weighted average fair value of options granted during the year ended June 30, 2013				$	1.00
Balance at June 30, 2013		560,000		$	1.22		5.96
Granted		25,000		$	1.11		5.00
Exercised		-		$	-		-
Forfeited		(275,000	)	$	1.23		-
Expired		(35,000	)	$	1.15		-
Outstanding at June 30, 2014		275,000		$	1.21		1.70	$	-
Exercisable at June 30, 2014		275,000		$	1.21		1.70	$	-
Weighted average fair value of options granted during the year ended June 30, 2014				$	0.79

In September 2012, the Company issued 100,000 shares of common stock in exchange for $50,000 in connection with the exercise of 100,000 options to purchase shares of the Company's common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise price of the options was $1.25 per share. The Company recognized a loss resulting from the reduction of the exercise price of the options exercised in the amount of $391 representing the difference in the fair market value of the repriced options as compared to the fair market value of the original options on the exercise date. The fair market value of the options was determined using the Black-Scholes options pricing model.

In March 2013, the Company granted ten year options to purchase 150,000 shares of common stock at an exercise price of $1.33 per share to a consultant. The options vest annually over a three year period, subject to continued service as a consultant. The options were valued using the Black-Scholes model using a volatility of 93.11 (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.23%. The value of these options, $154,415, will be recognized as expense over the requisite service period.

In June 2013, the Company granted a consultant ten-year options to purchase 125,000 shares of common stock at an exercise price of $1.10 per share. The options vest in equal amounts annually on the anniversary date of the grant over three years, subject to continued engagement as a consultant. The Company valued the options at $119,618 using the Black-Scholes option pricing model using a volatility of 91.6%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 10.0 years, the term of the option and a discount rate of 2.49%. The resulting expense will be recognized over the requisite service period, three years.

In October 2013, the Company granted five-year options to purchase 20,000 shares of common stock at an exercise price of $1.18 per share to two consultants. The Company valued the options at $16,670 using the Black-Scholes option pricing model using a volatility of 91.94%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 5.0 years, the term of the options and a discount rate of 1.38%.

In March 2014, the Company granted five-year fully vested options to purchase 5,000 shares of common stock at an exercise price of $0.85 per share to a consultant. The Company valued the options at $2,962 using the Black-Scholes option pricing model using a volatility of 89.96%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 5.0 years, the term of the options and a discount rate of 1.76%. The expense was recognized during the three months ended March 31, 2014.

Warrants Issued as Settlements

	Number of Warrants			Weighted Average Exercise Price		Remaining Contractual Life
Balance at June 30, 2012		344,508		$	1.05		0.92
Granted		350,000		$	0.63		5.00
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		(344,508	)	$	1.05		-
Outstanding at June 30, 2013		350,000		$	0.63		4.22
Exercisable at June 30, 2013		350,000		$	0.63		4.22
Weighted average fair value of warrants granted during the year ended June 30, 2013				$	0.33
Balance at June 30, 2013		350,000		$	0.63		4.22
Granted		-		$	-		-
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at June 30, 2014		350,000		$	0.63		3.22
Exercisable at June 30, 2014		350,000		$	0.63		3.22
Weighted average fair value of warrants granted during the year ended June 30, 2014					N/A

On September 21, 2012, the Company granted five year warrants to purchase 350,000 shares of the Company's common stock at an exercise price of $0.63 per share to a director in recognition of his exemplary five years of service to the Company. The warrants vested immediately. The Company valued the warrants at $115,883 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.32%.

In May 2013, warrants to purchase 344,058 shares of common stock at an exercise price of $1.05 per share held by a director expired.

A summary of warrants issued for cash and changes during the periods June 30, 2012 to June 30, 2013 and from June 30, 2013 to June 30, 2014 is as follows:

Warrants issued for cash or services

	Number of Warrants			Weighted Average Exercise Price		Remaining Contractual Life
Balance at June 30, 2012		4,461,200		$	1.46		2.46
Granted		362,500		$	1.16		10.00
Exercised		(1,865,000	)	$	0.50		-
Forfeited		-		$	-		-
Expired		(1,425,000	)	$	1.60		-
Outstanding at June 30, 2013		1,533,700		$	1.25		2.06
Exercisable at June 30, 2013		1,533,700		$	1.25		2.06
Weighted average fair value of warrants granted during the year ended June 30, 2013				$	0.44
Balance at June 30, 2013		1,533,700		$	1.25		2.06
Granted		1,863,421		$	1.58		3.53
Exercised		(20,000	)	$	1.25		-
Forfeited		-		$	-		-
Expired		(340,000	)	$	1.60		-
Outstanding at June 30, 2014		3,037,121		$	1.45		2.73
Exercisable at June 30, 2014		3,037,121		$	1.45		2.73
Weighted average fair value of warrants granted during the year ended June 30, 2014					N/A

On September 21, 2012, the Company granted five year warrants to purchase 50,000 shares of the Company's common stock at an exercise price of $0.63 per share to the Company's Investor Relations firm in recognition of their performance over the past year. The warrants vested immediately. The Company valued the warrants at $21,787 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 5 years, the term of the warrants, and a discount rate of 0.70%.

During the year ended June 30, 2013, the Company issued 1,820,000 shares of common stock in exchange for $910,000 in connection with the exercise of 1,820,000 warrants to purchase shares of the Company's common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise prices of the warrants ranged from $1.25 to $1.75 per share. The cost of repricing warrants recognized by the Company amounted to $70,491 for the year ended June 30, 2013. The cost represents the incremental increase in the fair value of the repriced warrants as compared to the original warrants granted, valued on the exercise date. The fair value of the warrants was determined using the Black-Scholes option pricing model.

In March 2013, the Company issued 9,171 shares of common stock in connection with the cashless exercise of warrants to purchase 45,000 shares of common stock with an exercise price of $1.25 and a fair market value of the Company's common stock of $1.57 on the date of exercise.

In May 2013, the Company issued five year warrants to purchase 312,500 shares of common stock at an exercise price of $1.25 per share in connection with two private placements with its Chief Operating Officer and principal stockholder.

During the year ended June 30, 2013, warrants to purchase 1,425,000 shares of the Company's common stock at an exercise price of $1.60 per share expired unexercised.

In July 2013, the Company issued five year warrants to purchase 29,412 shares of common stock at an exercise price of $1.30 per share in connection with a private placement with an accredited investor.

In July 2013, the Company issued five year warrants to purchase 500,000 shares of common stock at an exercise price of $1.30 per share to its principal stockholder in connection with a $1.0 million convertible note agreement.

In August 2013, the Company issued 20,000 shares of common stock in exchange for $25,000 in connection with the exercise of warrants with an exercise price of $1.25 per share.

In October 2013, the Company issued five year warrants to purchase 100,000 shares of common stock at an exercise price of $1.00 per share in connection with a private placement with its principal shareholder.

In October 2013, the Company issued five year warrants to purchase 200,000 shares of common stock at an exercise price of $1.00 per share in connection with private placements with a director and his wife.

In October 2013, the Company issued five year warrants to purchase 120,000 shares of common stock at an exercise price of $1.00 per share in connection with private placements with three accredited investors.

During the year ended June 30, 2014, warrants to purchase 360,000 shares of common stock at an exercise price of $1.25 per share expired unexercised.

Options to Purchase Common Stock and Stock Appreciation Rights

Stock-based compensation expense recognized under ASC 718-10 for the fiscal years ended June 30, 2014 and 2013 was $1,682,833 and $1,497,534, respectively, for stock options and stock appreciation rights granted to employees, directors and a consultant. This expense is included in selling, general and administrative expenses in the consolidated statements of operations. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. At June 30, 2014, the total compensation cost for stock options and stock appreciation rights not yet recognized is $836,656. This cost will be recognized over the remaining vesting term of the options and stock appreciation rights of approximately five years.

XML

INCOME TAXES

12 Months Ended

Jun. 30, 2014

INCOME TAXES [Abstract]

INCOME TAXES

8.

INCOME TAXES

Due to the net losses incurred, there was no income tax provision for the fiscal years ended June 30, 2014 and 2013. Deferred tax assets and liabilities as of June 30, 2014 and 2013, were as follows:

	June 30, 2014			June 30, 2013
Net operating loss carryforward	$	10,754,202		$	8,817,486
Allowance for bad debt		38,051			15,250
Stock-based compensation		1,493,004			1,304,426
Less: Deferred tax liability - depreciation		(2,627	)		(9,557	)
Net deferred tax assets		12,282,630			10,127,605
Less valuation allowance		(12,282,630	)		(10,127,605	)
Net deferred tax asset	$	-		$	-

The Company had available at June 30, 2014, net operating loss carryforwards for federal and state tax purposes of approximately $28,578,798 that could be applied against taxable income in subsequent years through June 30, 2034. The amount of net operating loss carryforward that can offset future taxable income may be limited in accordance with IRC Section 382 following certain ownership changes.

Based on the weight of available evidence, both positive and negative, a valuation allowance to fully provide for the net deferred tax assets has been recorded since it is more likely than not that the deferred tax assets will not be realized. The valuation allowance was increased by $2,155,025 during fiscal year ended June 30, 2014.

Reconciliation of the differences between income tax benefit computed at the federal and state statutory tax rates and the provision for income tax benefit for the fiscal years ended June 30, 2014 and 2013 was as follows:

	For the Fiscal Year Ended June 30,
	2014						2013
	Amount			%			Amount			%
Tax at U.S. statutory rate	$	(2,401,741	)		-34.00	%	$	(1,775,395	)		-34.00	%
State taxes, net of federal benefit		(255,305	)		-3.61	%		(188,025	)		-3.60	%
Other		502,021			7.10	%		(66,830	)		-1.28	%
Change in valuation allowance		2,155,025			30.51	%		2,030,250			38.88	%
	$	-			0.00	%	$	-			0.00	%

XML

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Jun. 30, 2014

COMMITMENTS AND CONTINGENCIES [Abstract]

COMMITMENTS AND CONTINGENCIES

10.

COMMITMENTS AND CONTINGENCIES

The Company leases office and warehouse space located in Jupiter, Florida and rents space in an industrial yard in Irvine, California under a month-to-month lease. In February 2013, the Company entered into a one year lease agreement for a support facility in Brooklyn, New York at a monthly rent of $3,600. In February 2014, the Company extended the lease at a monthly rent of $4,000. Effective August 31, 2014 the Company terminated the lease. Rent expense for the fiscal year ended June 30, 2014 and 2013 was $169,547 and $143,614, respectively.

On November 14, 2012, the Compensation Committee approved new employment agreements for the Company's then Chief Executive Officer, then President, Chief Technology Officer and Chief Financial Officer. The employment agreements each provide for base salaries of $150,000 and 800,000 stock settled stock appreciation rights ("SARS") of which (i) 200,000 vested immediately, (ii) 200,000 vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 vest upon the Company generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period. The Company's then Chief Executive Officer, then President and Chief Technology Officer agreed to cancel the 250,000 stock options granted to each of them in their prior employment agreements. These executives' base salary will increase to: (i) $170,000 upon the Company generating $3,000,000 in revenue in any 12-month period, (ii) $190,000 upon the Company generating $5,000,000 in any 12-month period and (iii) $200,000 upon the Company generating $6,000,000 in any 12-month period.

Additionally, the Compensation Committee approved a four-year employment agreement for the Company's Executive Chairman. Prior to his employment agreement being terminated for cause, the Executive Chairman received a base salary of $200,000 per year and was granted 800,000 restricted stock units vesting on identical terms as the SARs (which have been cancelled). All of the five senior executives receive (or were to receive prior to the terminations of their employment) a monthly car allowance of $600 per month. The Compensation Committee has the discretion to award each of the employed executives a bonus based upon job performance, revenue growth or any other factors determined by the Compensation Committee.

In August 2011, the Company entered into a settlement agreement with a former shareholder of Dyn-O-Mat, the Company's predecessor. At the time of the Company's formation, the Company was unable to contact the investor in order to offer the investor shares of GelTech in exchange for the investor's shares of Dyn-O-Mat. The investor came forward in May 2011 seeking to receive the same offer made to Dyn-O-Mat shareholders in 2007. Under the settlement agreement, the Company paid the investor $50,000, which has been recorded as a loss on settlement as of June 30, 2011. In addition, the Company's Chief Technology Officer and his father agreed to pay the investor an additional $125,000 prior to December 31, 2011. As of June 30, 2013, this amount has not yet been paid.

The Company was sued by a former employee on June 23, 2008, alleging breach of a consulting agreement and an employment agreement entered into in May and June 2007, respectively. In addition, the plaintiff seeks to recover certain of his personal property, which was used or stored in the Company's offices, and alleges the Company invaded his privacy by looking at his personal computer (which was used in the Company's business) in the Company's offices. A jury trial was held for the lawsuit in July 2012. At the conclusion of the trial, the plaintiff was awarded $200,000 under his invasion of privacy and fraudulent misrepresentation claim, $5,000 on the trespass claim,$841,000 on the breach of consulting agreement claim and $200,000 against the Company's CEO on a claim of civil theft, which by law results in an award of $600,000 for the plaintiff. The Company's board of directors approved the indemnification of the Company's CEO for the $600,000. The Company filed a post-trial motion for Judgment Notwithstanding Verdict, New Trial and Remittitur, requesting that the judge set aside or reduce the amounts of the jury verdict.

Based upon the verdicts, the Company recorded a litigation accrual of $1,646,000 as of June 30, 2012. In November 2012, the insurance carrier paid the plaintiff $200,000 in settlement of the invasion of privacy and fraudulent misrepresentation awards. As a result, the Company reduced the amounts accrued for these awards resulting in other income of $200,000 for the period ended December 31, 2012.

In January 2013, the court ruled on the Company's post-trial motions in this litigation dismissing the $200,000 civil theft verdict (which was subject to triple damages) against the CEO and reducing the $841,000 breach of the consulting agreement award to $500,000. The Company then filed a motion seeking a new trial on damages. The Company received a favorable ruling on this motion and received a new trial on the damages. As a result of the reduction in the award for breach of the consulting agreement from $841,000 to $500,000 and the vacating of the award for civil theft which the Company had previously accrued $600,000, the Company recorded other income of $941,000 for the year ended June 30, 2013. The Company expects the trial to determine damages took place in September 2014. Each side has until October 14, 2014 to file briefs and proposed orders to the court, after which the judge will review the briefs and consider the trial testimony in rendering a decision.

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Preferred Stock) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value per share	$ 0.001	$ 0.001

XML

INVENTORIES (Tables)

12 Months Ended

Jun. 30, 2014

INVENTORIES [Abstract]

Schedule of Inventories

Inventories consisted of the following at June 30, 2014 and 2013:

	2014		2013
Finished goods	$	491,409	$	333,987
Raw materials		352,455		254,716
	$	843,864	$	588,703

XML

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Property, Plant and Equipment [Line Items]
Demonstration costs	$ 4,195	$ 10,889
Shipping and handling costs related to sales of products	52,594	51,943
Research and development	274,005	179,158
Advertising costs	$ 42,575	$ 26,931
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares considered antidilutive	9,742,840
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares considered antidilutive	3,387,121
Stock Options For Convertible Notes Reserved [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares considered antidilutive	6,707,094
Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years

XML

SUBSEQUENT EVENTS (Details) (USD $)	12 Months Ended			12 Months Ended					12 Months Ended	1 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Oct. 31, 2012	Jun. 30, 2014 Private Placement [Member]	Jun. 30, 2014 Stock Options [Member]	Jun. 30, 2013 Stock Options [Member]	Aug. 31, 2013 Warrants [Member]	Mar. 31, 2013 Warrants [Member]	Jun. 30, 2014 COO and Principal Shareholder [Member] Private Placement [Member]	May 31, 2013 COO and Principal Shareholder [Member] Warrants [Member]	Oct. 31, 2013 Director [Member] Stock Options [Member]	Sep. 30, 2013 Director [Member] Stock Options [Member]	Jul. 31, 2013 Director [Member] Stock Options [Member]	Mar. 31, 2013 Director [Member] Stock Options [Member]	Dec. 31, 2012 Director [Member] Stock Options [Member]	Jul. 31, 2012 Director [Member] Stock Options [Member]	Sep. 30, 2012 Director [Member] Warrants [Member]	Jul. 31, 2014 Subsequent Event [Member] Private Placement [Member]	Jul. 31, 2014 Subsequent Event [Member] Warrants [Member] Private Placement [Member]	Jul. 31, 2014 Subsequent Event [Member] COO and Principal Shareholder [Member] Private Placement [Member]	Jul. 31, 2014 Subsequent Event [Member] COO and Principal Shareholder [Member] Convertible Note [Member]	Jul. 31, 2014 Subsequent Event [Member] Director [Member] Stock Options [Member]
Subsequent Event [Line Items]
Common stock issued for interest, shares																					107,143
Accrued interest																					$ 75,000
Options granted					1,425,500	4,622,500					60,000	15,000	50,000	125,000	5,000	230,000						470,000
Options granted, exercise price					$ 1.34	$ 0.55					$ 1.17	$ 1.01	$ 1.30	$ 0.99	$ 0.36	$ 0.91						$ 0.70
Vesting date																						Jun. 30, 2015
Term										5 years	10 years	10 years	10 years	10 years	10 years	10 years	5 years		2 years			10 years
Volatility rate											91.94%	91.60%	93.11%	93.11%	89.86%	91.04%	90.09%					88.55%
Expected term											6 years 6 months	5 years	6 years 6 months	6 years 6 months	6 years 6 months	5 years 6 months	2 years 6 months					5 years 6 months
Discount rate											1.89%	1.62%	2.67%	1.25%	0.90%	0.82%	0.32%					1.79%
Common stock and warrants issued for cash, shares				2,575,579					1,817,932									1,855,188		1,603,087
Number of shares callable by warrants				1,258,378					908,966	312,500							350,000	906,586		801,544
Exercise price of shares called by warrants			$ 0.50				$ 1.25	$ 1.25		$ 1.25							$ 0.63	$ 2.00
Proceeds from the sale of stock and warrants through private placements	$ 1,705,000	$ 300,000		$ 1,705,000					$ 1,125,000									$ 1,025,000		$ 850,000

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Narrative) (Warrant) (Details) (USD $)	1 Months Ended	3 Months Ended	12 Months Ended		1 Months Ended		12 Months Ended			1 Months Ended			12 Months Ended						1 Months Ended
	Oct. 31, 2012	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Aug. 31, 2013 Common Stock [Member]	Mar. 31, 2013 Common Stock [Member]	Jun. 30, 2013 Common Stock [Member]	Jun. 30, 2014 Maximum [Member]	Feb. 28, 2013 Chief Operating Officer [Member] Common Stock [Member]	Aug. 31, 2013 Warrant [Member]	Mar. 31, 2013 Warrant [Member]	Sep. 30, 2012 Warrant [Member]	Jun. 30, 2014 Warrant [Member]	Jun. 30, 2013 Warrant [Member]	Jun. 30, 2014 Warrant [Member] Common Stock [Member]	Jun. 30, 2013 Warrant [Member] Common Stock [Member]	Jun. 30, 2013 Warrant [Member] Minimum [Member] Common Stock [Member]	Jun. 30, 2013 Warrant [Member] Maximum [Member] Common Stock [Member]	Sep. 30, 2012 Warrant [Member] Director [Member]	May 31, 2013 Warrant [Member] Director [Member] Common Stock [Member]	Sep. 30, 2012 Warrant [Member] Investor Relations Firm [Member]	May 31, 2013 Warrant [Member] Chief Operating Officer [Member]	Oct. 31, 2013 Warrant [Member] Investor [Member]	Jul. 31, 2013 Warrant [Member] Investor [Member]	Oct. 31, 2013 Warrant [Member] Principal Stockholder [Member]	Jul. 31, 2013 Warrant [Member] Principal Stockholder [Member]	Oct. 31, 2013 Warrant [Member] Director and his wife [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term								10 years											5 years		5 years	5 years	5 years	5 years	5 years	5 years	5 years
Number of shares callable by warrants						45,000													350,000		50,000	312,500	120,000	29,412	100,000	500,000	200,000
Exercise price of shares called by warrants	$ 0.50				$ 1.25	$ 1.25				$ 1.25	$ 1.25								$ 0.63		$ 0.63	$ 1.25	$ 1.00	$ 1.30	$ 1.00	$ 1.30	$ 1.00
Fair value																			$ 115,883		$ 21,787
Volatility rate																			90.09%		90.09%
Expected term																			2 years 6 months		5 years
Discount rate																			0.32%		0.70%
Warrants expired													340,000	1,425,000	360,000	1,425,000				344,058
Warrants expired, exercise price													$ 1.60	$ 1.60	$ 1.25	$ 1.60				$ 1.05
Warrants exercised, shares issued					20,000	9,171	1,820,000
Proceeds from exercise of warrants	40,000		25,000	910,000	25,000					25,000
Warrants exercised											45,000	1,640,000	20,000	1,865,000		1,820,000
Warrants exercised, exercise price													$ 1.25	$ 0.50		$ 0.50
Warrants exercisable, exercise price													$ 1.45	$ 1.25			$ 1.25	$ 1.75
Cost of repricing warrants to induce exercise		70,491		70,491
Fair market value, price per share						$ 1.57			$ 0.37		$ 1.57
Convertible note, amount																										$ 1,000,000

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]
Balance at Jun. 30, 2012	$ (2,965,902)	$ 24,914	$ 19,809,070	$ (22,799,886)
Balance, shares at Jun. 30, 2012		24,914,474
Common stock issued for cash	1,658,000	3,539	1,654,461
Common stock issued, shares		3,539,321
Common stock issued in connection with stock purchase agreement	810,003	1,334	808,669
Common stock issued in connection with stock purchase agreement, shares		1,333,820
Common stock and warrants issued for cash	300,000	375	299,625
Common stock and warrants issued for cash, shares		375,000
Common stock upon exercise of options	6,534	12	6,522
Common stock upon exercise of options, shares		11,667
Common stock issued upon exercise of warrants	910,000	1,829	908,171
Common stock issued upon exercise of warrants, shares		1,829,171
Common stock issued for interest	77,784	210	77,574
Common stock issued for interest, shares		210,226
Grant of restricted stock units	90,000	200	89,800
Grant of restricted stock units, shares		200,000
Convertible note conversions	435,495	871	434,624
Convertible note conversions, shares		870,992
Cancellation of restricted stock units grant under clawback provision	(90,000)	(200)	(89,800)
Cancellation of restricted stock units grant under clawback provision, shares		(200,000)
Options and stock appreciation rights vested	1,407,534		1,407,534
Beneficial conversion feature of debt offerings	309,342		309,342
Cost of repricing warrants to induce warrant exercise	70,491		70,491
Cancellation of stock appreciation rights grant under clawback provision	(67,920)		(67,920)
Net loss	(5,221,747)			(5,221,747)
Balance at Jun. 30, 2013	(2,270,386)	33,084	25,718,163	(28,021,633)
Balance, shares at Jun. 30, 2013	33,084,671	33,084,671
Common stock issued for cash	2,131,527	3,353	2,128,174
Common stock issued, shares		3,352,726
Common stock issued in connection with stock purchase agreement	570,000	577	569,423
Common stock issued in connection with stock purchase agreement, shares		577,428
Common stock and warrants issued for cash	1,705,000	2,576	1,702,424
Common stock and warrants issued for cash, shares		2,575,579
Common stock upon exercise of options	18,200	20	18,180
Common stock upon exercise of options, shares		20,000
Common stock issued upon exercise of warrants	25,000	20	24,980
Common stock issued upon exercise of warrants, shares		20,000
Common stock issued for interest	355,426	437	354,989
Common stock issued for interest, shares		436,912
Convertible note conversions	82,132	235	81,897
Convertible note conversions, shares		234,663
Options and stock appreciation rights vested	1,682,833		1,682,833
Beneficial conversion feature of debt offerings	913,898		913,898
Net loss	(7,111,945)			(7,111,945)
Balance at Jun. 30, 2014	$ (1,898,315)	$ 40,302	$ 33,194,961	$ (35,133,578)
Balance, shares at Jun. 30, 2014	40,301,979	40,301,979

XML

INVENTORIES

12 Months Ended

Jun. 30, 2014

INVENTORIES [Abstract]

INVENTORIES

4.

INVENTORIES

Inventories consisted of the following at June 30, 2014 and 2013:

	2014		2013
Finished goods	$	491,409	$	333,987
Raw materials		352,455		254,716
	$	843,864	$	588,703

XML

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Stock-Based Compensation) (Details) (USD $)	12 Months Ended					12 Months Ended				1 Months Ended			12 Months Ended							1 Months Ended						12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Sep. 30, 2008	Jan. 31, 2007	Jun. 30, 2014 Maximum [Member]	Jun. 30, 2014 Chairman of the Board [Member] Initial Grants [Member]	Jun. 30, 2014 Chairman of the Board [Member] Annual Grants [Member]	Jun. 30, 2014 Director [Member] Initial Grants [Member]	Jun. 30, 2013 Director [Member] Annual Grants [Member]	Apr. 30, 2010 Director [Member] Annual Grants [Member]	Mar. 31, 2010 Director [Member] Annual Grants [Member]	Jun. 30, 2014 Director [Member] Annual Grants [Member]	Jun. 30, 2014 Chair of a Committee [Member] Initial Grants [Member]	Jun. 30, 2014 Chair of a Committee [Member] Annual Grants [Member]	Jun. 30, 2014 Member of a Committee [Member] Initial Grants [Member]	Jun. 30, 2014 Member of a Committee [Member] Annual Grants [Member]	Jun. 30, 2014 Stock Options [Member]	Jun. 30, 2013 Stock Options [Member]	Oct. 31, 2013 Stock Options [Member] Director [Member]	Sep. 30, 2013 Stock Options [Member] Director [Member]	Jul. 31, 2013 Stock Options [Member] Director [Member]	Mar. 31, 2013 Stock Options [Member] Director [Member]	Dec. 31, 2012 Stock Options [Member] Director [Member]	Jul. 31, 2012 Stock Options [Member] Director [Member]	Jun. 30, 2014 Non-Employee, Non-Director Options [Member]	Jun. 30, 2013 Non-Employee, Non-Director Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 1,682,833	$ 1,497,534																$ 1,680,358	$ 1,480,377							$ 2,475	$ 17,157
Unrecognized compensation expense	$ 836,656																				$ 10,702		$ 287,405	$ 1,360
Shares authorized		15,000,000	4,500,000	3,500,000	1,500,000
Options granted							50,000	70,000	30,000	100,000	50,000	20,000	100,000	10,000	20,000	5,000	10,000	1,425,500	4,622,500	60,000	15,000	50,000	125,000	5,000	230,000	25,000	275,000
Vesting period							3 years		3 years					3 years		3 years							3 years	3 years
Minimum percentage of fair market price for an exercise price, exceeding benchmark ownership percentage	110.00%
Percentage of ownership of outstanding stock, benchmark	10.00%
Term						10 years														10 years	10 years	10 years	10 years	10 years	10 years

XML

STOCKHOLDERS' EQUITY (DEFICIT) (Schedule of Stock Options Activity) (Details) (USD $)	1 Months Ended		12 Months Ended
	Sep. 30, 2012	Feb. 28, 2013 Employee Options and Stock Appreciation Rights [Member]	Jun. 30, 2014 Employee Options and Stock Appreciation Rights [Member]	Jun. 30, 2013 Employee Options and Stock Appreciation Rights [Member]	Jun. 30, 2012 Employee Options and Stock Appreciation Rights [Member]	Jun. 30, 2014 Options Issued to Directors [Member]	Jun. 30, 2013 Options Issued to Directors [Member]	Jun. 30, 2012 Options Issued to Directors [Member]	Jun. 30, 2014 Non-Employee, Non-Director Options [Member]	Jun. 30, 2013 Non-Employee, Non-Director Options [Member]	Jun. 30, 2012 Non-Employee, Non-Director Options [Member]
Number of Options
Balance			6,337,007	4,589,507		1,200,833	857,500		560,000	540,000
Granted			1,425,500	4,622,500		495,000	610,000		25,000	275,000
Exercised	(100,000)					(20,000)	(11,667)			(100,000)
Forfeited		(1,325,000)		(2,875,000)			(255,000)		(275,000)
Expired									(35,000)	(155,000)
Outstanding			7,762,007	6,337,007	4,589,507	1,675,833	1,200,833	857,500	275,000	560,000	540,000
Exercisable			4,352,674	3,696,174		1,389,168	795,168		275,000	285,000
Weighted Average Exercise Price
Balance			$ 0.75	$ 1.04		$ 1.16	$ 1.36		$ 1.22	$ 1.16
Granted			$ 1.34	$ 0.55		$ 1.19	$ 0.95		$ 1.11	$ 1.23
Exercised						$ 0.91	$ 0.56			$ 0.50
Forfeited				$ 0.92			$ 1.38		$ 1.23
Expired									$ 1.15	$ 1.00
Outstanding			$ 0.87	$ 0.75	$ 1.04	$ 1.12	$ 1.16	$ 1.36	$ 1.21	$ 1.22	$ 1.16
Exercisable			$ 0.93	$ 0.90		$ 1.14	$ 1.24		$ 1.21	$ 1.21
Weighted average fair value of options granted			$ 0.69	$ 0.41		$ 0.76	$ 0.72		$ 0.79	$ 1.00
Weighted Average Remaining Contractual Life
Granted			7 years 9 months 22 days	9 years 7 months 21 days		10 years	10 years		5 years	10 years
Exercised						10 years
Outstanding			5 years 11 months 23 days	6 years 7 months 13 days	5 years 11 months 12 days	7 years 7 months 13 days	8 years 15 days	7 years 11 months 16 days	1 year 8 months 12 days	5 years 11 months 16 days	3 years 1 month 21 days
Exercisable			4 years 6 months 18 days	5 years 8 months 12 days		7 years 4 months 10 days	7 years 3 months		1 year 8 months 12 days	2 years 2 months 19 days
Aggregate Intrinsic Value
Outstanding			$ 792,305	$ 2,505,808		$ 8,337	$ 165,386			$ 6,250
Exercisable			$ 265,364	$ 1,056,738		$ 8,404	$ 98,654

XML

ACCOUNTS RECEIVABLE (Tables)

12 Months Ended

Jun. 30, 2014

ACCOUNTS RECEIVABLE [Abstract]

Schedule of Accounts Receivable

Accounts receivable at June 30, 2014 and 2013 was as follows:

	2014			2013
Accounts receivable	$	95,869		$	77,802
Allowance for doubtful accounts		(60,593	)		(40,525	)
	$	35,276		$	37,277